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Summary 
Colloidal systems are increasingly being used in consumer products. Special 
interest is drawn to their application as delivery vehicles. To this end, there is the 
need of novel synthesis methods to produce colloids with tailored size and 
morphology in absence of harsh conditions and toxic constituents. One exceptional 
material for such purposes is calcium carbonate (CaCO3), as it can be synthesized 
in mild conditions besides being endogenous to the body, safe, biodegradable and 
biocompatible. Yet, there are still limitations that could hinder its use as a viable 
delivery system, e.g. shortcomings regarding the morphological and size control, 
the particle instability in aqueous solutions as well as in the sustained release of 
encapsulated molecules. In this thesis, these aspects are studied in detail and new 
strategies are explored for the preparation of suitable colloidal carriers with 
biocompatible cellular interactions. To this purpose, distinct principles that govern 
biomineralization and complex coacervation are translated to synthetic systems and 
assessed in vitro by means of monoculture cellular experiments. These principles 
include: (1) the use of charged proteins and polymers as the assembling 
components during the complex coacervation; (2) the use of polyelectrolytes 
molecules to direct the mesoscale assembly of anisotropic nanoparticles; and (3) 
the study on how the physical and colloidal properties of CaCO3 systems can 
control particle-cellular interactions. 
The first project studied a combination of complex coacervation and CaCO3 
mineralization to produce pH-responsive microcarriers loaded with proteins. 
Complex coacervation is a phenomenon that occurs when two or more oppositely 
charged molecules (e.g. negatively-charged poly(acrylic acid) (PAA) and Ca2+ 
ions) form electrostatic complexes in aqueous solution. In this case, the 
complexation leads to the phase separation of fluid-like coacervate droplets, which 
are subjected to coalescence and growth. Accordingly, the size of these droplets 
increases with complexation time. By the addition of sodium carbonate, the 
droplets are mineralized into stable, amorphous CaCO3 microcarriers. It is 
hypothesized that charged proteins could also comprise one of the assembling 
components of the complex coacervate droplets. For that purpose, both positively-
charged lysozyme (LSZ) and negatively-charged bovine serum albumin (BSA) are 
added to the coacervation reaction and their encapsulation and release behavior are 
assessed. It is shown that positively-charged LSZ strongly binds to the coacervate 
droplets due to electrostatic attraction, which disturbs the coalescence and growth 
processes and limits the control of particle size. This results in highly-loaded 
CaCO3 particles in the micrometer range. On the other hand, negatively-charged 
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BSA is barely encapsulated due to repulsive forces between BSA molecules and 
coacervate droplets. As a consequence of low BSA-PAA coordination, the particle 
size of BSA-loaded carriers is similar to the unloaded ones. 
In a second approach, a platform for the synthesis of functional hybrid 
nanoparticles with tailorable morphology is described based on the controlled 
mesoscale self-assembly process. In this study, the precipitation of CaCO3 primary 
nanoparticles can be modulated by the presence of highly-carboxylated carbon dot 
nanoparticles (CDs). At higher particle concentration, the calcium supersaturation 
is lowered due to carboxyl-calcium coordination, which avoids the precipitation of 
microsized crystals in aqueous solution. Moreover, it is shown that the high density 
of carboxylic groups on the CD surface sequestered enough calcium ions to serve 
as templates for heterogeneous CaCO3 precipitation. These primary particles 
afterwards self-assemble into spheres or rods depending on the PAA concentration. 
At increasing polymer concentration, oriented assembly becomes more prevalent 
yielding rod-like particles. The hybrid particles show colloidal stability in cell 
medium and absence of cytotoxicity towards adenocarcinomic cells. Moreover, 
due to the particles porosity, Rhodamine B can be encapsulated and the release 
triggered by adjusting the environmental pH. 
Besides the two mentioned methods to control size, crystallinity and morphology 
of calcium carbonate carriers, the understanding of cellular interaction also plays 
an important role in the design of drug delivery vehicles. The high solubility of 
CaCO3 in aqueous solutions can hinder its use as a novel delivery system. These 
particles are shown to either readily dissolve or to phase-transition into more stable 
phases depending on the ionic strength of the medium, on particle size and on 
crystallinity. In order to understand how the physical properties, like size, 
morphology and crystallinity can influence the phase stability and cellular 
response, four calcium carbonate particle systems commonly described in the 
literature are assessed with regard to colloidal stability, phase transformation, 
cytotoxic effects and cellular internalization. In this study, the calcite nanoparticles 
maintain the morphological features as no phase transformation occurs within the 
timeframe of the experiments. However, the vaterite particles transform to calcite 
phase in cell culture medium. This transition is shown to be size-depend and can be 
effective hindered by supplementing the medium with the protein serum albumin. 
In regard to the dissolution behavior, the amorphous phase is the only one affected, 
being more pronounced in the presence of amino acids and phosphate ions. In 
addition to the stability experiments, the cellular responses against human 
osteoblasts indicate that increased extracellular and intracellular calcium 
concentration can improve the cellular viability as well as shows that particle 
internalization can occur within 24 hours for a large range of particle sizes. 
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In conclusion, this thesis focuses on the use of essential biomineralization concepts 
aiming to prepare CaCO3-based delivery vehicles with appropriate size and 
morphology. The studies focused on the loading ability, colloidal and crystal phase 
stability as well as cellular outcome. In a general way, the results presented here 
are of high interest to researchers focused on the aqueous-based synthesis of 
CaCO3 particles, in the in vitro cellular interactions of CaCO3 and in the design of 
biodegradable delivery vehicles with improved cellular uptake and viability. 
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Zusammenfassung 
Kolloidale Systeme werden zunehmend in Konsumgütern eingesetzt. Dabei ist die 
Anwendung als Wirkstoffträger von besonderem Interesse. Zu diesem Zweck ist 
die Entwicklung von neuartigen Syntheseverfahren notwendig, mit welchen 
Kolloide mit maßgeschneiderter Größe und Morphologie in Abwesenheit von 
harten Bedingungen und Schadstoffen produziert werden können. Ein 
vielversprechendes Material für solche Zwecke ist Calciumcarbonat (CaCO3), da 
es unter milden Bedingungen synthetisiert werden kann und für den Körper 
endogen ist. Weiterhin ist es sicher, biologisch abbaubar und biokompatibel. 
Dennoch gibt es noch Einschränkungen bezüglich der morphologischen Kontrolle 
von Partikeln, in der Partikel-Instabilität in wässrigen Lösungen sowie in der 
Beladungs- und Freisetzungskapazität, die die Verwendung von CaCO3 
Nanopartikeln erschwerenkönnten. In dieser Arbeit werden diese Aspekte 
detailliert untersucht und neue Strategien zur Herstellung geeigneter kolloidaler 
Träger mit biokompatiblen zellulären Wechselwirkungen untersucht. Dazu werden 
verschiedene Prinzipien, welche die Biomineralisierung und die komplexe 
Koazervation bestimmen, in synthetischen Systeme umgesetzt und in vitro beurteilt 
werden. Diese Prinzipien beinhalten: (1) die Verwendung von geladenen Proteinen 
und Polymeren als Bausteine während der komplexen Koazervation; (2) die 
Verwendung von Polyelektrolytmolekülen, um die mesoskalige Anordnung von 
anisotropen Bausteinen zu leiten; und (3) die Studie darüber, wie die 
physikalischen und kolloidalen Eigenschaften der CaCO3 Systeme 
Wechselwirkungen zwischen Partikeln und Zellen kontrollieren. 
Das erste Projekt nutzt eine Kombination aus komplexer Koazervation und CaCO3-
Mineralisierung, um pH-responsive Mikroträger zu produzieren, die mit Proteinen 
beladen sind. Komplexe Koazervation ist ein Phänomen, das auftritt, wenn zwei 
oder mehr entgegengesetzte geladene Moleküle (z. B. negativ geladene 
Poly(acrylsäure) (PAA) und Ca2+-Ionen) elektrostatische Komplexe in wässriger 
Lösung bilden. In diesen Fällen führt die Bildung von Komplexen zur 
Phasentrennung von flüssigkeitsähnlichen Koazervat-Tröpfchen, die einer 
Koaleszenz und einem Wachstum ausgesetzt sind. Dementsprechend nimmt die 
Größe der Tröpfchen mit der Komplexierungszeit zu. Durch die Zugabe von 
Natriumcarbonat werden diese Tröpfchen zu stabilen, amorphen CaCO3-
Mikroträgern mineralisiert. Es wird vermutet, dass geladene Proteine auch eine der 
Zusammenbaukomponenten der komplexen Koazervat-Tröpfchen enthalten 
können. Zu diesem Zweck werden sowohl positiv geladenes Lysozym (LSZ) als 
auch negativ geladenes Rinderserumalbumin (BSA) der Koazervierungsreaktion 
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zugegeben und deren Einkapselungs- und Freisetzungsverhalten beurteilt. Es zeigt 
sich, dass positiv geladenes LSZ aufgrund der elektrostatischen Anziehung stark an 
die Koazervattröpfchen bindet und damit den Koaleszenz- und Wachstumsprozess 
stört. Dies führt zu hochbelasteten, großen CaCO3-Partikeln mit minimaler 
Kontrolle über die Größe. Andererseits ist das negativ geladene BSA aufgrund von 
Abstoßungskräften zwischen dem geladenen Protein und den Koazervat-Tröpfchen 
kaum eingekapselt. Als Folge der geringen BSA-PAA-Koordination wird die 
Partikelgröße von BSA-beladenen Trägern in ähnlicher Weise durch die 
Komplexierungszeit gesteuert. 
In einem weiteren Forschungsansatz wird eine Plattform für die Synthese von 
funktionellen Hybrid-Nanopartikeln mit maßgeschneiderter Morphologie basierend 
auf der Kontrolle über die mesoskalige Assemblierung beschrieben. Dafür kann die 
Ausfällung von CaCO3-Primärnanopartikeln durch die Anwesenheit von 
hochcarboxylierten Kohlenstoff-Dot-Nanopartikeln (CDs) moduliert werden. Bei 
höherer Konzentration können diese Partikel die Übersättigung von CaCO3 
aufgrund der Carboxyl-Calcium-Koordination senken, was die Ausfällung von 
mikroskopischen Kristallen in wässrigen Lösungen vermeidet. Darüber hinaus 
wird gezeigt, dass die hohe Dichte der Carboxylgruppen auf den CD-Oberflächen 
genügend Calciumionen bindet, um als Templat für die CaCO3-Ausfällung zu 
dienen, wenn Carbonat zugegeben wird. Diese Primärteilchen assoziieren sich 
anschließend in Abhängigkeit von der PAA-Konzentration in Kugeln oder 
Stäbchen. Bei zunehmender Polymerkonzentration dominiert die orientierte 
Assemblierung, wobei stabförmige Partikel erzeugt werden. Die Hybridpartikel 
zeigen hohe kolloidale Stabilität im Zellmedium und die Abwesenheit von 
Zytotoxizität gegenüber Adenokarzinomzellen. Darüber hinaus kann aufgrund der 
Partikel-Porosität Rhodamin B eingekapselt werden und die Freisetzung durch 
Anpassung der Umgebungen pH-Wert ausgelöst werden. 
Neben den beiden genannten Methoden zur Kontrolle der Größe, der Kristallinität 
und der Morphologie von Calciumcarbonat-Trägern spielt das Verständnis der 
zellulären Wechselwirkung eine wichtige Rolle bei der Gestaltung von 
Wirkstoffträgern. Eine intrinsische Eigenschaft von CaCO3, die ihre Verwendung 
als Trägersystem behindern kann, hängt mit ihrer Löslichkeit in wässrigen Medien 
zusammen. Hier wird gezeigt, dass CaCO3-Partikelsich leicht lösen oder eine 
Phasenumwandlung eingehen hinzu stabileren Phasen in Abhängigkeit von der 
Ionenstärke des Mediums, der Teilchengrße und der Kristallinität. Um zu 
verstehen, wie CaCO3-Eigenschaften wie Größe, Morphologie und Kristallinität 
die kolloidale Stabilität und zelluläre Reaktion beeinflussen können, werden vier 
oft genutzte Calciumcarbonat-Partikelsysteme, die in der Literatur bereits 
eingehend beschrieben werden, hinsichtlich der kolloidalen Stabilität, 
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Phasentransformation, zytotoxischen Effekte und zellulärer Internalisierung 
beurteilt. Die Calcit-Nanopartikel (90 nm) behalten die morphologischen 
Merkmale bei, da keine Phasenumwandlung innerhalb des Zeitrahmens der 
Experimente stattfindet. Allerdings verwandeln sich Vateritpartikel innerhalb von 
96 Stunden in Zellkulturmedium zu Calcit. Dies trat bei den 600 nm Partikeln auf, 
aber nicht für die 1 μm Vateritpartikel und kann durch die höhere Oberfläche und 
Reaktivität der kleineren Partikel erklärt werden. Darüber hinaus wird gezeigt, dass 
der Phasenübergang durch die Ergänzung des Mediums mit dem Protein 
Serumalbumin wirksam verhindert wird. Die Auflösung von amorphen Partikeln 
ist in Zellmedium mit höherer Ionenstärke stärker ausgeprägt, im Gegensatz zu in 
Millipore-Wasser. Hier erhöhen Aminosäuren und Phosphatsalze, welche sich im 
Zellmedium befinden, wahrscheinlich die Auflösungsrate von weniger stabiler 
CaCO3-Phasen. Die zellulären Reaktionen von menschlichen Osteoblasten 
gegenüber CaCO3-Partikel zeigen, dass eine erhöhte extrazelluläre Calcium-
Konzentration die Zellviabilität erhöht. 
Diese Arbeit beschäftigt sich somit mit der Umsetzung grundlegender Konzepte im 
Zusammenhang mit der Biomineralisierung in der Synthese von CaCO3-basierten 
Wirkstoffträgern mit kontrollierter Größe, Morphologie, Beladung sowie 
kolloidaler Stabilität und Stabilität der Kristallphase. Die dargestellten Ergebnisse 
sind für Forscher von besonderem Interesse, die sich auf die Einkapselung und 
Freisetzung von Arzneimitteln oder anderen bioaktiven Molekülen konzentrieren, 
und allgemeiner in der wässrigen Synthese von anorganischen Partikeln mit 
maßgeschneiderter Anisotropie. Darüber hinaus liefern die Ergebnisse der in vitro-
Assessments Einblicke in zelluläre Wechselwirkungen mit CaCO3, die die 
Gestaltung von Wirkstoffträgern mit verbesserter zellulärer Aufnahme und 
Viabilitätunterstützen.  
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Nomenclature 
?????? ? Ionic activity product of phase 1 
A549 Adenocarcinomic human alveolar basal epithelial cells 
ACC Amorphous calcium carbonate 
BSA Bovine serum albumin 
CaCO3 Calcium carbonate 
CDs Carbon nanodots 
CNTs Carbon nanotubes 
DAPI 4′,6-Diamidin-2-phenylindol fluorescent dye 
DDS Drug delivery systems  
?? Hydrodynamic radius  
DLVO theory Theory first defined by Derjaguin, Landau, Vervey, and Overbeek and used to predict the stability of dispersions 
DMEM Dulbecco's Modified Eagle Medium 
?? Permittivity in vacuum ? Dielectric constant 
EPR Enhanced permeability and retention effect 
ENPs Engineered nanoparticles 
FCS Fetal calf serum  
FL Fluorescence intensity 
?(??) Henry’s function 
?? Equilibrium constant ? Hamaker constant 
HBSS Hank's Balanced Salt Solution 
HOB Human osteoblast cell line 
I Ionic strength of the solution 
IEP Isoelectric point 
??? Inverse Debye length 
? Boltzmann’s constant 
?? Debye length 
 xv 
 
??? Solubility product of CaCO3 
LSZ Lysozyme 
?? Molecular weight ? Avogadro’s number 
PAA and 
PAANa 
Poly(acrylic acid) sodium salt 
PdI Polydispersity index  
PEG Poly(ethylene glycol) 
PEI Poly(ethylenimine) 
? Modulus of the scattering vector 
Q.Y. Fluorescence Quantum Yield 
RhB Rhodamine B fluorescent dye 
RPMI Roswell Park Memorial Institute medium 
RT Room temperature 
SSA Specific surface area 
T Temperature 
?? Electrophoretic mobility 
UV Ultraviolet visible light 
?? Volume of nitrogen 
W/O or O/W Water in oil; oil in water emulsion 
??? Double layer force ???? Van der Waals attractive force ? Density  
? Viscosity  
?? and  ?? The surface charge densities per unit area 
ΔGgrowth Variation in the free energy due to growth 
ΔGnucleation Variation in the free energy due to nucleation ⠩ ????? ?→? Variation in the Gibbs-free energy during phase-transition 
ΔHcryst Enthalpy of crystallization 
ΔScryst Entropy of crystallization ?? Doppler shift ? Exponential decay rate 
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1. Introduction and Aims of the Work 
1.1. General Introduction 
The use of engineered nanoparticles (ENPs) in consumer products is becoming 
increasingly prevalent.1 As a consequence of the toxicity associated with the high 
surface area and activity of ENPs,2 the development of a nanoparticle system that 
minimizes these harmful effects is highly desirable. One possible approach is the 
use of biodegradable and biocompatiblecarriers.3 Lipid-based particles have 
become the pharmaceutical vehicle of choice with the approval of several 
liposomal formulations.4,5 However, due to the limited stability in body and the 
propensity to leakage, polymeric particles appeared as another viable option.3,6 
Polymers approved by the Food and Drug Administration of the Unities States,7 
like chitosan and poly(lactate), received special attention as they are well tolerated 
by the body. Yet, in the long term, their degradation products can still cause 
undesirable side-effects.7 
Endogenous materials, like calcium phosphate, calcium carbonate and 
phosphosilicates hold great potential as materials for delivery vehicles.6 They 
possess excellent biocompatibility and upon degradation, there is almost no risk of 
induced toxicity as their ions are already present in the body at high 
concentrations.8 In the case of calcium carbonate (CaCO3), its solubility is known 
to increase under acid environments.9 This feature has been used to rationalize the 
use of CaCO3 particle systems in targeting and delivering drugs to solid tumors, as 
the particles barely release the cargo at neutral physiological pH, while rapidly 
releasing it at the acidic pH in the tumor microenvironment (pH <6.5).9-11 The pH-
sensitivity combined with its biocompatibility makes CaCO3 of great interest in 
biomedical research as a nanoengineered platform for the delivery of molecules to 
biological systems.9 
Calcium carbonate is already broadly used in industry due to its large 
availability and low cost of synthesis. It is extensively applied as fillers in paint, 
plastic, gums and paper,12-13 as an abrasive in tooth paste,14 in antacids10 and as an 
excipient in effervescent tablets.14 In biomedical research, besides its 
aforementioned application as a delivery vehicle based on the pH-sensitive route, 
this material can be especially interesting to biological systems that either responds 
to Ca2+ ions or to carbonate ions. Accordingly, calcium ions are known to regulate 
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cell cycle,15 induce apoptosis,16 stimulate cell growth and differentiation.17 
Therefore, a boost in the extracellular calcium concentration by CaCO3 carrier 
dissolution may offer new ways to stimulate bone regeneration17 or even induce 
calcium-mediated cytotoxicity.16 In addition to the release of calcium, the 
carbonate ions are reported to play a pivotal role in the inhibition of tumor growth 
by persistent alkalization of solid tumors.11 
However, some shortcomings to the use of CaCO3 have been identified in terms 
of its physical properties (size, morphology, water solubility and crystallinity), in 
the loading and release ability as well as in regard to the instability in water.18 As 
shown in Figure 1.1 - item 1, the first limitation is related to the control over the 
morphology of CaCO3 particles in the sub-micrometer scale. In nature, calcium 
carbonate occurs in six different morphologies: calcite, vaterite, aragonite, ikaite 
and monohydrocalcite, as well as hydrated amorphous phases. These crystals are 
normally large, with a size ranging from 3 to 50 µm, and possess a variety of 
different crystal morphologies. Despite that, observations of CaCO3 biominerals in 
mollusk shells19 and sea urchin spines20 revealed crystals with unusual shape, and 
most importantly, smaller particle size (under 3 µm). Inspired by nature, detailed 
biomineralization studies established the foundation on the control over size, 
polymorphism and morphology with the help of inorganic (Mg2+ ions and 
polyphosphonate)19,21 and organic (proteins and macromolecules)22 additives. 
These additives can act as antiscalants,23,24 growth initiators,25,26 habit modifiers27,28 
or in the stabilization of amorphous phase.29,30 Based on the principles that regulate 
the roles of additives in the modification of crystal nucleation and growth, it is 
possible to design CaCO3-based delivery systems with tailored morphology and 
size, as reported by a considerable number of publications.6,12,31-33 However, it is 
worth mentioning that to date, most synthesis methods do not allow the regulation 
of the physical properties in the sub-micrometer scale.  
The particle size has long been studied as a key parameter to be controlled in 
delivery systems, as a result of the improved cellular internalization at the 
nanoscale,34,35 as well as due to particle escape at the tumor-specific leaky tissues, 
known as enhanced permeability and retention effect (EPR).36,37 Recently, the 
morphology and aspect ratio have come to attention as equally important 
parameters.38-40 Anisotropic particles have been shown to benefit from lower 
phagocytosis clearance, as the internalization by macrophages is dependent on the 
particle-to-cell orientation.41 In this context, there is still the need for a synthesis 
method that would allow for one-pot preparation of anisotropic CaCO3 particles. 
Another challenging aspect that needs to be considered is related to the 
inclusion and release of the cargo molecules (Figure 1.1 - item 2). The 
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encapsulation of pharmaceutical molecules within particles, offers enough 
protection from the environment until its release42 as well as provide the means to 
for site-specific bioavailability.43 Common procedures for encapsulation based on 
CaCO3 particles involve pre-loading methods, like the co-precipitation44-50 and 
emulsion-based co-precipitation,51-53 as well as the post-loading, in which the cargo 
is physically adsorbed onto porous carriers.54 As one-pot methods are faster and 
easier to scale-up, the pre-loading methods are usually preferred. In this context, 
the complex coacervation is a technique widely used in the food industries for the 
encapsulation of fish oil55 and antioxidant oils.56 Considering that this approach has 
already been utilized to controlled synthesis of CaCO3 particles in water,57-58 its use 
as can potentially allow the encapsulation of charged biomolecules within the 
precipitated nanoparticles. 
The last property evaluated in this thesis is related to the stability of CaCO3 
particles in aqueous solutions. Due to the relatively high solubility product in 
aqueous solution, reports show that CaCO3 particles can be extremely unstable in 
the presence of water or humidity.59 In many cases, upon dispersion CaCO3 
particles will readily dissolve (Figure 1.1 - item 3i). This dissolution is observed to 
be phase-dependent, being more pronounced with the less stable phase, like the 
amorphous phase. Moreover, the presence of calcium chelators, like amino acids 
and phosphate salts,60 can potentially accelerate the rate of dissolution. As opposed 
to dissolution, calcium carbonate particles may also tend to phase-transition to 
more stable phases (Figure 1, item 3ii), especially at the nanoscale, at which the 
solubility and reactivity increases due to an enhanced surface to volume ratio.61 
The aforementioned behaviors make these particle systems unstable in water and 
may hinder their use as delivery system. Given that the thermodynamic driving 
force for the phase-transformation and dissolution is already well described in 
terms of the solubility product and the Gibbs free energy,62 the study on how these 
properties may affect the cellular interaction is still poorly studied and yet, full of 
relevance.  
Despite being generally regarded as safe, calcium carbonate particles in the size 
range of 50 nm to 1 µm may cause toxicity when compared to their bulk 
counterpart.14 This effect is more pronounced as smaller particles can potentially 
cross lipid-based cellular membranes63 and with that, disrupt cellular functions.64 
In general terms, the influences in the cellular response caused by CaCO3 particle 
systems can be regarded in two different aspects. The first is related to increased 
extracellular and intracellular calcium concentration due to particle dissolution in 
medium or within lysosomes.16,65 Studies revealed contradictories results, as the 
reported cells show both improved viability16 or partially died.14 The second 
interaction comes from the additives used to control crystallization.30,58,66 Upon 
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dissolution in medium, organic molecules are released and can possibly cause 
toxicity by membrane damage.67 For that, studies that identify the impact of 
different CaCO3 colloidal systems on the cellular interactions may provide useful 
for future application. 
 
 
  
 
Figure 1.1: A summary of the main issues limiting the translation of CaCO3 particles 
towards the use as delivery vehicles. 1. Shortcomings in controlling the morphology of 
particles, i.e. size (i) and aspect ratio (ii). 2. The ability to encapsulate and release of the 
cargo in a controlled manner. 3. The limited particle stability in aqueous solution, in 
which particles prematurely dissolve releasing their cargo (i), or phase-transform to 
more stable polymorphs in the micrometer range (ii). 
Chapter 1 
   
5 
 
1.2. Aim of the Work  
As introduced, CaCO3 particle systems have the potential to be used in health 
care as delivery vehicles. However, poor control over morphology at the sub-
micrometer scale, limited ability to encapsulate and release therapeutic molecules, 
and particle instability in aqueous solutions could hinder its translation towards 
viable biomedical systems. In this doctoral thesis, the major focus is on 
overcoming the aforementioned pitfalls by developing synthesis methods that 
allow tailored particle size, morphology, and crystallinity; as well as on 
determining how these properties affect the in vitro biological response.  
In order to modulate the particle size and allow the synthesis of protein-loaded 
CaCO3 carriers, the complex coacervation method is identified as a possible option. 
For that, the complex coacervation approach is modified to allow the electrostatic 
coordination of positively and negatively-charged proteins within the coacervate 
phase, which is then stabilized by the mineralization by subsequent addition of 
carbonate ions. The following hypotheses will be discussed in more detail in the 
Chapter 6: 
 The charged proteins can comprise one of the assembling components of 
the complex coacervation due to electrostatic coordination. 
 The electrostatic interactions regulate the protein encapsulation efficiency. 
Accordingly, positively-charged proteins are more likely to be 
encapsulated at higher efficiencies due to the heterocoagulation with the 
negatively-charged polyelectrolyte.  
 The release of occluded molecules can be triggered by carrier dissolution 
in acidic environment.  
Aiming to control the aspect ratio of CaCO3 particles in a one-pot approach, 
carbon dots and poly(acrylic acid) are used to mediate the precipitation pathway 
and allow the formation of both rods and spheres in the sub-micrometer scale. The 
prepared particles are assessed for the delivery of small fluorescent model 
molecules to alveolar epithelial cells. Accordingly, the following hypotheses will 
be discussed in the Chapter 7:  
 Carboxylated carbon dots and poly(acrylic acid) can coordinate with 
calcium ions and potentially reduce CaCO3 supersaturation. As a result of 
this coordination, these particles serve as templates for the heterogeneous 
precipitation CaCO3 upon addition of carbonate ions. 
Chapter 1 
   
6 
 
 The use of poly(acrylic acid) to stability the particles can induce toxicity 
and reduce cellular viability. 
In chapter 8, calcium carbonate particles with different size, morphology and 
crystallinity are synthesized and studied based on the changes in the dissolution 
behavior, colloidal stability and phase-transition in different cell nutrition medium. 
Moreover, the biological behavior of these particles systems is compared in terms 
of cytotoxicity and cellular internalization in the in vitro assessments. In this study, 
the following hypotheses will be highlighted: 
 Less thermodynamic stable phases, like amorphous and vaterite phase, 
may dissolve or phase-transform to calcite phase within the timeframe of 
the cellular experiments affecting the cellular outcome. 
 The phase-transition and dissolution can be more pronounced as the 
surface-to-volume ratio increases as well as in the presence of calcium 
chelators. 
 Poly(acrylic acid), an additive used to stabilize the amorphous particles, 
can potentially induce toxicity and reduce cellular viability. 
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2. Calcium carbonate particles as delivery vehicles  
Overview: In this chapter, a comprehensive overview of the literature involving calcium 
carbonate as an engineered particle is highlighted. Moreover, a brief description of the 
main synthesis methods for calcium carbonate nanoparticles is described along with the 
observations on the phase transformation that can occur in aqueous solutions. This chapter 
also describes the complex coacervation and the mesoscale self-assembly mechanisms 
applied to the preparation of synthetic calcium carbonate particles.  
2.1. Introduction to calcium carbonate as an engineered material 
CaCO3 exists in six different crystal polymorphs, some anhydrous (calcite, 
aragonite and vaterite) and some hydrated (amorphous, ikaite and 
monohydrocalcite).1 Calcite is the most stable phase and can be found in the 
mollusk shells2 and sea urchin spines.3 Aragonite, the second most stable phase, is 
the main inorganic component of the nacre shell,4 which is an exquisite 
hierarchical structure with enhanced mechanical properties used for protection and 
support. Vaterite is the least stable of the anhydrous polymorphs and can be found 
for example on the shell of most gastropods. An overview of the main properties of 
each crystal system is given in table 2.1. 
According to table 2.1, the morphology of naturally occurring crystals is fixed. 
However, with the help of additives, it can be changed from what is reported. In 
fact, the mineralization of calcium carbonate by microorganism allows the control 
of crystal size, shape, orientation, phase, texture and location.2 This occurs via the 
regulation of the ionic reactants and by the use of additives, which can be either 
inorganic dopants or organic additives.5 Common inorganic additives, like 
Magnesium ions, are present in seawater in seawater at much larger concentrations 
than calcium ions: 50mM for Mg2+ and 12mM Ca2+.2 This ion is known to increase 
the solubility of calcite and therefore, at higher concentrations, it can favor the 
formation of the aragonite phase. At lower concentrations, Mg2+ can alter the 
morphology of calcite to a prismatic form.2 
Morphological control can also be executed with the help of organic additives. 
Proteins like dentin, collagen and chitin are commonly found occluded in 
biominerals. The protein concentration can range from the very small quantities in 
the urchin spines (around 0.02wt%), to an interconnected network in between 
tablets of nacre sheet, to a collagen matrix in bone (20wt%).2 The use of organic 
matrixes allows the nanostructural arrangement of the organic and inorganic 
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components, which is often organized into hierarchical levels. It is also reported 
that the mechanical properties of hierarchically-structured materials are enhanced 
providing better structural support and protection.  
The study of biomineralization processes revealed some key organic and 
inorganic additives that can be used synthetically to mimic the crystallization 
pathway and with that, allow the morphological and size control. These studies 
have been reviewed by L. Gower2, H. Cölfen6, F. Meldrum5, and N. Sommerdijk7 
and established the foundation on biomimetic mineralization. The translation of the 
knowledge acquired on biomineralization to the production of synthetic CaCO3 
systems has also been extensively reviewed by H-B. Yao4 concerning structural 
properties inspired by nacre, by S. Sharma8, Y. Boyjoo9, D. Trushina10 and D. 
Volodkin11 in the micro- and nanometer-sized materials for biological applications 
and by S. Kim12 in regard to energy and environmental applications. 
Significant effort has been devoted to the use of calcium carbonate in industry. 
Current industrial applications of calcium carbonate are very simple due to the low 
mechanical properties. As an example, in paper and paint industries, it is used as 
fillers and in toothpaste as an abrasive material. However, the use of CaCO3 is 
slowly shifting towards biological applications, due to its pH-sensitive dissolution, 
biocompatibility, and degradability. Moreover, novel synthesis techniques allow 
the encapsulation and release of pharmaceutical ingredients. Given the potential of 
this material, the following chapters will discuss in detail some key limitations that 
need to be addressed for the development of tailored CaCO3 particles as carriers to 
biological systems. 
2.2. Crystal growth under thermodynamic and kinetic control 
In order to explain the typical synthesis routes used to prepare synthetic calcium 
carbonate particles in the nano- and micrometer range, it is first required the 
understanding of the role of additives in the nucleation and crystal growth in 
aqueous solution and how they allow control over the final morphology, 
crystallinity and particle size. 
According to the classical crystallization theory in water in absence of 
additives,2,6 in a supersaturated solution containing [Ca2+] and [CO32-] ions, the 
driving force to precipitation is the degree of supersaturation (S), expressed as 
S= ????, where ? is the species concentration and ??? is the solubility product. 
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In other terms, it can be expressed by the difference in the solute concentration at 
the supersaturation (?) and at equilibrium (??), ?? = ? − ??.19 As the nucleation 
begins, there is a critical equilibrium radius that determines whether the nuclei are 
thermodynamically stable or not. If the size is larger than the critical radius, the 
nuclei grow by ion-by-ion diffusion or layer-by-layer adsorption. While doing so, 
the overall solute concentration decreases as the solute is being consumed by the 
nucleation and growth processes. As time elapses, the solute concentration reaches 
an equilibrium (??) with the precipitated particles, in which the rates of nucleation 
and dissolution are equal. This process is schematically presented in the Figure 
2.1a. 
The precipitation and crystal growth process can also be described in terms of 
thermodynamic and kinetic control, as illustrated in the figure 2.1b. ΔG represents 
the variation in the Gibbs free energy over the course of the precipitation process. 
At constant temperature (T), this can be expressed in terms of the enthalpy of 
crystallization (ΔHcryst) and entropy of crystallization (ΔScryst), as ΔG= ΔHcryst -
TΔScryst.20 Accordingly, two pathways are possible: thermodynamic (A) or kinetic 
(B).  
In the thermodynamic controlled crystal growth, Pathway A, the activation 
energy for the crystallization can be correlated to the sum of the free energies per 
unit volume of nucleation (ΔGnucleation) and growth (ΔGgrowth), as ΔG A = ΔGnucleation A 
Table 2.1. Overview of different properties of calcium carbonate phases. 
Properties Calcite Aragonite Vaterite 
Crystal 
system13 
Trigonal- 
Rhombohedra Orthorhombic Hexagonal 
Lattice constant 
a: 4.991 
c: 17.062 
ϒ: 120° 
a: 4.959 
b: 7.964 
c: 5.738 
a: 4.130 
c: 8.490 
ϒ: 120° 
Natural 
morphology5 Rhombohedra Needles 
Spherical for 
polycrystalline 
aggregates 
Relative 
enthalpy 14,15,a  0.4 3.4 to 3.8 
Log Ksp16,17,b - 8.4 - 8.3 - 7.9 
n.r. – not reported. a Relative enthalpy18 to calcite (kJ/mol) at 25°C. b Logarithmic form 
of the solubility product constant of CaCO3 particles dispersed in water at 25°C. 
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+ ΔGgrowth A. As reviewed by Meldrum and Cölfen,5 additives can be used to 
modify the crystallization by adsorption to the nucleation surface. As a result, the 
surface energy is lowered, and so is the nucleation rate. This promotes the growth 
predominantly on the uncoated surfaces.  
In contrast to thermodynamic control,5 Pathway B describes processes in the 
presence of high concentration of additives, known as kinetically-controlled 
pathway. This process starts with the formation of precursors phases, which are 
high soluble and therefore do not require high activation energies, ΔGB. These 
precursors are usually highly hydrated, amorphous phases. If the formation of the 
precursor phase is induced by a polyelectrolyte, it is referred as Polymer-Induced 
Liquid Precursor (PILP phase). As consequence of the instability of these phases, 
they are susceptible to phase transformation with low activation energy, ΔGT1, into 
less hydrated phases but still amorphous in nature: the amorphous calcium 
carbonate (ACC) phase. Once again, this unstable phase is susceptible to phase-
transform to crystalline phases (ΔGT2 and ΔGT2 respectively). Since this is a 
stepwise process, there is the possibility to manipulate the crystallization in order 
to favor specific shapes or sizes.5 
As previously described, the presence of additives changes the mineralization 
pathway resulting in distinct effects on the crystal nucleation and growth.7 
Common additives have been shown to play different roles in mineralization:22 
(i) antiscalants hinder mineral growth by disturbing the crystal nucleation.23,24 
Table 2.1 (continued) 
Properties Monohydrocalcite Ikaite Amorphous 
Crystal 
system13 Trigonal Monoclinic n.r. 
Lattice constant 
a: 10.553 
c: 7.544 
ϒ: 120° 
a: 8.792 
b: 8.312 
c: 11.021 
β: 110.5° 
n.r. 
Natural 
morphology5 n.r. n.r. Various 
Relative 
enthalpy 14,15,a n.r. n.r. 24 
Log Ksp16,17,b -7.6 -7.4 -6.3 
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(ii) growth initiators induce local supersaturation and nucleation via ion 
complexation.25,26 
(iii) habit modifiers restrain crystal growth by selective adsorption.27,28 
(iv) stabilization of amorphous, highly hydrated phases (ACC).29,30 
Accordingly, additives have been shown to play multiple roles at once,31 which 
can make the quantitative assessment of their action a challenging task. Gebauer 
and colleagues31 showed that simple titration of Ca2+ ions provides information on 
the interaction and influence of different additives in the crystallization process. 
The results from these experiments allowed the classification of additives in five 
categories, in which three of them fall within the previously described roles. The 
other two are the adsorption of ions and the influence on soluble-cluster formation. 
Surfactants like cetrimonium bromide (CTAB) and Sodium dodecyl sulfate 
(SDS)9,32,33 are shown to have the hydrophilic head groups adsorbed onto specific 
crystal habits, and the final crystalline phase is attributed to the surfactant 
orientation and strength of attraction between surfactant and CaCO3 nuclei. 
Biomolecules such as cellulose,34,35 silk36 and starch37-40 favor the formation of 
porous vaterite at low additive concentrations as well as increase of the specific 
surface area.9 Moreover, amino acids,41 albumin11 and lysozyme42 are shown to be 
highly incorporated to the crystals (up to 10wt%) and alter their physical 
properties, for example hardness. Another class of very important additives are 
polyelectrolytes, like poly(acrylic acid),30,43 poly(aspartate),22,44,45 and 
 
Figure 2.1: a) Three stages of classical theory of crystallization.21 I. prenucleation, II. 
nucleation, III. growth. ????*: minimum concentration for nucleation, ????*: maximum 
concentration for nucleation, ??: solute concentration at equilibrium. b) Pathway A: 
classical crystallization pathway, Pathway B: kinetically-controlled pathway. Adapted 
from L. Gower2 and H. Cölfen.6 
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dendrimers.46,47 Generally, by increasing the concentration of polyelectrolytes, less 
stable phases are stabilized, and the crystal morphology seems to be regulated by 
adsorption-related processes.  
In this context, one of the challenging aspects in the biomimetic mineralization 
is the construction of synthetic materials that resemble their natural counterparts in 
regard to structure as well as physical properties.7 For that, the understanding of 
the interplay between additives and the inorganic phases is essential to prepare 
useful biomimetic materials with a well-defined morphology. 
2.3. Phase-transformation and dissolution in aqueous medium  
As described in Table 2.1, calcium carbonate exists in different crystalline 
amorphous phases. Accordingly, all polymorphs have a certain solubility in 
aqueous solution, which scales with the thermodynamic stability of each crystal 
phase:17 more stable phases have a lower the solubility product. In water or 
humidity, these less stable crystals (or metastable phases) are susceptible to the 
phase-transition to a more stable polymorph via different mechanisms. The 
reduction in the Gibbs-free energy is the driving force for such transformation and 
it can be described by equation 1 as: 48 
⠩ ????? ?→? = ⠩ ?ℎ??? ? −  ⠩ ?ℎ??? ? =  −??2 ln ??ℎ??? ???ℎ??? ? Eq. 1 
where ? is the gas constant, ? is the temperature, ? the ionic activity product of 
each phase, ??????? ?→? is the driving force for the phase transition from a less 
stable phase with Gibbs-free energy ??????? ? to a more stable phase with Gibbs-
free energy equals to ??????? ?,. According to the Ostwald Law, at sufficiently 
high supersaturation, the polymorph that crystallizes first is the most soluble and 
the least stable.10,49 This explains why the phase-transformation is a stepwise 
process, going from less stable polymorphs towards the formation of the stable 
calcite phase. For more information of the thermodynamic pathway of phase 
transformation refer the publication by Trushina10. 
In the case of amorphous CaCO3 particles (ACC) in aqueous solution, the 
transformation of ACC occurs via dissolution-precipitation mechanism.14,50 
Accordingly, the ACC particles dehydrate to less hydrated state, and eventually, 
crystalline nuclei precipitate via heterogeneous nucleation. This crystalline phase  
subsequently dissolves and recrystallizes to give space to a more stable phase. 
Eventually, the calcite phase will be formed. Interestingly, Zou et al.51 describes 
that, in aqueous solution, the favoring of the crystalline phase is dependent on the 
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ACC particle size. Smaller particles (66 nm) favor the transformation to vaterite 
phase, while larger particles (196 nm) phase-transforms directly to calcite. Konrad 
et al.52 reports that the transformation of ACC into crystalline is only triggered 
after the physisorption of a critical amount of water, thus providing evidence that 
the solid-state transformation might not play as an important role in the phase-
transformation of the amorphous phase. 
The phase transformation of less stable crystalline phases to calcite is shown to 
occur via heterogeneous nucleation and interface-controlled growth. According to 
Peric and colleagues1, the transformation from aragonite to calcite crystals occurs 
preferentially at surface defects (like cleavages or fractures), in which calcite 
nuclei are formed with an expansion of about 8% in volume. The enthalpy of phase 
transformation of aragonite-calcite is reported at about -0.3 kJ/mol, indicating that 
the transformation is an energetically-favored, endothermic process.14,15 In 
contrast, the vaterite-calcite transformation occurs with a decrease in volume of 
about 2% and the enthalpy of phase transformation is around -3.5 kJ/mol. 
The phase-transformation rate is known to be depend on the intrinsic nature of 
the particles (composition and crystal phase)14 and can largely be accelerated by 
the presence of water/humidity.1,15 Besides the intrinsic properties, the 
environmental conditions, like presence of proteins, amino acids, calcium-
chelating moieties and high ionic strength are also known to enhance the 
transformation rate.53-55 The role of ionic strength is described by Parakhonskiy and 
colleagues56, as the recrystallization to calcite does not occur in ethanol and is 
accelerated with increased ionic strength. In Millipore water, the phase-transition 
starts at around 48 hours of incubation, while for phosphate saline buffer (PBS) at 
around 5 hours.  
Another important consideration is the dissolution behavior of these particles in 
water. This can be specially a problem, if the released ions can induce toxicity in 
cellular studies.57 In the case of weak salts, like CaCO3, the solubility is highly 
dependent on the pH. This is governed by the equilibrium equation 2, which 
already considers the hydrolysis of the carbonate ion:13 
?? = ??? ?1 + [H?]???  +
[H?]???? ???? Eq. 2 
where ??? is the solubility product of CaCO3 phase that vary from 3.7×10−9 to 
8.7×10−9 M2 at 25 °C for different phases, ??? and ??? are the equilibrium 
constants set as 2.5×10−4 M2 and 5.61×10−11 M2 at 25 °C respectively (equilibrium 
equations are described on section 10.1). Accordingly, the solubility is highly 
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dependent on the pH, as plotted in the Figure 2.2. This instability at acidic pHs can 
actively be used to trigger the dissolution of CaCO3 particles in solid tumors.13 In 
cancer therapy, it is well documented that the tumor pH is more acidic than that in 
the blood due to increased production of and slow exportation of lactate and CO2.58 
It is also important to mention that the instability in aqueous solution is more 
pronounced at the nanoscale since both the solubility and reactivity are enhanced 
with increasing surface free energy.56,57,59 Diedrich and colleagues60 described the 
relationship in terms of particle size, surface area, and dissolution rate for 
nanoscale materials. Accordingly, for spherical particles this effect can be 
described using the modified Kelvin equation, as: 
s?? = exp ?
4 γ V??? ?? Eq. 3 
where ?? and s designate the solubility of a particle of infinite diameter and of 
diameter ?, respectively, γ refers to the surface free energy, and V̅ stands for the 
solid phase molecular volume. Accordingly, the solubility of the particles increases 
at the nanoscale. This is experimentally demonstrated60 using amorphous SiO2 
particles, in which by reducing the average particle size from 177 nm to 25 nm, the 
normalized dissolution rates are 0.3 log units faster.60 
2.4. Synthesis route for CaCO3 engineered particles 
Based on the biomineralization principles, different synthesis methods have 
been developed. The most common routes are based on the use organic additives. 
These techniques can be sorted into four main approaches9 as described in Figure 
2.3. Each one of the routes will result in different morphologies, size and crystal 
phase. 
Spontaneous precipitation reactions rely on the use of additives at high 
concentration to control the properties of the final crystal. In this technique, by 
mixing the two supersaturated solutions, one rich in calcium ions and the other in 
carbonate ions, particles precipitate within a few hours and are collected via 
centrifugation or freeze-drying. Experimental parameters, such as pH, temperature, 
[Ca2+]:[CO32-] ratio, additive concentration and additive type, can be varied to 
obtain the desired polymorph, morphology and size of particles. 9 
One important modification of the spontaneous precipitation involves the 
combination with solvents, like polyols56,61-65 and polyglcerol.66 A review by D. 
Trushina10 and colleagues shows that the use of alcohols can facilitate the 
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formation of vaterite crystals due to the strong electric interaction of OH-groups 
with the vaterite surface, which reduces the surface energy of this phase and makes 
it thermodynamically more stable than aragonite or calcite. Moreover, the high 
local viscosity of compounds like glycerol can significantly limit the rate of 
diffusion and effectively slow down the particle growth. 
In the slow carbonation reactions, CO32- ions are introduced via the slow 
hydrolysis of dimethyl carbonate (DMC) or ammonium carbonate ((NH4)2CO3) 
under alkaline conditions. As the addition of carbonate is dependent on both 
hydrolysis reaction and diffusion, typically long reaction times are involved.9 Both 
the aforementioned techniques are usually considered bio-inspired, as the additives 
of choice mimic the biomineralization processes. As reviewed by Y. Boyjoo and 
colleagues,9 these techniques result in a mixture of different polymorph (ACC, 
calcite, vaterite and aragonite) and the size ranges from nano to micrometer size. 
CaCO3 particles are also produced by microemulsions. The use of reverse water 
in oil (W/O) emulsions allows for the synthesis of particles with narrow particle 
size distribution in the nano-range,9 owing to the physical constraints created by 
the micelles during the mineralization. As the crystallization occurs within water 
micelles stabilized by surfactant or polymer in the oil phase, the oil/water interface 
act like a cage which controls the nucleation and growth, resulting in nanosized, 
monodispersed particles.8 Similarly to the precipitation and carbonation reactions, 
the morphology and crystal phase of the final CaCO3 particles can be controlled by 
the [Ca2+]:[CO32-] ratio, pH, temperature, additional additives as well as by the 
surfactant-to-water ratio.9 
 
Figure 2.2: The pH-dependent solubility of calcium carbonate at varying pHs. ??? and ??? are the equilibrium constants of H2CO3 and HCO3- . ??? is the solubility product of 
CaCO3. Equilibrium equations can be found on Appendix 10.1. 
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The CO2-bubbling technique allows the production of CaCO3 particles by 
flushing carbon dioxide through a slaked lime solution, Ca(OH)2.9 Due to the basic 
nature of the slaked lime solution, the synthesis occurs at high pH, yielding most 
commonly the calcite phase with rhombohedral morphology. According to 9, the 
final particles are highly aggregated, specially due to the nanometer-sized obtained. 
Typical parameters used to control the process are: temperature, stirring speed, 
supersaturation, gas volumetric flow rate and reaction time.  
In summary, most of the fabrication methods are one-pot processes that enable 
the synthesis of both nano- and micrometer sized CaCO3 particles with various 
morphologies and polymorphs. These synthetic particles have been tested in a 
wide range of applications, from fillers to more complex delivery systems. In the 
next section, it will be highlighted a few techniques used for the encapsulation of 
molecules within the CaCO3 particles systems. 
2.4.1. Encapsulation methods for CaCO3 particles 
It has long been suggested that CaCO3 can be potentially used as a drug carrier 
due to its biocompatibility and biodegradability, low cell cytotoxicity and cost-
effectiveness.67 For that, it is required that a cargo should be encapsulated within 
the particles and released in a controlled fashion to the environment. According to 
 
Figure 2.3: Commonly described synthesis routes for the preparation of CaCO3 particles 
from solution: a) spontaneous precipitation, b) slow diffusion, c) emulsion, d) CO2 
bubbling. Adapted from 9. 
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Sharma8, the low encapsulated amount of e.g. therapeutic molecules that can be 
achieved by calcium carbonate and phosphate is one of the major limitations that 
need to be addressed. As reviewed by Volodkin11, two methods have been 
developed to encapsulate the cargo using CaCO3 carriers: pre-loading techniques 
(co-precipitation and microemulsion methods) and post-loading techniques 
(adsorption and immobilization). 
The most common method for the encapsulation of molecules is the co-
precipitation method.68-73 As previously reviewed,8 this technique involves the 
spontaneous precipitation of the CaCO3 phase from an aqueous solution already 
containing the cargo to be encapsulated. As an example, Chen and colleagues69 
used this technique produced 100 nm-particles loaded with DNA and doxorubicin 
(DOX), at a loading content of 1.3wt% and an encapsulation efficiency of more 
than 90%. Utilizing the same technique, Koker et al.73 reports the synthesis of 3 
µm-particles loaded with ovalbumin.  
Similarly, the emulsification process is another very common technique at the 
laboratory scale for the preparation nanoparticles due to the wide range of 
morphologies and good encapsulation efficiencies.42,74-76 Fujiwara and colleagues75 
described the synthesis of mesoporous capsules with a diameter of around 5 µm. 
These particles were tested for the encapsulation of bovine serum albumin, 
ovalbumin, papain, lysozyme and DNA. The encapsulation efficiencies largely 
varied depending on protein size and charge, but BSA was encapsulated with the 
highest efficiency, 92%, while LSZ the worst one, with an efficiency of about 
0.01%. 
Post-loading methods rely on the high porosity of the samples for good 
encapsulation efficiencies.39,77-81 According to Sharma,8 the encapsulation 
efficiency of post loading techniques are, in many cases, still low compared to the 
use of soft nanoparticles, like liposomes and hydrogels. For optimized cargo 
adsorption, the parameters like particle size, crystalline, specific surface area and 
morphology need to be tailored. As previously reviewed,10 vaterite particles 
specially benefit from high porosity and nanostructured surface, which allows them 
to adsorb large proteins with high efficiency. Accordingly, proteins like catalase, 
insulin, aprotinin, and protamine adsorb at different efficiencies at the vaterite 
surface due to varied thermodynamic protein affinity.81 This can be experimentally 
determined by calculating the Gibbs free energy derived from the adsorption 
isotherms. Moreover, positively-charged catalase and insulin bind strongly to the 
vaterite microspheres due to the electrostatic attractive forces. The opposite occurs 
for aprotinin and protamine. 
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The chemical immobilization strategy has been reported for the loading calcium 
carbonate nanoparticles.82 In this technique, α-amylase was covalently-
immobilized on glutaraldehyde-activated, silanized CaCO3 particles at around 200 
mg/g of nanoparticles. It must be noted that due to the silanization reaction, the 
silica coating alters the surface chemistry of the particles, which can modify the 
cellular interactions and the biodegradability. Recently developed, the solvent-
exchange method is another technique that allows the loading of CaCO3 cores with 
an amount exceeding that for the physiosorption.11 For that, a solution containing 
the CaCO3 particles and the protein to be encapsulated is set to a pH equal to the 
isoelectric point of the protein (IEP). As a result, large quantities of protein 
spontaneously precipitate in the pores of the particles, as this is a surface-mediated 
process. 
2.5. Complex coacervation  
The description of coacervation was introduced by Bungenberg de Jong in 
1929.83 Two main types of coacervation have been described and differ by the 
phase separation mechanism. Simple coacervation is achieved when a 
homogeneous solution of charged macromolecules undergoes liquid-liquid phase 
separation, giving rise to a polymer-rich, dense phase and polymer-depleted 
supernatant,84 in which both liquid phases are incompatible, immiscible and are in 
equilibrium. The mechanism involves the partial desolvation or dehydration of 
macromolecules, by e.g. addition of salts or alcohol.85,86 Complex coacervation is 
induced by electrostatic interaction and comprises two or more oppositely charged 
colloids.  
Both techniques are widely used in the food industries to encapsulate fish oil87 
and in cosmetics, to encapsulate antioxidant oils.88 Recent research reported the  
 
Figure 2.4: a) Illustration of the coacervate-directed method. b) Intermediate and final 
stage of electrostatic coordination between PAA and Ca2+ ions. Adapted from 94. 
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encapsulation and delivery of growth factors,89 genes,90,91 as well as proteins.92 
Furthermore, coacervates are currently being investigated for their role in protocell 
formation and as models of protocell assembly.93  
As mentioned before, polyelectrolytes are also useful additives to modulate the 
mineralization of CaCO3. It was first hypothesized by Huang and colleagues94 that 
polyelectrolytes could primarily form complex coacervate droplets upon 
complexation with calcium ions, and later be mineralized by addition of carbonate 
ions. This approach, known as controlled-addition method, is described in Figure 
2.4a. Firstly, poly(acrylic acid) (PAA) in dispersed in aqueous solution, to which a 
solution containing Ca2+ ions is added. Accordingly, PAA can coordinate with 
positively-charged Ca2+ ions. The structure of the coordination is proposed in three 
different intermediate types, as depicted in Figure 2.4b. This coordination, or ion 
pairing is endothermic and is entropically driven.95 As a result of the complexation, 
it is suggested that PAA molecules become more hydrophobic and phase-separate, 
forming polymer-rich, liquid-like particles known as complex coacervate 
droplets.94 Due to hydrated nature, these droplets grow by the Ostwald-Ripening 
process, a time-dependent process in which bigger particles grow in expense of 
smaller ones by successive aggregation and coalescence. This means that the 
particle size of the droplets could be controlled by complexation time. By adding 
sodium carbonate to the droplets-containing solution, the fluidic particles are 
mineralized into stable and colloidally stable calcium carbonate particles. This 
process was further developed to be produce micromolded amorphous parts,96 and 
then modified for the encapsulation of proteins.30 
With the controlled-addition method,94 monodispersed CaCO3 particles with 
controlled size are obtained. Further reports on the basis of complex coacervation 
and mineralization focused on the preparation of micromolded ceramic 
components96 and even PAA/Ca2+ hydrogels that can be reversibly molded into 
transparent films.43 In this thesis, complex coacervation is studied as both a method 
to encapsulate proteins within CaCO3 particles as well as to modulate the particle 
size, as will be described in chapter 6. 
2.6. Mesoscale self-assembly and colloidal crystals 
As previously described, additives not only affect the nucleation but also the 
growth of CaCO3 particles. Many studies report the formation of 3D arrays of 
isooriented single crystal particles, refereed as mesocrystals.97 This term was first 
coined by Cölfen98 and has a certain similarity with the concept of colloidal 
crystals. The difference is that mesocrystals have a well-defined structure at the 
atomic level, while colloidal crystals do not.99 The term mesocrystal is generally 
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used in the biomineralization community referring to crystals formed by mesoscale 
transformation,97 while colloidal crystal is often used by the colloidal assembly 
community referring to crystals created by oriented assembly.100 
According to the classical growth mechanism, which can also occur in the 
presence of additives, the growth of the nucleated primary nanoparticles occurs by 
the ion-by-ion addition mechanism, which results in the formation of rough, 
irregularly-shaped single crystals loaded with the polymer additive (Figure 2.5, 
b).101 In the case of mesocrystal formation, growth occurs under a multistep 
kinetically driven reaction. In this pathway, the crystallization follows a stepwise 
process that starts with the nucleation of primary nanoparticles. Their growth 
occurs by the assembly of particles or complexes to the primary nanoparticles, 
referred to as mesoscale transformation, which can occur rapidly and unoriented, 
or, in some specific cases, it can be oriented by the adsorption of macromolecules 
onto specific crystallographic growth planes of primary nanoparticles (Figure 2.5, 
a).97,102 This ordered structure is a result of  nanoparticle-macromolecule 
interactions, which allows the assembly to take place in a mutually oriented 
fashion forming higher-order superstructures.97 The primary nanoparticles that 
form the superstructure can either fuse to form one single crystal or remain at the 
nanoscale, depending on the binding affinity between nanoparticles and 
macromolecules.98 If oriented assembly takes place with crystallites that do not 
 
Figure 2.5: Schematic growth of calcite in the presence of polymeric additives. 
a) Oriented-self assembly of primary building blocks, which then fuse to create a single 
crystal loaded with polymer additive. b) Classical crystallization via ion-by-ion addition to 
the single crystal surface, in which, due to the occlusion of additives, the morphology is 
irregular and the roughness is more pronounced.104 
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fuse together, the resulting superstructures are often referred to as mesocrystals.66 
On the other hand, if the primary particles fuse, they can form a single 
crystal.66,97,103 
Both processes of mesoscale assembly105 and directed colloidal assembly100 can 
be used for the preparation of novel particle systems. One interesting example is 
the nacre, which is formed from mutually perfectly crystallographically aligned 
aragonite tablets.6 This hierarchical structure provides improved mechanical 
properties and has served as inspiration for the fabrication ultra-strong artificial 
nanocomposites.6 Another example is the strategy that uses non-spherical building 
blocks to produce anisotropic colloidal crystals described on Chapter 7.106  
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3. Colloidal stability of engineered nanoparticles 
Overview: This chapter introduces the concept of the DLVO theory, which 
describes the interparticle interactions in aqueous solutions. The theory uses the 
van der Waals and electrostatic forces to estimate the stability of a suspension. 
Moreover, it describes the formation of surface charge due to ionization of surface 
groups and relates it to the zeta-potential and colloidal stability. 
3.1. Introducing the DLVO Theory 
Understanding the interactions between particles in aqueous solutions is of 
importance in material science, as it allows researchers to understand and better 
control the stability of particles in a medium by improving surface charge densities 
and by particle surface functionalization.1 The DLVO theory treats the colloidal 
stability in terms of the balance of attractive van der Waals forces and repulsive 
electrical double-layer forces.2 With the superposition of these forces, both the 
stability and aggregation behavior in aqueous solutions can be estimated.2 In 
practical terms, dynamic light scattering (DLS) experiments can be used to monitor 
the particle size and zeta-potential, and the results are used to validate the DLVO 
theory. The original DLVO theory does not encompass all forms of interactions 
though. For a better correlation between theory and experimental data, other 
repulsive forces, e.g. hydration forces, as well as specific attractive forces (e.g. 
depletion, hydrophobic or magnetic forces) are considered in the extended DLVO 
theory. 
3.2. Total energy of interaction 
The DLVO theory, first defined by Derjaguin, Landau, Vervey and Overbeek, 
was developed to describe the colloidal stability and aggregation of a suspension. 
This theory is used to rationalize the forces acting on particles and surfaces3 based 
on two additive contributions: van der Waals and double layer interactions.  
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The van der Waals attractive force (????) results from the interaction of 
induced, instantaneous, or permanent dipoles generated at the inter-atomic bonds, 
which can destabilize a colloidal system. The total ???? is referred to as the sum 
of three types of dipole-dipole interactions (Keesom force), dipole induced dipole 
interactions (Debye force), and fluctuating dipole-induced dipole interactions 
(London force).4 The ???? can be simplified as: ???? = − ??? ??? , where H is the 
Hamaker constant and h defines the distance between the particles. The Hamaker 
constant depends on the material and medium properties2 and can be 
experimentally determined by surface force apparatus with typical values ranging 
around 10−21 to 10−19 J. 
The double layer interaction (???) act as a repulsive force and with that, helps 
the stabilization of a suspension. Most particles in water environments carry some 
surface charge due to the ionization or dissociation of surface groups. The 
overlapping of the electric double layer of two particles induces a repulsive force 
caused by osmotic interactions between conterions.4 This can be approximated as ??? = − ? ???????? exp(−?ℎ), in which ?? and  ?? are the surface charge densities per 
unit area, ?? is the permittivity of vacuum, ? the dielectric constant of water and ? 
the inverse Debye length. The latter is given by ??? = ?.? ??√? , where I is the ionic 
strength of the solution. 
 
Figure 3.1: Illustration of forces (a) and potential energy (b) between two positively-
charged particles as a function of the separation distance. Adapted from 5. 
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The combination of these forces can be viewed in terms of the interparticle 
forces (nN) or potential energy (???) (Figure 3.1). Positive forces and potential 
energies represent repulsive interactions, which provide the stabilization for 
particles dispersed in water. Accordingly, at infinity and at short distances, van der 
Waals attractive forces dominate the interactions, while at intermediate distances, 
the double layer forces are more pronounced. Looking at the potential energy 
(Figure 3.1b), there are two regions where energy is minimized, which correspond 
to the points where the net forces are equal to zero. The first one is referred to as 
the primary minimum and at larger distances, there is the secondary minimum. The 
energy minima depict particle distances where flocculation or aggregation can 
occur, whereas the energy maximum represents the energy barrier that prevent 
particles from coming into contact.4 To provide colloidal stability, it is necessary 
the energy maximum to be much larger than the thermal energy of the particles, 
which usually is in the order of magnitude of ???.1 
According to DLVO theory, there is a dependency between the balance of 
forces and the ionic strength due to screening effects caused by counter ions 
present in solution.2,5 At low ionic strength or high surface charge densities, the 
repulsive forces are less screened and the interaction is dominated by the double 
layer contribution. At high salt levels, the interaction is dominated by the attractive 
van der Waals forces,2 which explains the poor stability in a high ionic 
concentration medium. In this context, the insight provided by the DLVO theory 
allows researchers to better control the stability of particles by improving surface 
 
Figure 3.2: a) Illustration of the electric double layer model showing the Stern, the 
Diffuse layer, as well as the shear plane where the zeta-potential is measured. Adapted 
from 4. b) Representation of the zeta-potential of CaCO3 particles dispersed in ultra-pure 
water. The isoelectric point (IEP) represents the pH in which the net charge is equivalent 
to zero. Adapted from 7. 
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charge densities, changing the environmental conditions or functionalizing the 
particle surface. 
3.3. The electric double layer and zeta-potential 
Inorganic colloidal particles establish a surface charge in aqueous media.6 
Usually, the protonation or deprotonation of surface groups as a result of the 
environmental pH is one of the different mechanisms responsible for inducing the 
surface charge. As reviewed elsewhere,4 oxide particles present hydroxyl groups at 
their surface that can deprotonate and establish negative charges, or protonate, 
yielding positive charges. Similarly, amino groups can protonate and carboxyl 
groups deprotonate, leading to positively charged -NH3+ and negatively charged -
COO- groups. 
As a result from the colloidal surface charge, an electric field is established 
around colloidal particles in aqueous solution.4 This is able to trap a layer of 
oppositely charged counter-ions around the particles, commonly known as electric 
double layer (Figure 3.2a). This double-layer is comprised of a first layer of 
counter-ions, the so-called Stern layer, and the Diffuse layer, which consists of 
both mobile cations and anions. A common parameter to characterize colloids in 
solution is the zeta potential (Ψζ). This parameter is represented in Figure 3.2a, as 
the electrostatic potential measured at the shear plane between the double layer and 
the bulk medium.4 
For particles with amphoteric surfaces, the surface charge of a particle is 
dependent on the pH of the suspension (Figure 3.2b).4 At pH values near the 
isoelectric point (IEP), which is defined as the pH in which the charge is equal to 
zero, the overall surface charge reduces and with that, so does the repulsive ??? 
force which leads to particle aggregation. For CaCO3 in Millipore water, the 
measured IEP is around 6, proving that a stable suspension is just possible at basic 
environments. In acid conditions, as previously shown, the particles rapidly 
dissolve. Moreover, the stability of a suspension is commonly associated by high 
zeta potential, with a magnitude higher than 30 mV. 
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4. CaCO3 particles and their cellular interactions 
Overview: Chapter 4 first describes the principles of drug delivery and then 
highlights relevant papers that use calcium carbonate colloids as delivery vehicles, 
followed by a description of the colloidal properties, like size, morphology, and 
surface charge, and their influences on the cellular response. In addition, the 
formation of protein-corona is described and its effect in the particle stability is 
highlighted. Finally, a brief overview is also given on the surface functionalization 
of CaCO3 carriers. 
4.1. Principles of drug delivery 
The development of effective ways to deliver molecules to targeted tissues using 
nanoparticle systems can improve the therapeutic outcome of several clinical 
diseases, including cancer,1,2 cystic fibrosis3 and other infectious diseases.4 Over 
the past 3 decades, researchers assessed the role of nanoparticles in the delivery of 
proteins, genes and therapeutic drugs.5 A critical assessment of the results obtained 
in this field is given in this section, along with a description of drug delivery 
systems (DDS) for controlled and sustained release, as well as the controversy on 
the enhanced permeation and retention effect (EPR effect). 
The rationale behind the use of nanoparticles as delivery systems comes from 
the idea of a “magic bullet”,6,7 first idealized by Nobel Prize winner Paul Ehrlich. It 
describes a drug that is able to selectively target and hinder the growth of 
infected/tumor cells without harming healthy cells. In a way, a particulate system 
could potentially do as described as long as its physical and chemical properties are 
well adjusted. The first strategy is inspired by microorganisms, which are already 
designed for the interaction with selected cells in our body.5 By mimicking the 
physical and chemical properties of virus and bacteria, nanoparticle systems might 
be able to interact with cells in a similar way. As reviewed by Yoo and colleagues,5 
particle systems are reported to be functionalized with external viral capsid 
structures and peptides for immune recognition. In this context, Nicolas and co-
workers6 reviewed possible ways for particle functionalization with ligands aiming 
specific cell targeting. Due to easy functionalization, lipid-based particles emerged 
as the pharmaceutical vehicle of choice with the approval of several liposomal 
formulations.8,9 In addition to lipid, polymers like chitosan and poly(lactate)6,10,11 
also received special attention as they are well tolerated by the body. 
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Besides the functionalization ability, delivery systems based on the particles 
also benefits from the protection against premature degradation in the body as well 
as from the solubilization of hydrophobic molecules, as reviewed by Peer9 and 
colleagues. This review also shows that particle distribution can passively target 
solid tumors by the so called EPR effect.9 This effect describes the extravasation of 
particles from “leaky” blood vessels into the tumor tissue. As normal tissues have 
intact blood vessels, the drainage of particles occurs predominately around solid 
tumors.12 Despite a huge body of work based on this effect,13 the passive targeting 
still did not translated to clinical formulations.7,14 
Nanoparticle-based drug delivery systems are designed to release the cargo 
molecules in a controlled manner, aiming to reach the minimum therapeutic 
concentration for extended periods.15 The release of molecules can occur by at least 
three different mechanisms: i. diffusion through the carrier;16 ii. carrier erosion or 
dissolution;17 iii. osmotic-controlled release, in which the release is controlled by 
the diffusion of water from the body to the interior of the carrier. In this context, 
more than one mechanism can occur simultaneously. Attempting to improve on the 
delivery ability, recent reports show the design of smart nanocarriers based on 
biodegradable hydrogels,1,18 lipids and inorganic materials,14 which are capable of 
sensing the environment and triggering the release accordingly.19  
It is worth point out that despite decades of research, the improvements to actual 
clinical delivery formulations are marginal.2 Critical assessments on this 
topic2,4,20,21 showed that in order to advance on the already established delivery 
systems, researchers need to focus on improving the encapsulation and delivery 
efficiencies, targeting abilities, in vitro models and theoretical simulations, and 
especially, improve clinical trials. In addition, Lepeltier and colleagues4 and Pelaz 
and colleagues20 highlight that the focus of nanoscience should not be limited to 
cancer research, but also towards infectious diseases and biological devices. 
4.1.1. Delivery of biomolecules using calcium carbonate colloids 
In the case of CaCO3, the potential application as drug delivery system benefits 
from the high  biocompatibility and also the pH-sensitivity of this material.22 In 
this section, a literature overview is given on the use of CaCO3 as carriers of large 
biomolecules and low molecular-weight pharmaceutical agents. 
Biomolecules, like amino acids, proteins and peptides, consist of chains of 
amino acids folded into a specific three-dimensional structure, which provides its 
biological activity.23 Due to their biological activity and chemical and enzymatic 
instability,24,25 the delivery of biomolecules can be very challenging. The delivery 
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vehicles provide protection from the environment while also avoid
degradation and loss of activity. 
As reviewed by Sharma and co-workers,10 biomolecules 
approach for treating genetic diseases or cancer and can also be used in vaccination 
and imaging. CaCO3 sub-micrometer particles (300 nm in diameter) prepared by 
direct precipitation have shown to improve the delivery of insulin transdermally in 
both normal and diabetic mice.26 At the nanoscale, another report
nm lipid-coated CaCO3 particles are successfully loaded with a therapeutic peptide 
by the double-emulsion technique and were tested with a lung cancer cell line. 
Accordingly, this system can also retard tumor growth in vivo
Fujiwara and colleagues28 described the synthesis of mesoporous capsules with a 
diameter of around 5 µm. These particles successful encapsulated
albumin and lysozyme. Kon et al.29 reports the synthesis of hybrid particles 
prepared by the direct precipitation technique which are capable of encapsulating 
both Amylase and gold nanoparticles. Figure 4.1a displays the sustained release 
profile of Amylase within 24 hours as well as the calculated enzymatic activity, 
which remained fairly constant at around 90%. This paper is a prime e
how useful CaCO3 particles can be for the long-term delivery of biomolecules
minimal loss of activity. 
The delivery of low molecular-weight drugs can also benefit from the protection 
and site-targeting offered by nanoparticles, e.g. in cancer treatment.
by Dizaj and colleagues,30 calcium carbonate particles have been tested for the 
encapsulation and release of anti-neoplastic drugs, like doxorubicin,
Figure 4.1: a) The release and activity profile of amylase from CaCO
Reproduced with permission 29. b) Camptothecin release profile from CaCO
pHs. Reproduced with permission  39. 
ing their 
delivery is a safe 
27 shows that 70 
. At the microscale, 
 and released 
xample on 
 with 
10 As reviewed 
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etoposide,35 methotrexate,36,37 and camptothecin.38,39 Moreover, the sustained 
release of small anti-microbial gentamicin molecules have also been reported.40,41 
The release profile of gentamicin occurs within 120 hours at pH 7.4 (Figure 4.1b). 
At pH 6 and 4, the release is completed in under 5 hours. Considering the 
differences in the release profile that occurs at acidic and neutral pH, the sensitive 
release can play major role in intracellular delivery to acidic endosomes as well as 
to acidic cancer microenvironments. 
4.2. Assessing the in vitro cellular response 
In order to gain insight on the effect of the colloidal properties on the cellular 
response, it is first essential to understand what these responses are and how they 
can be measured in vitro. Usually, particles are seeded to a model cell line by 
means of a suspension or an aerosol formulation depending on the desired 
administration route to be simulated.42-44 In this thesis, the particles are added to 
the cells as a particle suspension dispersed in appropriate cell culture medium 
(Figure 4.2). The particles are subjected to diffusive and sedimentation forces,45 
and with that, are transported to the cells where they can interact and the cellular 
outcome is assayed. One of the possible cellular responses is cytotoxicity, which is 
the quality of being toxic to cells. Toxicity can encompass a variety of cell fates, 
such as necrosis,46 halt of cell growth and even apoptosis.44 Among several 
different techniques to quantify the cytotoxicity of biomaterials, in this thesis, the 
mitochondrial activity and cell membrane damage assays are chosen. Another 
possible interaction of nanoparticles and cells is the internalization, which is 
characterized by the crossing of a cellular membrane.44 In the case of fluorescently-
labeled particles, the cellular internalization can be assessed by means of 
fluorescence microscopy. Otherwise, the internalized nanoparticles can be 
analyzed by transmission microscopy of biological samples.47 Taking into 
consideration the standard techniques that make possible the assessment of cellular 
response, most studies have focused on the effect of three colloidal properties: 
particle size, surface charge and morphology.13 
4.2.1. The effect of particle size 
Due to their small size, engineered nanoparticles can interfere with several 
biological functions, like biodistribution, clearance by macrophages48 and escape 
from blood circulation through the leaky tissues in solid tumors.13 Moreover, 
particles in the size range of 5 nm to 1 µm can potentially interact with cells as 
they are in the same size range as the structures that regularly interact with cells, 
like proteins, extracellular matrix fibers, bacteria and viruses.49,50 Furthermore, at 
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this scale, it is recognized that colloids can cross lipid-based membranes,51 and in 
some  cases, disrupt normal cellular functions.47 
Recent in vitro studies describe the relevance of particle size on toxicity, cellular 
uptake and inflammatory response.52,53 It is reported that the use of latex beads 
with size ranging from 50 to 500 nm revealed that both the mechanisms of 
internalization as well as the localization of particles within murine tumor B16 cell 
line are size-dependent.54 Accordingly, the beads smaller than 200 nm are 
internalized by the clathrin-mediated mechanism, while larger particles are 
internalized via the caveolae mechanism.  
Another study on the internalization of polystyrene particles in human 
astrocytoma and human lung carcinoma cell lines shows that 40 nm particles are 
internalized faster than 100 nm.55 Moreover, at the nanometer scale, it is now a 
general consensus that smaller particles (2 and 6 nm) are internalized at higher 
quantities than larger (around 15 nm) particles.56 It is also reported that 64 nm 
polystyrene nanoparticles can drive the inflammatory response of in A549 cell line 
to a higher extent than larger 202 and 535 nm particles.57 All these findings 
corroborate to the idea that the undesirable effects of engineered nanoparticles, like 
cytotoxicity and inflammatory responses, are size-dependent. 
Considering that the particle size an important parameter to be controlled in 
 
Figure 4.2: Representation of the 
different zones involved in the in vitro 
assessment of cellular interactions. (1) 
The particles in a suspension are 
transported to the monolayer of cells by 
sedimentation and diffusion forces, where 
they can interact (2) resulting in either 
toxicity or improved cell viability. (3) 
Another possible interaction is the 
particle internalization within the uptake 
zone. 
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delivery system, the particle aggregation in medium should be considered when 
designing the system. As reviewed by W. Stark,51 particles in suspension are 
subjected to Brownian motion and as a result of interparticle collisions, the 
agglomeration rate, ????? , is primarily dependent on the square of nanoparticle 
number concentration (??), according to equation 4: 
????? = − 4 ???3 µ ? ??? Eq. 4 
where ? is the Fuchs stability ratio, ??? thermal energy and µ viscosity. 
According to equation 4, the agglomeration rate does not directly depend on 
particle size, but on the number concentration. This explains why nanoparticle 
suspensions tend to agglomerate faster than microparticle suspensions even when 
having the same particle mass concentration. The aggregation will reduce the 
mobility of the particles, and as a result, it can potentially alter the size-dependent 
toxicity profile described above. 
4.2.2. The effect of particle shape  
Viruses and bacteria are a prime example on how morphology can mediate the 
in vivo interactions and functions. As reviewed by Albanese,50 viruses occur in a 
variety of different shapes, like icosahedral, bullet-shaped, or rod-shaped or have 
even asymmetric morphology. Accordingly, it is recognized that the geometries 
dictate their ability to infect specific cell types and may alter their residence time 
inside the cell. 
In regard to synthetic particles, their design and function in vivo can benefit 
from the understanding gained from biological systems. It is now a general 
consensus that the uptake of particles by cells scales with aspect ratio.58,59 
Parakhonskiy et al.60 reports that the frequency of internalized calcium carbonate 
particles into non-phagocytic cells increases with elongated particles in the 
micrometer range. The same holds true for the internalization of particles in the 
nanometer scale. According to Huang and colleagues,61 mesoporous silica particles 
with larger aspect ratios (2 – 4), were taken up in larger amounts and had faster 
internalization rates. 
It is worth mentioning that the aforementioned behavior varies according to cell 
type. In the case of macrophages, the engulfment of anisotropic particles is 
orientation-dependent. The control over macrophages uptake is especially 
interesting in pulmonary application, as the major mechanism of defense in the 
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lungs against exogenously inhaled particles is by macrophage clearance. As 
reviewed by Champion and colleagues,62 large polystyrene particles (within 1 to 5 
µm) are rapidly taken up by macrophages (Figure 4.3, c). However, particles with 
anisotropic geometry may hinder the macrophage engulfment depending on the 
attachment orientation. Moreover, it has been reported62 that ellipsoidal particles 
attached to a macrophage at the pointed end are internalized within a few minutes 
while attached to flat side, the particles are not internalized over extended periods. 
As a result, the particle anisotropy is a feature that can possibly hinder rapid 
macrophage clearance of synthetic particles but can improve uptake by non-
phagocytic cells.62,63 
4.2.3. The effect of particle charge 
The particle charge also plays an important role on cellular influences, as 
reviewed elsewhere.64–66 The general consensus dictates that charged particles are 
more toxic than neutral forms and also that positively-charged particles act more 
toxic than negatively-charged ones.64,65 The same holds true for cellular uptake, in 
which the positively charged particles have enhanced association with the 
negatively charged cell membranes, which results in particle internalization.67 It is 
shown that at the micrometer scale, uptake of polystyrene particles by dendritic 
cells is improved with particles that display a positive net charge.68 However, it is 
worthwhile mentioning that research has also shown that anionic nanoparticles can 
be internalized at a faster rate than their positive counterparts depending on the 
mechanisms of internalization.64 In regard to phagocytic cells, the internalization 
occurs preferentially with negatively charged particles.65 This can be associated 
with the fact that macrophages evolved to ingest of bacteria, which display a net 
negative charge. Moreover, according to Lee and colleagues,15 an increase in the 
magnitude of surface charge also favors the uptake of chitosan nanoparticles by 
macrophages. 
The generalization of such effects may not always hold true as a result of 
different nanoparticle surface chemistry as well as cell types.6765 Moreover, the 
charge of the particles is highly dependent on the pH, ionic strength and on the 
presence of ions or molecules that can physically adsorb at the particle surface. 
Consequently, analytical measurements for surface charge determination should be 
performed in a nutrition medium that mimics the pH as well as the main 
constituents of serum, like proteins, amino acids and ionic strength.  
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4.3. The formation of protein-corona 
Engineered nanoparticles have high zeta-potential in water, which allows them 
to form stable dispersions. However, upon dispersion in cell nutrition medium, the 
suspension loses its stability as a result of high protein content and high ionic 
concentration. The adsorption of charged proteins onto particles is known as 
protein-corona.69 Accordingly, the protein-corona can not just affect
stability in medium but also significantly alters the cellular interactions.
The process of corona formation occurs due to an increase in the entropy upon 
adsorption of proteins onto the surface of the particles.70 As shown in Figure 4.4, 
proteins attach to or detach from the particle surface with varying rates according 
to their equilibrium constants (??).74 This process can be difficult to 
varies depending on the intrinsic physicochemical properties of the particles, like 
size, surface functionalization, hydrophobicity and surface roughness.
this is a dynamic process, both in terms of corona composition and also in regard to 
the strength to which the proteins are attached to the particles.70 
In order to gain insight on the variation of surface charge and aggregation 
behavior as a result of protein-corona formation, Limbach and colleagues
assessed the zeta-potential of common engineered oxide nanoparticles in both 
Millipore water and serum-supplemented nutrition medium. As reported, the 
colloidal stability scales with the magnitude of the zeta-potential: the higher the 
zeta-potential, the more stable is the suspension and less likely to occur 
aggregation. For suspensions in Millipore water at pH 7.4, the zeta-
a wide range of zeta potential, ranging from -25 to +55 mV. However, upon 
Figure 4.3: Macrophages uptake depends on orientation for asymmetrical exogenous 
particles (a, b), while is just size dependent for spherical particles (c). Reproduced with 
permission 62. 
 colloidal 
70–73 
predict, as it 
70 Moreover, 
75 
potential covers 
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redispersion in cell culture medium, the nanoparticles undergo protein adsorption, 
which results in comparable low surface charge density, under -25 mV, and favors 
rapid agglomeration. 
In regard to the effect on the cellular interactions, positively-charged particles 
are known to strongly bind to proteins in the medium, which can reduce cellular 
uptake due to particle aggregation.67 According to Shahabi and colleagues76, the 
presence of protein in cell culture medium caused a shift in surface charge of 
mesoporous silica particles from +36 mV to -10 mV as a result from the formation 
of a protein-corona. The particles are internalized at a lower number when 
compared to the absence of a protein-corona. 
In the case of calcium carbonate, the protein corona plays an important role not 
just on colloidal stability but also on phase-transformation. Svenskaya et al.77 
reports the formation of a protein-corona in a suspension of CaCO3 particles with 
an average size of 900 nm incubated in cell culture medium supplemented with 
10% inactivated fetal bovine serum (FBS). Accordingly, the major highlight of this 
paper is the description that the particles phase-transformation is suppressed 
because of the corona surface stabilization up to 168 hours. In a similar study on 
the composition of the protein-corona, CaCO3 has its isolectric point around pH 
6,78 which means that this material is negatively charged at physiological pH. 
Consequently, there is a preferential adsorption of positively-charged proteins, like 
immunoglobulin, apolipoprotein, thrombin and fibrinogen.79 
 
Figure 4.4: Representation of protein-corona formation in serum-supplemented medium. 
Adapted from 74.  
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4.4. Approaches for surface functionalization 
As the primary contact between cells and nanoparticles occurs via the particles 
surface, it is possible to control their interactions by tailoring the surface 
properties.71 One interesting example of this interplay can be found in particles 
delivered by intravenous infusion: functionalized particles with poly(ethylene 
glycol) (PEG), also referred as PEGylation, can hinder the opsonization and 
therefore avoid immune recognition and premature clearance.80 Moreover, the 
functionalization of particles with antibodies enables active targeting of specific 
cells by nanoparticles.80 
Surface modification using calcium carbonate can be complicated, as this 
material can dissolve at acidic pH or phase-transform to more stable polymorphs in 
buffers and solvents. Most common techniques used for the functionalization of 
CaCO3 particles have been reviewed elsewhere,10,81 and are depicted in Figure 4.5. 
The methods for surface functionalization can be sorted in three distinct categories: 
the chemical modification by silane coupling agents or covalent binding (a), the 
adsorption of polyelectrolytes (b) and the use of additives during mineralization 
(c). 
The coupling of silane agents at the calcium carbonate surface is an efficient 
method and occurs by a condensation-like polymerization, in which hydroxyl 
groups at the particle surface react with the coupling agent. In this controlled 
reaction, the particles are capped with the organic compound. As the organic 
chains can have different functional groups and chain lengths, this technique is 
very useful for improving stability in medium as well as for anchoring further 
functionalization moieties. Silanization is reported to improve colloidal stability by 
steric hindrance provided by large silane molcules.82,83 Other functionalization 
methods based on covalent binding have been reported for CaCO3 particles, for 
example: the EDC/NHS cross-linking of carboxylates with primary amines to 
functionalize particles with rabies virus glycoprotein peptide84 and the biotin-
avidin binding method34 to functionalize the particles with a specific aptamer for 
cancer cells.  
One limitation of the chemical modification technique is that the particles need 
a high concentration of specific surface groups, otherwise the reactions will not 
occur or occur at low yields. Moreover, in the case of silanization, due to the 
monolayer of silane formed around the particles, the nature of the particle is 
changed, which can affect nanoparticle-cellular interactions and degradability.  
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Another possible way to modify the surface of particles is based on the 
physisorption of polyelectrolytes. Poly(ethylenimine) (PEI) was reported to 
improve the stability of CaCO3 particles in medium upon physisorption.85 In a 
similar way, the layer-by-layer technique86 uses templates for the successive 
adsorption of polyelectrolytes with opposite charge (Figure 4.5b). The primary aim 
of this technique is the formation of a cohesive polymeric capsule upon template 
dissolution. However, if the template is not dissolved, core-shell particles are 
formed.60,87 The control of the surface charge by polymer adsorption is reported to 
improve cellular uptake60 as well as to regulate hydrophobicity of carriers by 
adsorption of muco-adhesive polymer and surfactants.87 As a large variety of 
organic molecules can be absorbed, they can provide additional chemical activity 
and a variety of different surface groups for further functionalization. However, 
due to the weak electrostatic interaction, these adsorbed molecules are likely to 
desorb in changing conditions.  
 
Figure 4.5: Surface functionalization approaches for CaCO3 particles: a) Chemical 
modification by silanization. Adapted from 83. b) Layer-by-layer adsorption of 
polyelectrolytes (e.g. poly(ethylenimine)) with opposed charge to the particle surface. 
Adapted from 90. c) Modification by inclusion of additives during mineralization. 
Hydrophilic-hydrophobic copolymers form micelles in water. After mineralization, the 
hydrophilic tales (poly(ethylene glycol)) provide steric stabilization. Adapted from 88 
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One of the most promising techniques to functionalize CaCO3 is by using 
additives during the mineralization process. Different types of additives have been 
described on Chapter 2. However, now these additives not just control the 
mineralization but also provide the surface functionality (Figure 4.5c). Copolymers 
are very useful in this case because one part of the polymer can modify the 
precipitation while the other provides the surface functional groups. Copolymers 
like Poly(ethylene glycol)-b-poly(L-aspartic acid) (PEG–PAsp)88 are reported to 
both mediate the CaCO3 mineralization and provide the stealth protection of PEG 
molecules. Similarly, a tri-block copolymer was reported to provide coronal PEG, 
poly(L-aspartic acid) (PLA) as the crystallization-mediator, and the hydrophobic 
poly(L-phenylalanine) (PPhe) as the hydrophobic core.89 The resulting particles are 
used to deliver hydrophobic docetaxel to a cancer cell line. 
4.5. Biomedical applications of calcium carbonate particles  
A large body of work is being generated with a focus on calcium carbonate 
colloids for biological applications. Here, a few selected and promising areas of 
research are highlighted. As shown in Chapter 2, the solubility product of this 
material greatly increases in acidic environments. The released carbonate ions are 
studied as a potential pH buffer.91,92 Som et al.91 prepared CaCO3 nanoparticles that 
exhibited the ability to persistently neutralize the extracellular tumor 
microenvironment. As a result of this pH neutralization, a halt in growth of solid 
tumors is reported. Following the same idea, Raliya and co-workers92 showed that 
vaterite nanoparticles can maintain neutral gastric pH values three times longer 
than commercially available antacids.  
Another topic of research is related the preparation of bioactive scaffolds for 
osteogenic bone implants and tissue engineering as a result of optimal CaCO3 
biodegradation.93,94 Microparticles are reported to be prepared in bulk quantities 
and used either as a suspension or shaped into the desired scaffolds. In the case of 
bone implants,93 microparticles comprised of both amorphous and vaterite phases, 
are used to promote osteogenic activity due to the release of calcium ions. It is 
highlighted that these implants are highly osteogenic when prepared with the pure 
calcite phase, which turns out to be biologically inert. Moreover, Affolter-
Zbaraszczuk and colleagues94 reported a system for tissue engineering using hybrid 
organic-inorganic materials with promising build-up of any type of targeted tissue. 
This system is optimized by the presence of extracellular matrix components like 
gelatin, hyaluronic acid, fibronectin, which in combination with CaCO3 
microparticles allows substantial cell adhesion and growth. An advantage of using 
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scaffolds prepared out of this material in comparison to hydroxyapatite is the 
complete degradation within 3 months when placed in a bone defect.95 
Recently, CaCO3 particles are also studied as an ultra-sound contrast agent. For 
this application, particles with size ranging from 150 - 220 nm are synthesized 
either by the direct precipitation technique with addition of block-copolymers88,96 
and alginate97 or by emulsification.84 The systems are based on the release of CO2 
upon CaCO3 dissolution in acidic environment, e.g. in tumor microenvironments. 
The released CO2 enhances the ultra sound signal, acting as a contrast agent. Since 
CaCO3 particles do not normally dissolve at physiological pH, this system holds 
potential for tumor imaging. 
Another potential use of calcium carbonate particles is in the photodynamic and 
photothermal therapy, which are emerging alternatives for the treatment of tumors 
and bacterial biofilms.98 In the photodynamic therapy, a light-sensitive molecule is 
irradiated with a laser source, which leads to an electronic excitation of the 
photoactive dye. As a result, singlet oxygen species are produced and elicit cell and 
bacteria death.98 Commonly used photosensitizers are chlorin E688,99 and 
sulfonated aluminum phthalocyanines, which are encapsulated within CaCO3 
particles and released at the target site.77 Similarly for photothermal therapy, 
localized heat is generated by light absorption in the near infrared wavelength, 
which causes cell death. For that, light sensitive materials are encapsulated, like 
polyaniline (PANI)38 or even functional nanoparticles, like iron oxide100 or gold.101 
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5. Experimental methods and principles 
Overview: The following chapter describes the characterization techniques utilized 
in this dissertation as well as highlights the key fundamentals aspects of each 
method. 
5.1. UV-Vis spectroscopy 
Ultraviolet-visible spectroscopy is a technique that uses the absorption or the 
reflectance in the visible range as an analytical method for the quantitative 
determination of the concentrations of dissolved molecules in a specific medium. 
In this thesis, this is used for the quantification of calcium ions and proteins in 
buffers.  
5.1.1. Quantification of calcium ions in solution 
The free calcium ion concentration is quantified using a colorimetric method 
based on o-cresolphthalein complexone.1 The kit Fluitest CA-CPC was purchased 
from Analyticon Biotechnologies AG and assayed using the Multiskan GO device 
(Thermo Scientific). For that, the suspension to be analyzed was centrifuged at 
5000 rpm for 5 minutes to remove dispersed particles. From the centrifuged 
solution, 10 µL of the supernatant was transferred to a 96-well plate containing 
 
Figure 5.1: Concentration curve obtained for free calcium ion detected using Fluitest CA-
CPC kit. The curve is prepared by a serial dilution of the standard 2.5 mM acquired with 
the kit. 
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50 µL of Reaction Mixture 1 Buffer pH 10.7 (2-Amino-2-Methyl-1-Propanol 
buffer). Another 50 µL of Reaction Mixture 2 (o-cresolphthalein complexone) was 
then added to the well plate and shaken for 30 s to allow homogeneous mixing. 
Under alkaline condition provided by the buffer, the calcium-o-cresolphthalein 
complex is formed. This compound has a bright purple color and adsorbs at 570 
nm.  
The absorbance of the resulting complex can be correlated to the calcium 
concentration with a standard concentration curve, as shown in figure 5.1. 
According to the company, the absorbance values are stable from 5 minutes to 1 
hour after preparation. In chapter 6 and 8, the calcium concentration in the sample 
is calculated using standard curve by a serial dilution of the standard 2.5 mM 
acquired with the kit. 
5.1.2. Quantification of proteins in buffer 
Proteins can be quantified in the near UV at 280 nm due to the presence amino 
acids with aromatic rings and at 200 nm due to peptides bonds.2 The protein 
absorbance (??) can be correlated with the protein concentration described by 
Lambert-Beer law, ?? = ???, where ? is the extinction coefficient (which varies 
from protein to protein), ? is the protein concentration and ? is the length of the 
cuvette. However, this technique is deemed unreliable as impurities could affect 
the extinction coefficient and the absorbance intensities.3 Accordingly, the 
quantification of protein used in this thesis is based on standard concentration 
 
Figure 5.2: BSA and LSZ standard curves measured at 280 nm. The equations represent 
the linear regression used for the calculation of the protein concentration.  For all 
experiments, protein quantification was performed in the linear range of the standard 
curve. 
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curves prepared prior to each experiment, as can be seen in Figure 5.2 for bovine 
serum albumin (BSA) and lysozyme (LSZ). The use of standard concentration 
curves allows for direct comparison between absorbance and protein concentration. 
More detail on this technique is described in chapter 6. 
5.2. Fluorescence spectroscopy 
Fluorescence (FL) spectroscopy is an analytical technique that uses the 
fluorescence properties of molecules in the UV range for the quantitative 
determination of concentrations4 or for imaging purposes.5 All molecules are 
known to interact with the electromagnetic radiation by the first law of 
photochemistry.6 The absorption of photons in a molecule by the irradiating light 
excites the electrons from the ground electronic state to a higher energy level, the 
excited electronic state.4 Collisions with other molecules and internal conversion 
can cause these electrons return to a ground electronic state of energy, which 
occurs with the emission of a photon with a lower frequency than the photon 
absorbed, referred as Stokes shift.5 This technique is used to assess the release of 
Rhodamine B from CaCO3 particles, for the quantification of the quantum yield of 
carbon nanodots (Chapter 7) and for fluorescence imaging (Chapter 8).  
5.2.1. Quantification of Rhodamine B in PBS 
FL spectroscopy is used for quantification of released Rhodamine B (RhB), a 
positively-charged, hydrophilic dye. Firstly, standard curves are generated by 
dissolving different amounts of RhB in phosphate-buffered saline (PBS) buffer at 
pH 7.4. The fluorescence emission intensities of the RhB solutions prepared at 
different concentrations (4, 8, 16 µM) are recorded at 485/590 nm 
Excitation/Emission using a microplate reader (Plate Chameleon II model 425-
155). The concentration curve is plotted in the Figure 5.3a, as well as the variation 
in the fluorescence intensities over time is plotted in the Figure 5.3b.  
5.2.2. Determining the fluorescence quantum yield of carbon nanodots 
The fluorescence quantum yield (Q.Y.) is defined as the ratio of photons 
absorbed and the photons emitted through fluorescence.7 Accordingly, it describes 
the probability of the excited state being deactivated by fluorescence rather than by 
non-radiative mechanisms.7 For the measurement of the quantum yield of carbon 
dots (CDs), a comparative method was used.7 In this method, a standard reference 
dye8 with known quantum yield was used to determine the yield of the sample. 
Here, 4′,6-Diamidin-2-phenylindol (DAPI) was used as reference, which has a 
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quantum yield of 4% in water.9 The DAPI dye has a maximum excitation at 
358 nm and emission at 461 nm.  
Due to the similar excitation and emission wavelengths to the carbon nanodots, 
which absorbs at 360 nm and emits at 470 nm, this dye was deemed suitable for the 
determination of the quantum yield of CDs. The quantum yield measurements were 
performed in an Infinite 200 PRO device (Tecan). Both the reference material and 
the sample were prepared at different concentrations in the selected medium, and 
the absorbance and fluorescence spectrum were recorded (Figure 5.4 a, b). It is 
important to mention that the absorbance intensity should not exceed 0.1. 
Moreover, the fluorescence spectrum needs to be integrated over the entire 
spectrum in order to obtain the overall emission of photons by fluorescence. By 
plotting the integrated photo emission and the intensity of absorbed photons, a 
straight line is observed with intercept at (0,0) and slope m (Figure 5.4 c). By 
comparing the slopes, it is possible obtained the Q.Y. of the sample (Figure 5.4 d). 
In this example, the slope m obtained for DAPI is 1x108, while m = 6x106 for CDs. 
By comparing the slopes, the calculated value for the quantum yield of CDs is 
0.24%. 
 
Figure 5.3: Concentration curve of Rhodamine B plotted from 0 to 96 hours of incubation 
in PBS buffer at pH 7.4 (a). The variation in the fluorescence intensity over 96 hours 
dissolved in the same medium (b). 
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5.3. Dynamic light scattering  
Dynamic light scattering (DLS) is a method used primarily to determine the 
particle size distribution and zeta-potential of colloidal dispersions or molecules in 
medium. For that, a dispersion in water is illuminated with a monochromatic, 
polarized laser light with a wavelength in the range of 350 to 
scattered light intensity is measured by a photon detector either at 173° or 
Due to the change in the wavelength that occurs when light is scattered by a 
particle subjected to Brownian motion, a phenomenon known as Doppler shift, it is 
possible to measure the diffusion coefficients of the particles. These are then 
converted to particle size distribution and polydispersity using a correlogram
Moreover, by applying an external magnetic field with a defined strength, it is 
possible to measure the electrophoretic mobility of the particles using 
Figure 5.4: Quantum yield of carbon dots using DAPI as standard. a) Absorbance 
measurements at different CDs concentrations. b) FL measurements at different CDs 
concentrations. c) Slope determination of CDs by plotting the Integrated FL versus the 
Absorbance. d) Integrated FL versus the Absorbance plots for both DAPI and CDs. 
dissolved in the same medium (b). 
680 nm. The 
13°.10 
. 
also 
the Henry 
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Equation, and with that, the calculation of zeta potential is possible. These two 
techniques are used in chapters 6, 7 and 8. 
5.3.1. Size measurement using DLS 
According to 11, by illuminating the suspension with a monochromatic laser 
light, the scattered intensity is time-dependent when observed on a microsecond 
time scale. The intensity fluctuations reflect the rate of diffusion of the particles. In 
this technique, autocorrelation functions are used to extract the time dependence of 
a signal from the noise. From the decay of the correlation function (Figure 5.5 a), 
the diffusion coefficient (?) is calculated by ? = ???, where ? is the exponential 
decay rate and ? is the modulus of the scattering vector. Using the Stokes-Einstein 
equation ?? = ??? ???, it is possible to convert the diffusion coefficient into the 
hydrodynamic radius (??) taking into account the Boltzmann’s constant (?), the 
temperature (?) and the medium viscosity (?). Accordingly, the ?? represents the 
radius of an equivalent rigid sphere that diffuses at the same rate of the measured 
sample.  
The size distribution curve (Figure 5.5 b) derived from the correlogram can 
display a large range of particle sizes, from 0.1 nm to 5 µm. The variation in the 
size distribution can be related to the natural variations in the synthesis processes 
 
Figure 5.5: a) Representative 
correlogram. b) Illustration of the 
intensity-averaged size distribution. 
Adapted from 11. 
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or even to particles aggregation. The term that coins the degree of particle-to-
particle size variability is known as polydispersity index (PdI), which is 
dimensionless and ranges from 0 to 1. 
5.3.2. Zeta-potential measurement using DLS 
The concept of zeta-potential was previously described in chapter 3. This 
section will focus on the measurement of zeta-potential via the dynamic light 
scattering technique. As described above, DLS measures the particle mobility 
based on the Doppler shift (??). By applying an external field, the movement of the 
particles (electrophoretic mobility, ??) can be calculated by laser Doppler 
velocimetry (LDV).11 For that, a pair of mutually coherent laser beams derived 
from a single source is used. One of the laser beams is set as the reference, while 
other is passes through the sample. The electrophoretic mobility can be calculated 
using the Doppler shift equation, ?? =  ??? sin ??, where ? is the particle velocity 
(electrophoretic mobility), ? is the laser wavelength and ? the scattering angle. The ?? can be transformed into zeta-potential (?) using the Henry equation, ?? =? ???(??)
? ? . The term ?(??) stands for the Henry’s function, ? for the dielectric 
constant and ? for viscosity. ?? is a measure of the ratio of the particle radius to 
the Debye length. 
5.4. Electron microscopy 
Due to the limited resolution of conventional optical microscopes, which is 
determined by the wavelength of visible light, the use of electrons for imaging is a 
powerful tool. This technique allows for higher resolving power, surpassing the 
diffraction limit in light microscopy.12 The basic idea of electron microscopy 
involves a primary electron beam that is generated by thermionic emission in a 
cathode filament. The beam is focused by electromagnetic lenses and accelerated 
towards the specimen. Depending upon the technique, either the backscattered 
electrons or the transmitted electrons are detected and used for the image rendition. 
Two types of electron microscopes were used in this thesis: the Scanning Electron 
Microscope (SEM) and the Transmission Electron Microscope (TEM). This 
technique is used for the characterization of particle size and morphology in 
chapters 6, 7 and 8. 
5.4.1. Scanning electron microscopy 
SEM micrographs are created, as the name suggests, by scanning the surface of 
the sample in a raster scan pattern. According to 12, the primary electrons interact 
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with the sample within a volume, known as interaction volume. Inside the 
interaction volume, the incoming electrons can reflect back by elastic scattering. 
These are known as back-scattered electrons (BSE). Another possible event is the 
knock-out of electrons from the sample itself. These are known as secondary 
electrons (SE). Both the BSE and SE are captured by specific detectors rendering 
two types of images that differ as a result of the nature of each electron type. The 
SE detector allows for better spatial resolution while BSE for better compositional 
information, as the electrons are created deeper in the sample.  
In order to avoid accumulation of electrons at the sample surface and losses in 
image quality, conductive samples and sample holders are typically required. As 
most organic materials and ceramic samples are not conductive, the sputtering of 
gold or carbon creates a thin layer over the sample surface, which avoids electron 
accumulation. Another alternative to sputtering is the use of silicon wafers, which 
allow good electron conductivity.12 
In all SEM images used in this thesis, SEM samples are prepared as follows. 
Firstly, a suspension containing CaCO3 particles was centrifuged at 5000 rpm for 
10 minutes to concentrate the particles in a pellet. The supernatant was then 
discarded and the particles were pipetted directly to the sample holder. This holder 
is comprised of a piece of silicon wafer (4 x 4 mm) glued to the metal holder using 
a carbon tape. Samples were dried for 1 to 12 h in an oven at 70 °C prior to the 
analysis to remove any water from the samples. SEM micrographs were taken with 
a Supra 40 device (Carl Zeiss, Oberkochen, Germany) operated at 1 kV, using the 
in lens detector. 
5.4.2. Transmission electron microscopy 
In transmission electron microscopy, the electrons transmitted through the 
specimen are used for the image rendition. As the composition of the sample varies 
from point to point, so does the electron transmission. Brighter parts of the image 
indicate higher intensity of transmitted electrons. Given that, regions with higher 
atomic number scatter more electrons (i.e. by elastic scattering) and therefore 
appear darker than their surroundings. This is one the phenomena that gives 
contrast to the TEM micrographs and is known as mass-thickness contrast.12 
In this thesis, the preparation of samples for TEM is as follows. The particles in 
suspension were diluted to a concentration of 0.1 g/L in Millipore water. 5 µL of 
the solutions was pipetted onto a carbon-coated copper grid (PLANO GmbH, 
Wetzlar, Germany, Mesh 200). The grids were dried for 1 h at room temperature. 
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TEM micrographs were recorded using a Zeiss EM 900 SN 8246 operating at 
80 kV. 
5.5. X-ray diffraction 
X-ray diffraction (XRD) is a nondestructive technique for characterizing 
crystalline structures. This technique is used in chapters 6, 7 and 8. The principle is 
based around the constructive interference of a monochromatic beam of X-rays 
scattered from crystalline materials at specific angles, a phenomenon known as 
diffraction.13  
In this technique, X-rays are generated in a cathode tube in which a filament is 
heated by applying high voltages up to temperatures that cause thermionic 
emission of electrons. These electrons are accelerated towards a metal target, 
usually Cu, Fe and Mo. As the electrons hit the target at high energies, they are 
capable of dislodging inner electrons from the target material. Inside the target, 
outer electrons migrate to fill in the electron-deficient energy level. This occurs 
with the emission of characteristic X-rays. Typically, Kα X-ray is emitted and is 
used for the sample characterization. In this context, K refers to the vacancy in the 
K-energy level and α means that an electron drops from the nearest energy level, L 
energy level, to fill the vacancy. Following the The Kα X-ray emission, the beam is 
filtered to produce monochromatic radiation, collimated and directed to the sample 
 
Figure 5.6: X-ray diffraction overview of calcite, vaterite and amorphous phases. 
Amorphous structure shows no reflexes. Crystal phases: c – calcite, v – vaterite. 
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at varying angles. The angle of incidence will produce constructive interference if 
the Bragg’s law is satisfied, ?? = 2 ? sin(?). In this equation, ? is an integer, ? is 
the X-ray wavelength, ? is the interplanar spacing and ? is the diffraction angle. 
As the interplanar distances are specific for each crystalline structure, it is possible 
to differentiate different materials, crystalline phases, grain size, crystal defects, 
and even strain.13 
Figure 5.6 shows typical X-ray pattern of different crystalline phases of CaCO3 
(vaterite and calcite) and the amorphous phase. The experiments performed were 
performed in a Seiffert C300 device (GE Inspection technologies, Germany) 
operating at 40 mA and 40 kV. The beam was filtered with Ni filter to produce 
almost monochromatic Cu Kα? and Kα? radiation (λ=0.1542 nm). Diffraction 
patterns in the range of 5 to 70° were detected with a holding time of 1 second and 
a step scan of 0.025°. Powder diffraction files (PDF) of the International Centre for 
Diffraction Data (ICDD) were used to identify the crystal phases. 
5.6. Thermogravimetric measurements 
The thermogravimetric analysis describes the weight-loss of a sample as a 
function of increasing temperature, with pre-determined heating rate, final 
temperature, holding time and cooling rate. This technique provides insight in the 
chemical reactions and physical transitions that occur in the sample upon heating. 
Typical reactions, like thermal decomposition and water evaporation, occur with 
the formation of gaseous products, and therefore, there is an overall weight-loss. 
Other reactions can promote a gain in weight, e.g. corrosion of metals.14 
For the measurement, the samples were inserted within a crucible and placed 
inside a reaction chamber. This chamber can be flushed with different gases. 
Atmospheric air provides an oxidative atmosphere, while argon and nitrogen, an 
inert atmosphere is created. The weight of the sample was recorded as temperature 
increases and significant loss or gain in weight due to decomposition, oxidation, or 
loss of moisture can be detected. In chapters 7 and 8, the samples were tested using 
a STA 503 device (Bähr Thermoanalyse GmbH) heated up to 750 °C with a 
heating rate of 4 °C/min and flushed with 2 L/min of atmospheric air.  
5.7. Gas adsorption for determination of Specific Surface Area  
Gas adsorption measurement is a common technique for the characterization of 
surface area and pore size distribution of samples. Brunauer, Emmett, and Teller 
first described the fundamentals for the determination of the specific surface area 
(SSA) based on gas adsorption.15 This technique relies on the existence of a 
Chapter 5 
   
63 
 
dynamic equilibrium between free and adsorbed gas and that the covered surface is 
proportional to the partial pressure of the free gas.16 Commonly, the surface area is 
determined by volumetric measurement of nitrogen adsorption isotherms. For that, 
nitrogen is added to a chamber containing the sample to be analyzed, and the 
adsorbed amount of nitrogen is determined at various relative pressures (p/p0) at -
196 °C. Based on the physisorption isotherm to form a monolayer of Nitrogen 
atoms and on the area occupied by a single atom, the SSA can be determined as: ??? = ?????? , where ?? is the volume of nitrogen molecule, ? is the Avogadro’s 
number, ? is the cross-sectional area of the nitrogen molecule, ? is the density and ?? is the molecular weight.17 In chapters 7 and 8, the measurements of adsorption 
isotherms and the SSA calculation were obtained using a BELSORP 18-3 (Bel 
Inc., Japan). Prior to the adsorption measurements, all samples were out-gassed for 
24 hours at 100 °C under argon. 
5.8. In vitro cell culture experiments 
Normal cells have a finite life span of 20 to 100 generations due to the action of 
senescence genes, whose products hinder cell cycle progression. This factor made 
the in vitro experiments a very laborious technique for decades. However, by 
inactivating a number of cell cycle regulatory genes, it is possible to cultivate 
specific cell lines continuously, without the need of collecting tissue from patients. 
These genetically modified cells are known as immortalized cell lines and 
completely changed the way cell culture experiments are performed.18 Recently, 
the in vitro experiments using immortalized cells lines became the standard 
technique to analyze the biomaterial-cellular interactions.  
In vitro studies have a much lower complexity as they are performed in the 
absence of the physiological responses. In addition, the regulatory rules around in 
vitro experiments are less strict, which makes this technique an essential tool in the 
assessment of cytotoxicity and cellular internalization.19,20 In chapter 7,  the 
adenocarcinomic human alveolar basal epithelial cell line (A549) was used as 
model to evaluate the in vitro toxicity of CaCO3 particles. In chapter 8, the cell line 
of choice is the human osteoblast cell line (HOB). Different cell lines were used 
because the experiments were performed in different institutes, which established 
different research interests. At the Helmholtz-Institut für Pharmazeutische 
Forschung Saarland (HIPS), research focuses on the understanding and 
overcoming of the pulmonary barrier and therefore the use of the human alveolar 
cell line is more representative. On the other hand, the Advanced Ceramics Group 
focuses on the synthesis and application of ceramic materials for both mechanical 
and biological applications, especially towards bone and tooth research.  
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5.8.1. Cell culture of immortalized, mammalian cell lines 
For the HOB cells, the cells were cultured in DMEM supplemented with 10% 
heat-inactivated FCS and 1% antibiotics/antimycotics (AB/AM) in a cell incubator 
(C200, Labotect Labor-Technik-Göttingen, Germany) at 37 °C, 10% CO2 and 95% 
RH. The cells were cultured in 75 cm2 cell culture flasks until they were 80% 
confluent. For sub-culturing, cells were trypsinized with 5 mL of Trypsin-EDTA. 
After 30 seconds, 5 mL DMEM + FCS (10%) + AB/AM (1%) was added to stop 
the trypsinization. The total volume was transferred to a 50 mL Falcon tube, 
centrifuged at 4000 rpm for 6 minutes to concentrate the cells in a pellet form. The 
cells were then redispersed in fresh 5 mL DMEM + FCS (10%) + AB/AM (1%) 
and seeded into 75 cm2 cell culture flasks. For the experiments with nanoparticles, 
the cells were then trypsinized for 30 seconds with Trypsin-EDTA, dispersed in 
DMEM + FCS (10%) + AB/AM (1%) and seeded in wells of 24-well polystyrene 
plate (NUNC, Fischer Scientific, Germany) at a cell density of 2x104 cells per well. 
On the following day, the CaCO3 suspension in DMEM was added to the well-
plate and incubated for 24 h. In addition, for WST-1 assay, cells grown in culture 
medium were set as high control (100% cell viability), and others incubated with 
Triton X- 100 (2%, w/v) were used as low control (0% cell viability). For the LDH 
assay, the cytotoxicity was calculated relative to Triton X-100 as high control and 
cells in culture medium as low control. Samples were measured in triplicates and 
evaluated as mean and standard deviations (SD). 
For the experiments with the A549 cell line, the cells were cultured in RPMI 
supplemented with 10% FCS. One day prior to experiments, the cells were 
detached and seeded in a 24-well plate at a density of 1x104 cells per well. On the 
following day, the suspensions of CaCO3 in HBSS were added and incubated for 
4 h. In addition, for the MTT assay, cells grown in culture medium were set as high 
control (100% cell viability) and others incubated with Triton X-100 (2%, w/v) 
were used as low control (0% cell viability). For the LDH assay, the cytotoxicity 
was calculated relative to Triton X-100 as high control and cells in culture medium 
as low control. Samples were measured in triplicates and evaluated as mean and 
standard deviations (SD). 
5.8.2. Bioanalytical tools to assess in vitro colloidal toxicity  
In vitro studies allow researchers to assess the impact of colloidal systems in a 
cellular model, in which the interactions are limited and simplified to one 
immortalized cell line, but still can give a representative assessment on whether the 
particles-cellular interactions occurs in a positive way or shows possible signs of 
toxicity, prior to the exposure in vivo.21 The cellular response in the in vitro studies 
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can be assessed by several analytical tools. Most common ones are the cellular 
damage indicated by reduction in metabolic activity and the leakage of plasma 
membrane due to membrane rupture. As the toxicity can be a function of cell type, 
particle concentration and exposure time, these variables are fixed throughout the 
experiments, allowing high reproducibility of the results.21 
The leakage of plasma membrane can be used to assess the membrane integrity 
via the LDH assay (Figure 5.7a). Upon rupture or damage of the membrane, the 
cytosolic enzyme Lactate dehydrogenase (LDH) is released into the cell culture 
medium. The released LDH can be quantified by a coupled enzymatic reaction, in 
which the LDH catalyzes the conversion of lactate to pyruvate via NAD+ reduction 
to NADH. Diaphorase (an electron mediator provided in the kit) uses NADH to 
reduce a tetrazolium salt (INT) to a red-colored formazan product. Formazan can 
be quantified with a colorimetric assay at 490nm. The concentration of formazan is 
directly proportional to the amount of LDH released to the medium and therefore, 
cytotoxicity.21 
The tetrazolium salt (WST-1 or MTT) technique is another colorimetric assay 
used for the quantification of cell proliferation, viability and cytotoxicity (Figure 
5.7 b). This assay is also based on the cleavage of WST-1 salt to soluble formazan 
by a complex cellular mechanism that occurs primarily at the cell surface by the 
succinate-tetrazolium reductase system, which belongs to the respiratory chain of 
the mitochondria, and is only active in metabolically intact cells. Therefore, the 
amount of formazan dye formed directly correlates to the number of metabolically 
 
Figure 5.7: a) Membrane integrity measured by LDH assay. b) Cell viability measured by 
WST-1 or MTT assays. Adapted from datasheet provided by the manufacturers: a) 
Thermo Fisher, b) Roche Deutschland Holding GmbH.  
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active cells in the culture.21 A more detailed description of the colorimetric assays 
results can be found in chapters 7 and 8.  
5.8.3. Cellular uptake by TEM 
The estimation of cellular uptake of particles within cells can be performed by 
fluorescence techniques, in which both the particles and the cells are fluorescently 
labeled. This allows for the precise location particles agglomerates within 
endosomes, which are also labeled with fluorescent LyzoTrackers. However, as the 
particles used in this these studies are not fluorescently labeled, cellular uptake 
studies were analyzed by means of TEM.19 For that, osteoblasts cells treated with 
CaCO3 particles for 24 hours were washed once with PBS, detached with 
Trypsin/EDTA and transferred to 2 mL Eppendorf cups. The cups were centrifuged 
at 6000 rpm for 6 min, fixed with standard 2.5% glutaraldehyde, 2.5% 
formaldehyde in 0.1 M Na‐cacodylate for 1 hour at RT. After removal of the 
fixative, the cells were washed several times with phosphate buffer and post-fixed 
with osmium tetroxide solution for 1 hour at RT. The black pellet was washed 
twice and dispersed in 2% agar (Sigma‐Aldrich) in Millipore water, and allowed to 
solidify at 4°C. The pellet in agar was cut into squares of about 1 mm wide. The 
blocks were dehydrated in a graded series of ethanol (twice for 5 minutes in 30% 
and 50% ethanol, 3 times for 10 minutes in 70%, 90% and twice for 15 minutes in 
100% ethanol). Blocks were embedded in Epon 812. Ultrathin sections were taken 
with an ultramicrotome (Ultracut R, Leica, Wetzlar, Germany). In this study, 
surface markers, like uranyl acetate or ruthenium red, were not used, as the purpose 
of this experiment aimed at the visualization of internalized particles and not the 
visualization of intracellular membranes. A more detailed description of the 
particle internalization result can be found in chapter 8.  
5.8.4. Statistical analysis 
Quantitative data of cell viability and LDH activity are given as mean ± 
standard deviation of values obtained in three independently performed 
experiments. The statistical analysis is performed by two-tail-test analysis with 
unequal variances. P-values below 0.05 are considered to be statistically 
significant. 
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6. Coacervate-directed synthesis of CaCO3 microcarriers for pH-responsive 
delivery of biomolecules 
6.1. Introduction 
Abstract: We report the synthesis of pH-responsive microcarriers via the 
combination of complex coacervation and mineralization of calcium carbonate 
(CaCO3). Positively and negatively charged proteins (bovine serum albumin (BSA) 
and lysozyme (LSZ)) form electrostatic complexes with poly(acrylic acid) sodium 
salt (PAANa) and calcium ions in an aqueous solution, leading to the formation of 
spherical coacervate droplets. By addition of sodium carbonate, the protein-loaded 
droplets are mineralized into stable CaCO3 microcarriers. Since this inorganic 
material exhibits high solubility in acid, the release of protein from the carriers 
can be controlled via the pH of the environment. The process results in the 
successful generation of bulk amounts of monodispersed and colloidally stable 
microspheres with diameters as small as 300 nm. As the entire synthesis takes 
place under aqueous conditions, coacervate-directed encapsulation is suitable for 
sensitive active agents. Accordingly, the method presents a promising approach to 
synthesize pH-responsive microcarriers for drug delivery applications. 
Nanocarriers have established their place in biomedical applications as imaging 
and delivery vehicles.1 Recently, several types of nano-based carriers are entering 
clinical trials.2 However, due to restrictions on both ligand recognition and 
enhanced permeability and retention (EPR) effect, as well as the formation of 
complex nanoparticle coronas, nanosized drug carriers still face critical barriers for 
the translation into clinics.3,4 In order to enhance bioavailability of drugs at the 
disease site, it is highly desirable to include stimuli responsive properties in the 
carriers.1 The ability to trigger the release of active agents in response to 
endogenous changes can be largely exploited for the treatment for neoplastic 
diseases.4 In this context, we designed a bio-inspired strategy for synthesizing pH-
responsive microcarries based on the combination of two well-studied approaches: 
complex coacervation and the mineralization of calcium carbonate. 
Besides lipids, most drug nanocarriers are based on polymeric materials,2 due to 
their diversity, flexibility in synthesis methods and easy functionalization.5 
Amongst the various approaches for encapsulating active agents, coacervation has 
been used successfully for a long time, starting with the first description of the 
phenomenon by Bungenberg de Jong in 1929.6 Two main types of coacervation 
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have been described and differ by the phase separation mechanism. In simple 
coacervation, the mechanism involves the partial desolvation or dehydration of 
macromolecules.5,7 Complex coacervation, on the other hand, is induced by 
electrostatic interaction and comprises two or more oppositely charged colloids. 
Both techniques are widely used in the food industries e.g. in order to retard the 
oxidation of fish oil,8 or in cosmetics to encapsulate antioxidant oils.9 Recent 
research reported the use of complex coacervation to encapsulate and deliver 
growth factors,10 genes11,12 as well as proteins.13 Furthermore, coacervates are 
currently being investigated for their role in protocell formation and as models of 
protocell assembly.14 Several advantages arise from the coacervation method, for 
example the good encapsulation efficiencies,13 the ability of co-encapsulation and 
the conjugation of ligands for targeting approaches.11 The major drawback of this 
approach is the high instability of the complexes which might necessitate the use of 
potentially toxic stabilizers15 or cross-linkers.16 Moreover, in order to introduce 
pH-responsive behavior to the coacervates, additional molecules might have to be 
added. For instance, Pyranine-3 was used to produce pH sensitive microcapsules 
based on the self-assembly of nanoparticles on the surface of coacervate droplets.17  
By mineralizing the coacervates with inorganic materials that have high 
solubility in acid while being stable at neutral and basic pHs, it is possible to 
stabilize the coacervates, as well as to introduce pH-responsive behavior. One 
material that suits this purpose is calcium carbonate (CaCO3). It has long been 
suggested as a drug carrier due to its biocompatibility and biodegradability, low 
cell cytotoxicity and cost-effectiveness.18 One common procedure for 
encapsulation and sustained release of biomolecules with CaCO3 is the direct 
crystallization method.19–21 The incorporation of proteins is achieved by physical 
adsorption onto the synthesized crystals.19–21 The main characteristics of the 
produced carriers are the large particle size (1-5 µm), crystalline polymorphism 
and highly porous structure.21 Some disadvantages arise from this technique, i.e. 
the crystalline structure is subject to recrystallization in water if not well stabilized 
and might lead to changes in shape or polymorphism.20 Calcium carbonate 
nanoparticles produced by this technique are often used as templates to synthesize 
layer-by-layer polymer microcapsules.19 
Another method for the synthesis of CaCO3 particles that are loaded with active 
agents is co-precipitation. Here, the precipitation of calcium carbonate is initiated 
in a solution that already contains the molecules to be encapsulated, e.g. anti-
inflammatory drugs,22 hormones,23 proteins,20 genes24–26 and antigens.27 The 
morphology of products prepared via co-precipitation is rather heterogeneous, 
featuring macrosized plates or rods22 as well as nanosized particles.23 Emulsion-
based co-precipitation has also been used to encapsulate pesticides,28 genes29 and 
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growth factors.30 In this approach, emulsions containing calcium chloride, 
surfactant and biomolecules are prepared and the precipitation of nanocarriers is 
promoted by addition of sodium carbonate. High encapsulation efficiencies can be 
obtained with the co-precipitation method.24 
In the aforementioned approaches, the lack of control of morphology and 
polymorphism of the carriers is the main drawback. Polymers,31 
polysaccharides32,33 or even proteins34 can be used to modify the crystallization 
pathway of calcium carbonate and allow the control of the morphology and the 
stabilization of specific polymorphisms. This method is known as polymer-
controlled mineralization and results in either nanoparticles32 or highly porous, 
micron-sized particles.34 The wide variety of polymers and polyelectrolytes that 
can be used enables the synthesis of pH and temperature responsive carriers.35,36 
The incorporation of anti-cancer drugs35,37 and proteins33 can be either performed 
by physical adsorption after mineralization of the carriers34 or by co-precipitation.32 
In our work, we demonstrate a bio-inspired strategy for synthesizing pH-
responsive submicron-sized carriers based on the combination of complex 
coacervation and mineralization. Our group first modified a polymer-controlled 
approach proposed by Huang et al.38 in order to produce micropatterned parts39 and 
now to encapsulate model proteins. The coacervate-directed method (Scheme 6.1) 
starts with complex coacervation between negatively or positively charged 
biomolecules and poly(acrylic acid) sodium salt (PAANa). The polymer is used as 
an additive to modify mineralization, to stabilize amorphous calcium carbonate 
 
Scheme 6.1: Schematic synthesis approach of coacervate-directed CaCO3 microcarriers: 
complex coacervation between PAANa and the proteins in aqueous solution generates 
loaded-coacervate droplets, which are subsequently mineralized by the addition of sodium 
carbonate. 
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(ACC) and to incorporate the proteins into the coacervate droplets. In order to stop 
complexation and to stabilize the loaded droplets, sodium carbonate is added to the 
solution leading to the mineralization of the complex. Since the entire 
encapsulation process takes place in aqueous solutions, at room temperature and 
mild pH, the main benefits are the preservation of the bioactivity of the 
encapsulated biomolecules as well as the ability to easily scale up the system. 
Therefore, coacervate-directed microcarriers are highly promising for potential use 
in gene, drug, protein and growth factor delivery. 
6.2. Experimental section 
6.2.1. Materials 
Calcium chloride (CaCl2, purity ≥ 96%), sodium carbonate (Na2CO3, purity ≥ 
99.5%), poly(acrylic acid) sodium salt (PAANa, Mw = 8000 g/mol, 45 wt% in 
water), bovine serum albumin (BSA, lyophilized powder, purity ≥ 96%) and 
lysozyme (LSZ, lyophilized powder, purity ≥ 90%) were purchased from Sigma-
Aldrich and used without any further purification. The experiments were 
performed using double deionized water with a conductivity of 0.04 µS/cm from 
Synergy (Millipore, Darmstadt, Germany). 
6.2.2. Synthesis of CaCO3 and incorporation of proteins 
Briefly, 40 mL aqueous solution of PAANa and CaCl2 was prepared resulting in 
a final concentration of polyelectrolyte ranging from 700 to 1900 µg/mL with fixed 
calcium concentration of 12 mM. The complexation between Ca2+ and PAANa 
takes place immediately after mixing and leads to the phase-separation of liquid-
like complex coacervates. These droplets are a highly hydrated Ca2+/PAA 
complexes dispersed in the polymer-poor aqueous solution. After a specific period 
of time, the complexation time, 12 mM Na2CO3 was added. Since one of the main 
components of the coacervate droplets is calcium cations, the addition of carbonate 
mineralizes the complex. The samples were centrifuged (5000 rpm, 10 minutes) 
and the obtained precipitate was dried at room temperature for 2 days. The bulk 
amount of carriers produced per batch is dependent on the solution’s volume, 
which allows easy scale-up of the process. 
In order to prepare protein-loaded carriers, the respective biomolecule was 
dispersed in the aqueous solution prior to the addition of PAANa and CaCl2. The 
final concentration of proteins ranged from 0.2 to 0.3 mg/mL and all other 
parameters were kept the same. 
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6.2.3. Release behavior of proteins 
The obtained protein-loaded CaCO3 microcarriers were dried in air, weighed 
(about 20 – 30 mg per batch), and resuspended in 0.54 mL of acetic acid (ph 4.8), 
PBS buffer (pH 6) or PBS buffer (pH 7.4). The samples were mildly shaken for 
200 hours at room temperature. An aliquot of 350 µL was removed at each 
measurement time-point and replaced with an equal volume of the same buffer. 
The removed aliquot was centrifuged at 5000 rpm for 15 minutes and the protein 
concentration was determined by UV-Visible spectroscopy at 280 nm. The 
absorbance of polyacrylate was evaluated at this wavelength and is negligible. 
Biomolecule content and loading efficiencies are calculated as follows (equations 5 
and 6): 
??????????? ??????? = ?????????? ?????? ?? ???????????? (??)????? ????ℎ? ?? ????????????? (??)  Eq. 5 
??????? ??????????? = ?????????? ?????? ?? ???????????? (??)??????? ?????? ?? ???????????? (??)  100% 
 
Eq . 6 
6.2.4. Characterization of coacervate droplets and CaCO3 microcarriers 
Dynamic light scattering (DLS) as well as zeta-potential measurements were 
performed on a zetasizer device (Malvern, Nano ZSP). The morphology of the 
carriers was evaluated by scanning electron microscopy (Zeiss, SUPRA 40), with 
an acceleration voltage of 15 kV. X-ray diffraction analysis (XRD) was carried out 
using a JSO-Debyeflex 2002 device, with CuKα radiation (k = 1.542 A). The 
samples were ground to form a fine powder and scanned from 20° to 50°, 10 
seconds per degree. UV-Vis spectroscopy was performed on a Multiskan G0 
device (Thermo Scientific) at 280 nm.  
6.3. Results 
6.3.1. Influence of complexation time and protein incorporation on the 
coacervate droplets size 
The electrostatic interaction of Ca2+ cations with PAANa induces the self-
assembly of complex coacervate droplets. These are small complexes with an 
average size ranging from 200 to 400 nm formed by liquid-liquid phase separation 
from the initial solution. As mentioned above, this entropy-driven phenomenon is 
also known as complex coacervation,40 although the term is largely missing in 
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more recent literature, where it is sometimes replaced by purely descriptive 
terms.41 The main characteristics of the coacervates are the high instability (since it 
is a metastable phase) as well as the liquid-like behavior. As a result of these 
characteristics, after nucleation, the coarsening of the droplets happens most likely 
through diffusion and accumulation of polymer and Ca2+.42 Ostwald ripening does 
not seem to play a role as a growth mechanism since the polydispersity of the 
coacervates remains constant over time and the tail of the size distribution curve is 
located on the large-diameter side (Supporting Figure 6.1, Appendix 10.2).43 
Figure 6.1 depicts the tendency of growth as a function of complexation time as 
well as the influence of the polyelectrolyte and proteins on the droplets size. 
For native coacervates (Ca2+/PAANa in the absence of proteins), the initial size 
is highly dependent on the PAANa concentration. By increasing the polymer 
concentration, the number of nucleation sites is increased along with a reduction in 
the particle size. Moreover, the droplets grow at different rates depending on the 
polymer concentration. For 700 µg/mL of PAANa, coacervates grow steadily 
within the 14-minute-experiment, while for 1900 µg/mL this growth behavior is no 
longer noticeable. The growth process is related to the stability of the coacervates 
in solution. Since the coacervate droplets are electrostatically stabilized, droplets 
with higher net charges are less susceptible to aggregation and growth. (Supporting 
Figure 6.2).44,45 Moreover, it is possible to tailor the size by controlling the 
polymer concentration; if the concentration is increased from 700 to 1900 µg/mL, 
the particle size decreases from 800 nm to 300 nm. 
BSA-loaded coacervates were prepared with final BSA concentration of 0.2 g/L. 
The incorporation of BSA slightly decreases the coacervates size compared to 
unloaded droplets. The rate at which the coacervates grow is not affected by the 
incorporation of BSA (Figure 6.1).  
When lysozyme is incorporated into the droplets, the coacervate size drastically 
changes (Figure 6.1). The effect of LSZ on the coacervates is thought to be related 
to the formation of another complex coacervate, comprised of LSZ and PAANa. 
The electrostatic interaction of LSZ and PAANa is described in previous 
studies.46,47 These complexes are larger than Ca2+/PAANa, ranging from 800 nm to 
1.2 µm depending on the polymer concentration. This can be explained by the 
increased incorporation of LSZ due to stronger complexation compared to BSA. 
Furthermore, diffusion-controlled transport is still the predominant growth 
mechanism and reveals the metastability of the complex.  
6.3.2. Characterization of mineralized microcarriers 
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As seen from the DLS results (Figure 6.1), the size of coacervate droplets is 
highly dependent on the complexation time (tendency to grow over time as a result 
from the liquid-like behavior) and the polymer concentration. Based on this, it is 
possible to tailor the size of the final microcarriers by tweaking these two 
parameters. Since small carriers are desired for drug delivery applications, the 
complexation time was set to 1 minute and sodium carbonate was added to the 
solution in order to mineralize the microcarriers. Figure 6.2 summarizes the final 
size of native, BSA and LSZ-loaded microcarriers measured by DLS. For native 
and BSA-loaded, increasing the polymer concentration yields smaller carriers. 
However, for LSZ-loaded carriers this tendency is no longer observed due to the 
formation of larger LSZ/PAANa coacervates. 
The morphology of carriers has shown to affect the cellular uptake of 
nanoparticles48 and therefore this facet was assessed by SEM (Figure 
incorporation of both negatively and positively charged molecules does not seem 
to influence the spherical geometry of the mineralized microcarriers. In the case of 
LSZ loading, smaller particles of about 20 nm can be observed adsorbed to the 
bigger particles. Since mineralization takes place at high supersaturation 
conditions, these small, unstable particles are formed and adsorb at the surface of 
the mineralized coacervate droplets.39 For all samples, the size of the mineralized 
microcarriers is consistent with the DLS data. In some of the samples, formation of 
Figure 6.1: Dynamic Light Scattering (DLS) overview of the mineralized microcarriers
function of PAANa concentration: Native, BSA and LSZ-loaded microcarriers. [Ca
was kept constant at 12 mM. Each value is represented as means ± standard deviation of 3 
samples. 
6.3). The 
 
 size as a 
2+]=[CO32-] 
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open capsules could be observed. Note, however, that the intact carriers are not 
hollow, as was confirmed by STEM analysis (Supporting Figure 6.3). 
Zeta potential measurements can be used to assess the adsorption behavior of 
the molecules onto the surface of the particles. For carriers loaded with LSZ, by 
increasing the LSZ concentration from 0 to 0.5 g/L, the zeta potential changes from 
- 35 to -26 mV (Table 6.1). Most likely, positively-charged LSZ is adsorbed on the 
surface of negatively charged carriers. The zeta potential measured for BSA 
remains constant at about -35 mV, which means that absorption does not seem to 
take place, mainly due to electrostatic repulsion between negatively charged BSA 
and CaCO3.  
The amorphous polymorphism of the samples was verified by XRD analysis 
(Supporting Figure 6.4). Hydrophilic polymers are well known to stabilize the 
amorphous phase as well as to alter the morphology of the final product.31 The 
various effects of LSZ49 and BSA34 on the stabilization of polymorphism and 
morphology of CaCO3 are also reported in the literature. 
6.3.3. Incorporation of proteins 
Yield of carriers, loading efficiency and biomolecule content is detailed in 
Figure 6.4. For all experiments, the yield of carriers is around 20 mg, even with the 
incorporation of BSA or LSZ. Moreover, according to the UV measurements, 0.23 
 
Figure 6.2: Dynamic Light Scattering (DLS) overview of the mineralized microcarriers 
size as a function of PAANa concentration: Native, BSA and LSZ-loaded microcarriers. 
[Ca2+]=[CO32-] was kept constant at 12 mM. Complexation time was set to 1 minute. Each 
value is represented as means ± standard deviation of 3 samples. 
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nM of BSA were encapsulated per milligram of CaCO3 carriers, resulting in an 
efficiency of about 0.2%. The scarce encapsulation of BSA was probably caused 
by the electrostatic repulsion of PAANa and BSA, since both of them are 
negatively charged at synthesis pH of 7. However, the LSZ experiment showed 
that 7 - 8 nM of LSZ were encapsulated per milligram of CaCO3 carriers, which 
equals an efficiency of 17 – 33 %. Most likely, the electrostatic attraction between 
PAANa and LSZ is responsible for the better efficiency. 
6.3.4. Release of proteins from microcarriers 
The amount of proteins released from the carriers was cumulatively plotted in 
figure 6.5. The release profile is highly pH dependent, which suggests that the 
main mechanism of release is the dissolution of the carriers. 
At neutral pH, the complete BSA content is released within 50 hours (Figure 
6.5). If the experiments are performed at pH 4.8, the same amount of protein is 
released within a tenth of that time, 5 hours. Experiments that took place at pH 6 
showed a similar release behavior as for pH 7. In general, BSA-loaded carriers 
show a rapid release curve at all evaluated pHs when compared to LSZ. Moreover, 
 
Figure 6.3: SEM micrographs of native, BSA and LSZ-loaded microcarriers as a function 
of PAANa concentration (700, 1400 and 1900 µg/mL). [Ca2+]=[CO32-] was kept constant 
at 12 mM. Complexation time was set to 1 minute. 
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the release of BSA was completed before full dissociation of the carriers, which 
leads to two conclusions, (a) BSA is physically adsorbed to the surface of the 
carriers and therefore the release is desorption-dependent or (b) the molecules are 
encapsulated close to the surface of the carrier, which leads to complete release 
without full dissociation of the particles. By analyzing the zeta potential 
measurements, the first hypothesis is unlikely, since the zeta potential remains 
constant with varying BSA concentrations (Table 6.1).  
Regarding LSZ, the release profile shows sustained release over time with a 
notable absence of a burst release. At pH 4.8, LSZ was fully released within 140 
hours while at neutral pH the release reaches a plateau after 80 hours of about 30% 
of release. At pH 6, the release behavior was slightly faster than at pH 7. Both at 
pH 6 and 7.4, the release was slow and incomplete. The cationic nature of this 
protein (pKa = 11.35) gives rise to electrostatic interaction with the negatively 
charged carriers preventing complete release. Another possible explanation lies in 
the electrostatic nature of the complex LSZ/PAANa. If the pH is decreased, the net 
charge of PAANa reduced which weakens the complex and allows a complete 
release. 
Burst release of biomolecules from inorganic porous carriers have been reported 
elsewhere.50 In the case of calcium carbonate, it is mostly associated with the 
polymorph stability.22 Since the carriers are amorphous, the most unstable 
polymorph of CaCO3, burst release could be expected. However, due to the 
introduction of PAANa, which stabilizes the carrier, the initial burst release can be 
avoided. 
Table 6.1. Zeta potential (mV) of microcarriers as a function of protein 
concentration. Measurements were performed at pH 9 and 1400 g/L of PAANa. Each 
value is represented as means ± standard deviation of 3 samples. 
Protein concentration 0 g/L 0.2 g/L 0.5 g/L 
BSA -35.68 ± 2.41 -31.14 ± 4.50 -37.09 ± 6.92 
LSZ -35.68 ± 2.41 -28.24 ± 3.21 -26.14 ± 4.01 
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6.3.5. Proposed mechanism for protein encapsulation and release behavior 
The incorporation of proteins is based on the electrostatic interaction between 
PAANa and the respective molecule. In the case of BSA (Scheme 6.2a), calcium 
plays two roles: (1) it favors the formation of complex coacervate droplets 
comprised of highly hydrated Ca2+/PAANa and (2) it binds to both the carboxylate 
groups and the negative sites of BSA, forming the complex PAANa/Ca2+/BSA,51 
which is responsible for encapsulation. The Ca2+-mediated complex is only 
moderately effective in incorporating BSA (0.21 nM per mg of sample) and 
therefore results in low encapsulation capacities (0.02%). 
By contrast, in the case of LSZ, two complex coacervation phenomena take 
place simultaneously: (1) complex coacervation of Ca2+/PAANa and (2) complex 
coacervation of LSZ/PAANa, which is responsible for encapsulation (scheme 
6.2b). The competitive effect between the complexes leads to the formation of 
larger carriers with larger size and broader size distribution. Due to high 
electrostatic interaction between the polyelectrolyte/protein, higher encapsulation 
efficiencies (around 25%) are obtained. 
 
Figure 6.4: Yield of carriers, loading efficiency and biomolecule content for BSA and 
LSZ loaded carriers. Each value is represented as means ± standard deviation of 3 
samples. 
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After formation of the coacervates, Na2CO3 is added in order to stabilize the 
droplets by forming fully mineralized amorphous CaCO3 particles. This material 
exhibits a good solubility in acid environments allowing the triggered release of 
proteins by adjusting the pH of the solution (Figure 6.5). BSA molecules are 
encapsulated close to the surface of the carrier and are rapidly and completely 
released after 50 hours. The release of LSZ is slow and incomplete due to 
electrostatic interaction between the protein and the negatively charged carriers.
6.4. Conclusions 
In summary, the coacervate-directed mineralization approach allows the 
synthesis of pH-responsive carriers loaded with both negatively charged BSA and 
Scheme 6.2: Proposed mechanism for encapsulation of (a) BSA and (b) LSZ into the 
coacervate droplets. 
Figure 6.5: Release profile of BSA and LSZ from microcarriers in acetic acid pH 4.8, PBS 
buffer pH 6 and 7.4. Each value is represented as means ± standard deviation of 3 samples.
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positively charged LSZ. The synthesis starts by complexating PAANa and the 
respective protein within coacervate droplets, whose size can be tailored by the 
polymer concentration and the complexation time. In order to stabilize the protein-
loaded coacervate droplets and functionalize them with pH-responsive behavior, 
the complexes were mineralized via the addition of carbonate. The fully 
mineralized CaCO3 microspheres had a diameter between 300 and 800 nm, 
exhibited spherical morphology and were loaded with BSA and LSZ at 0.2 nM and 
8 nM per milligram of CaCO3, respectively. As expected, the release behavior of 
the proteins was triggered by changes in pH. BSA molecules were rapidly and 
completely released after 50 hours while the release of LSZ is slow and incomplete 
due to electrostatic interaction between the protein and the negatively charged 
carriers. Based on these features, we think that the coacervate-directed method 
presents a cost-effective, easy to scale-up way to synthesize tailorable submicron-
sized, pH-responsive CaCO3 carriers, which can be potentially used in gene, drug 
and growth factor delivery. 
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7. Self-assembly and shape control of hybrid nanocarriers based 
on calcium carbonate and carbon nanodots 
7.1. Introduction 
Abstract: We describe a platform for the synthesis of functional hybrid 
nanoparticles in the submicrometer range with tailorable anisotropic morphology. 
Fluorescent carbon dots (CDs) and poly(acrylic acid) (PAA) are used to modify 
the crystallization and assembly of calcium carbonate (CaCO3). Carboxylic groups 
on CDs sequester calcium ions and serve as templates for CaCO3 precipitation 
when carbonate is added. This creates primary CaCO3 nanoparticles, 7 nm in 
diameter, which self-assemble into spheres or rods depending on the PAA 
concentration. At increasing polymer concentration, oriented assembly becomes 
more prevalent yielding rod-like particles. The hybrid particles show colloidal 
stability in cell medium, absence of cytotoxicity as well as a loading efficiency of 
around 30% for Rhodamine B with pH-controlled release. Given the 
morphological control, simplicity of synthesis and efficient loading capabilities the 
CD-CaCO3 system could serve as a novel platform for advanced drug carrier 
systems. 
In the last years, nanotechnology has quickly established its role as a catalyst for 
rapid advances in medicine.1 Both diagnostics and treatment of several diseases, 
including but not limited to cancer, have been facilitated by the incorporation of 
imaging agents and active pharmaceutical ingredients in one multifunctional 
carrier.2,3 A large number of drug delivery systems (DDS) developed over the past 
5 decades addressed the limited cellular uptake by improving carrier-cellular 
interactions.4 Recent DDS approaches for improving biological interactions focus 
either on grafting an active-targeting moiety onto the carrier surface to maximize 
specific uptake5 or on tailoring carrier properties, such as geometry, to hinder 
macrophage engulfment6 and improving long-term circulation.7 
Besides the vast and rapidly advancing field of nanomedicine targeted to treat 
cancer, significant effort has also been put forth in the field of pulmonary delivery. 
In fact, pulmonary diseases are among global health hazards in terms of mortality8 
and therefore, the application of nanomedicine technology in diagnosis, treatment 
and prevention is of high importance. Due to the complex anatomy and physiology 
of the lungs, the design of novel pulmonary delivery systems takes into account 
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aerodynamic properties of the carriers as well as the innate immune defense 
mechanisms. Since the engulfment of anisotropic particles by macrophages is 
orientation-dependent, anisotropic particles can avoid rapid macrophage 
clearance.9 Moreover, the anisotropic geometry has shown to allow better lung 
penetration and accumulation, since anisotropic particles can align with the air 
flow.7 Given this, aspherical carriers find high potential in the treatment of 
pulmonary diseases, such as related to microbial infections. 
Nanoparticle size has long been studied as a key parameter for achieving 
efficient drug delivery by exploiting the enhanced permeability and retention effect 
(EPR).10,11 Recently, carrier morphology has emerged as an equally important 
parameter.12,13 Early reports described the enhancement of tissue-specific targeting 
by using non-spherical particles.14 However, due to difficulties in synthesis, a 
platform that allows geometrical control of biocompatible carriers in bulk 
quantities is of high interest. For such purposes, calcium carbonate can be a great 
option, since it is biocompatible and most importantly, some mechanisms involved 
in geometrical control have been studied in great detail over the past 25 years.15  
The crystallization of calcium carbonate can be controlled by the addition of 
soluble macromolecules, acidic proteins and cations like Mg2+.16,17 In 
biomineralization, the presence of these additives allows living organisms to 
synthesize hierarchical minerals and composite materials with intricate 
morphologies and outstanding mechanical properties. The understanding of 
principals involved during biomineral synthesis has served as a great source of 
inspiration for producing advanced synthetic materials.18 
 Additives have been shown to play different roles in mineralization:19 (i) 
antiscalants hinder mineralization by disturbing nucleation, (ii) growth initiators 
induce local supersaturation via ion complexation, (iii) habit modifiers inhibit 
crystal growth by selective adsorption and (iv) poly-anions are able to stabilize 
amorphous, highly hydrated phases. Acidic polymers, such as poly(acrylic acid),20 
poly(aspartate),19,21,22 or dendrimers23,24 have been shown to play multiple roles at 
once. Under kinetic controlled mineralization, the crystallization pathway of 
CaCO3 usually follows multiple steps, starting with formation of primary 
nanoparticles which then can self-assemble to form the final crystal. This 
controlled self-assembly of primary particles is  known as mesoscale assembly.25,26 
Polymers can adsorb onto specific crystallographic growth planes of primary 
nanoparticles, affecting both crystal growth and the assembly process.26 As a result 
of  nanoparticle-polymer interactions, the assembly can take place in a mutually 
oriented fashion forming higher-order superstructures.26 The primary nanoparticles 
that form the superstructure can either grow to form one single crystal or remain at 
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the nanoscale, depending on the binding affinity between nanoparticles and 
macromolecules. If oriented assembly takes place with stable crystallites, i.e. 
particles that do not fuse together, the resulting superstructures are often referred to 
as mesocrystals.27 
Carbon nanomaterials can also be used to modify the crystallization of calcium 
carbonate due to their surface chemistry. For example, carboxyl-functionalized 
carbon nanotubes (CNTs) can serve as nucleation sites for calcium carbonate, 
which grows around the CNTs forming spherical vaterite crystals.28 Graphene and 
graphene oxide have also been used as templates for controlling the nucleation and 
growth of CaCO3 crystals for structural materials29 as well as for the synthesis of 
bioactive hydroxyapatite bone replacement materials.30,31 Carbon dots have been 
reported to influence CaCO3 precipitation as well. They serve as templates for the 
nucleation of primary hybrid nanoparticles which then self-assemble into spherical 
sub-micrometer structures.32  
Carbon dots are especially interesting for biological applications due to their 
fluorescent properties and very small sizes, under 10 nm. This material usually has 
a relatively low quantum yield, less than 50% in comparison to the conventional 
quantum dots.33 However, surface passivation additives can be incorporated to 
improve the quantum yield of carbon dots,34 e.g. poly(ethylenimine) (PEI) or its 
monomer. The increase in photoluminescence is attributed to passivated defects on 
the carbon particle surface which act as excitation energy traps.35 Due to the 
various surface functional groups, including  hydroxyl, carbonyl, carboxyl and 
amine groups, CDs can form complexes with cations such as Fe3+ and Zn2+ 
allowing application as ionic-sensors.36  Moreover, CDs offer good 
biocompatibility and low cytotoxicity37 and therefore have a great potential for 
biomedical applications, such as bioimaging and biosensors.34,38 
Here, the fundamentals on the CaCO3 crystal growth were applied for designing 
drug carriers with two different morphologies: spheres and rods. The developed 
platform allows control of nanocomposite morphology while maintaining sizes 
under 500 nm, colloidal stability in cell medium, encapsulation of positively-
charged Rhodamine B by electrostatic interaction and pH-triggered release in acid 
due to carrier dissolution. Such a system can be potentially of interest for the 
treatment of pulmonary diseases. 
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7.2. Experimental section 
7.2.1. Materials 
Calcium chloride (CaCl2, purity ≥ 96%), sodium carbonate (Na2CO3, purity ≥ 
99.5%), poly(acrylic acid) sodium salt (PAANa, Mw 8000 g/mol , 45 wt% in 
water), poly(ethylenimine) branched (PEI, Mw 25000 g/mol) and Rhodamine B 
(479.02 g/mol, purity ≥ 95%) were purchased from Sigma-Aldrich and citric acid 
(C6H8O7, purity ≥ 99.5%) was purchased from Carl Roth GmbH. All chemical 
were used without further purification. The experiments were performed using 
double deionized water with a conductivity of 0.04 µS cm-1 from Synergy 
(Millipore, Darmstadt, Germany). Phosphate buffered saline (PBS) was prepared 
as follows: 129 mM NaCl, 2.5 mM KCl, 7 mM Na2HPO4 .7 H2O and 1.3 mM 
KH2PO4. The pH was adjusted to 7.4. Hanks' Balanced Salt Solution (HBSS) was 
prepared in accordance to supporting information 7.1 (Appendix 10.3). RPMI-1640 
cell culture medium (Gibco, Life Technologies) was used without further 
supplements. 
7.2.2. Synthesis of Carbon dots with different degree of carboxylation (CDs) 
Carbon dots are synthesized by an in-complete carbonization reaction of citric 
acid in water, as previously described.39 Briefly, 1 g of citric acid is dissolved in 10 
mL of Millipore water and heated to 130 °C. The samples were treated for 2 or 2.5 
hours. After the defined time, most of the water evaporated and the sample 
resembles an orange-yellow gel. After cooling to room temperature, the gel is 
dissolved in 50 mL of 10 g/L NaOH and centrifuged (6000 rpm for 30min) to 
remove any aggregates. The supernatant is kept and the pH is set to 10. Samples 
treated for 2h had a yield of 0.022 ± 0.003 g/L and the carboxylation degree 
[CD]COOH was 2.3 mol/g, while sample treated for 2.5h had a yield of 
0.005 ± 0.001 g/L and 0.5 mol/g of [CD]COOH. For calculation see Supporting 
Information 7.2. 
7.2.3. Carbon-dots-mediated precipitation of CaCO3 by Poly(acrylic acid) 
(PAA-CD-CaCO3) and Poly(ethylenimine) (PEI-CD-CaCO3) 
The synthesis of CaCO3 nanocomposites is performed by a one-pot approach. 
The synthesis starts with 6 mL aqueous solution of PAANa (final concentration of 
0, 0.15, 0.3, 0.5 and 0.7 g/L) mixed with CDs (final concentration of 0.013 g/L). 
After stirring the suspension for 10 minutes, an aqueous solution of CaCl2 is added 
to reach a final concentration of 32 mM. Subsequently, an aqueous solution of 
Na2CO3 is rapidly added keeping the ratio [Ca2+]=[CO32-] constant. Finally, the 
suspension is stirred for 48 hours to allow complete the mineralization. The 
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precipitated hybrid nanoparticles were centrifuged (5000 rpm, 30 min) and the 
supernatant is removed to extract free carbon dots. The pellet is redispersed in 10 
mL of Millipore water. 
To evaluate the influence of a cationic polymer on the assembly process, a 
second experiment was performed in which along with PAANa, PEI was added to 
the CDs solution and precipitation procedure followed as previously described. 
The polymers final concentrations are 0, 0.3 and 0.7 g/L, keeping the weight ratio 
PAA:PEI 1:1.  
7.2.4. Rhodamine B encapsulation and release from CD-CaCO3 
Rhodamine B, a low molecular weight fluorescent dye, was used as a 
hydrophilic model drug due to its hydrophilicity and positive charge. For RhB 
encapsulation, the dye is dissolved in the solution containing PAANa and CDs 
with final concentration of 12 µM and precipitation procedure followed as 
previously described. 
The release profile was determined by dispersing 10 mg of rod-shaped (0.7 g/L 
PAA-CD-CaCO3) in 1 mL of 0.3 M Citric acid – Sodium citrate buffer at pH 4.8 or 
PBS buffer at pH 7.4. The dispersion was kept under gentle stirring in the dark. At 
specific time points, 300 µL were drawn from the solution, centrifuged to remove 
any particle in solution and the fluorescence was measured at 575 nm (excited at 
500 nm) in a 96-well plate. No appreciable reduction on the fluorescence intensity 
was observed over the course of the experiment (Supporting Information 7.3). 
7.2.5. Stability of CD-CaCO3 in various physiological media 
PAA-CD-CaCO3 nanocomposites were centrifuged at 6000 rpm for 10 minutes, 
the supernatant was removed and the pellet redispersed in different media: 
Millipore water, Hanks Balanced Salt Solution (HBSS) and RPMI and RPMI 
supplemented with 10% (v/v) fetal bovine serum (FBS). The size and zeta potential 
were determined by a Zetasizer after 4 hours of incubation (Nano ZS, Malvern 
Instruments). The data is given as mean ± standard deviation (SD) based on three 
independent measurements. 
7.2.6. Toxicity Profile 
To assess relative toxicity of the nanoparticles, cell viability at different 
concentrations was evaluated by means of membrane integrity via LDH release 
and metabolic activity via mitochondrial enzymes (MTT). PAA-CD-CaCO3 
nanocomposites were centrifuged and redispersed in HBSS pH 7.4 at different 
concentrations. Cells A549 were cultured in RPMI supplemented with 10% FCS. 
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One day prior to experiments, the cells were detached and seeded in a 24-well plate 
at a density of 1 x 104 cells per well. In the following day, the suspensions were 
added and incubated for 4 h. In addition, for MTT assay, cells grown in culture 
medium were set as high control (100% cell viability) and others incubated with 
Triton X-100 (2%, w/v) were used as low control (0% cell viability). For the LDH 
assay, the cytotoxicity was calculated relative to Triton X-100 as high control and 
cells in culture medium as low control. Samples were measured in triplicates and 
evaluated as mean and standard deviations (SD). 
7.2.7. Characterization 
Potentiometric titration was performed with a pH electrode PHC3081 connected 
to Titralab Tim 840 automated titrator (Radiometer Analytical SAS, France) 
operating at an addition speed of 0.2 L/min. All triplicate measurements were 
carried out under 2 L/min N2 at room temperature. Each sample is comprised of 5 
mL CD dispersion and 15 mL water. The pH was adjusted to 4.2 by the addition of 
800 µL 1M HCl. Particle morphologies were visualized by transmission electron 
microscopy (TEM, Oxford Instruments - JEOL JEM 2011 and Zeiss - EM 900) and 
scanning electron microscopy (SEM, Zeiss - Supra 40). Before SEM, the 
dispersion was centrifuged and the supernatant was removed. Afterwards, a droplet 
of dispersion was placed on a silicon wafer and dried at 70°C for 2 h. Before TEM, 
the dispersion was diluted 1:5 and a droplet of dispersion was placed on a copper 
grid with Formvar film and dried in air. The samples did not require staining. X-
ray diffraction (XRD) was carried out using a Seifert XRD 3003 device (General 
Electric, Germany), with CuKa radiation (k = 1.542 Å). The samples were ground 
to form a fine powder and scanned for 2 s per degree from 20° to 70°. The specific 
surface area (SBET) of the samples was determined by nitrogen adsorption 
(Belsorp-Mini, Bel Japan), using the BET-method. Quantum yield was measured 
in an Infinite 200 PRO device (Tecan, Switzerland). 
7.3. Results 
The synthesis of CaCO3 nanocomposites is performed by a one-pot approach. It 
begins by preparing carbon nanodots via an incomplete carbonization reaction of 
citric acid in water.39 The reaction takes place in absence of passivation additives 
and results in low quantum yield CDs. Using DAPI as reference, the quantum yield 
measured was 0.3% (Supporting Information 7.4). The surface chemistry of CDs 
can be controlled by varying the duration of the carbonization reaction. Samples 
heat-treated for 2.5 hours showed a darker color and a lower carboxylation degree 
of 0.5 mol/g, while samples treated for 2 hours were lighter in color with higher 
carboxylation degree of 2.3 mol/g (Figure 7.1a, insets. For calculations see 
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Supporting Information 7.2). Moreover, TEM micrographs revealed a difference in 
size when comparing both samples. For CD with 2.3 mol/g, the size is around 2
± 0.15 nm while it is 15.72 ± 2.95 nm for a carboxylation degree
Despite the difference in particle size, maximum absorption at 360 nm was 
observed for both samples. If excited at 360 nm, the fluorescent maximum is 
observed at 470 nm situated in the blue color space (Figure 7.1b). 
The reaction proceeds with the addition of PAA at low concentrations to the 
carbon nanodot dispersion, followed by sequential addition of calcium chloride and 
sodium carbonate. This results in the immediate formation of primary 
nanoparticles as shown in Figure 7.2a. According to SEM and TEM micrographs, 
these nanoparticles are anisotropic with an average size of 7.4 ± 2.1 nm. The TEM 
micrographs suggest that the crystallites show a plate-like geometry, similar to the 
anisotropic carbon dots. Moreover, XRD reveals the crystalline nature of the 
primary nanoparticles, showing calcite polymorphism (figure 7.2b). After stirring 
for 4 hours, it is observed that the primary nanoparticles self
micrometer structures, as shown on Figure 7.2c. The assembly of submicro
particle is complete after 48 hours of stirring (figure 7.2d).   
As carboxylated additives are known to influence CaCO3 crystallization, the 
effect of PAA concentration (0, 0.15, 0.3, 0.5 and 0.7 g/L) as well as the 
carboxylation degree of CD (0.5 and 2.3 mol/g) was assessed with regards to final 
particle geometry and an overview is shown in Figure 7.3. At a low carboxylation 
degree, large calcite crystals immediately precipitated from the solution, 
independent of the PAA concentration (figure 7.3, bottom). Here, the carboxyl 
concentration of carbon dots and PAA is not sufficient to avoid precipitation and 
Figure 7.1: a) TEM micrographs of carbon dots with varying degrees of carboxylation 
([CD]COOH 0.5 and 2.3 mol/g). Inset shows the color of each dispersion at pH 10. b) 
Maximum absorption at 360 nm and emission at 470 nm of sample [CD]
Sample [CD]COOH 0.5 had similar fluorescence and absorbance spectra. 
.10 
 of 0.5 mol/g. 
-assemble into 
meter 
 
COOH 2.3. 
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the crystallization follows the classical pathway. Below 0.3 g/L of PAA, aspherical 
crystals with large particle size (5 - 7 µm) precipitated. At 0.7 g/L, the formed 
structures show rod-like morphology and particle size of around 1 µm.
At high carboxylation degree, the final morphology can be controlled by 
varying the concentration of the polymer. In the absence of the polymeric additive, 
calcite crystals immediately precipitated. The crystals look similar to the one
formed at low carboxylation degree and can be explained by the low concentration 
of crystallization inhibiting PAA. In this case, the carboxyl groups on the surface 
of the CDs alone are not sufficient for avoiding direct precipitation. However, by 
adding even small concentrations (0.15 g/L) of PAA, the formation of large 
crystals is prevented and sub-micrometer spheres are formed. At 0.3 g/L a 
combination of spheres and rods are formed (31/69% respectively). At 0.7 g/L 
PAA, all particles show a rod-like shape. Above this concentration, only very small 
nanoparticles (under 90 nm) are formed. This can be assigned to further polymer 
stabilization, which completely prevents aggregation (Supporting information 7.5). 
The influence of PAA molecular weight was evaluated by mineralizing the 
samples with 15k and 100k g/mol PAA at 0.15 and 0.7 g/L. The samples were 
mineralized with high carboxylation degree carbon dots and the results show 
(Supporting information 7.6) that there are no significant changes when increas
the M.W. to 15k g/mol. At 100k g/mol, both spheres and rods are formed at 0.1 g/L 
PAA. This highlights the ability to control the geometry of the carriers in a wide 
Figure 7.2: Precipitation of PAA-CD-CaCO3 at different stages: (a) SEM and TEM 
micrographs immediately after carbonate addition. Particle size measured by TEM 7.4 ± 
2.1 nm (n =30 ± deviation). (b) XRD pattern immediately after carbonate addition. (c) 
After 4 h, the nanoparticles self-assemble to form the rod microstructure (dashed curve 
delineates the final structure). (d) Assembled rod-like composite nanoparticles after 48 
h. Polymer concentration is 0.7 g/L, and CD carboxylic degree is 2.3 mol/g.
[CD]COOH 0.5 had similar fluorescence and absorbance spectra. 
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range of molecular weights. However, at extreme long chain lengths, the 
morphology is no longer controlled by PAA.  
The spheres and rod like carriers were characterized by means of zeta-potential 
and BET. Dispersed in water, the zeta-potential at pH 7.4 is around -38.9 ± 5.2 for 
0.7 g/L and -36.7 ± 7.0 mV for 0.3 g/L PAA. The difference in zeta potential is due 
to the difference in polymer concentration. For samples prepared with 0.7 g/L 
PAA, the median pore diameter calculated by Nitrogen adsorption-desorption was 
37 nm; the surface area 27 m2/g and total pore volume 0.24 cm3/g (Supporting 
information 7.7). While for 0.3 g/L PAA, median pore diameter was 23 nm, the 
surface area of 36 m2/g and total pore volume of 0.21 cm3/g. Pore size distribution 
calculated by BJH shows monomodal (about 6 nm) distribution of pores for both 
geometries. This pore size can be attributed to the space in between assembled 
nanoparticles, as revealed by TEM (figure 7.2c). Analysis of the XRD pattern of 
the final particles (Supporting information 7.8) showed that the most stable 
polymorph, calcite, is still present after 48 h of precipitation. 
 
Figure 7.3: SEM overview evaluating the influence of carboxylation degree (0.5 and 
2.3 mol/g) and poly(acrylic acid) concentration (0, 0.15, 0.3, and 0.7 g/L) on the 
morphology of the CaCO3 nanocomposites. h. Polymer concentration is 0.7 g/L, and CD 
carboxylic degree is 2.3 mol/g. Sample [CD]COOH 0.5 had similar fluorescence and 
absorbance spectra. 
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Aiming at the assessment of polymer charge on the final structure, similar 
experiments were performed using a combination of positively charged PEI and 
negatively charged PAA. Figure 7.4 shows the SEM overview of final structures 
precipitated for 48 hours at different PEI and PAA concentrations. Alone, PEI 
cannot prevent direct precipitation of large calcite crystals. By inclusion of PAA, 
final particles are under 1 µm in size. However, it is no longer possible to fully 
control the morphology as the nanoparticles highly aggregate, possibly as a result 
of electrostatic heteroaggregation. Moreover, the ζ-potential of the particles is 
around -31 ± 4.3 mV, which shows that PEI can absorb onto charged nanoparticles 
and interfere with the precipitation and self-assembly. 
Considering the biocompatibility of calcium carbonate and its pH-sensitivity, 
this system can be potentially used as drug carrier featuring controlled release 
properties. In order to evaluate the stability of the carriers in a biological 
environment, the carriers were dispersed in different media, incubated for 4 hours 
and then characterized by size and zeta-potential. The results are summarized in 
table 7.1. In Millipore water, both rods and spheres have high colloidal stability, 
with zeta-potential ranging around -36 mV. The rods have a hydrodynamic 
diameter of 458 nm (PdI 0.15) while the spheres are 313 nm (PdI 0.16). In Hank's 
Balanced Salt Solution (HBSS) the dispersion stability decreases. Zeta-potential in 
both samples dropped to -25 mV while the size increased to over 1 µm (PdI 0.29). 
Table 7.1 Particle Sizes and ζ-Potentials of PAA-CD-CaCO3 carriers in different 
media at pH 7.4. 
Shape Medium Size (nm)a,b PDI ζ-potential (mV)b 
Rods Millipore 458 ± 20 0.18 -38.9 ± 5.2 
Spheres Millipore 313 ± 15 0.14 -36.7 ± 7.0 
Rods HBSS 2270 ± 95 0.28 -24.5 ± 2.0 
Spheres HBSS 873 ± 112 0.29 -24.9 ± 3.7 
Rods RPMI 700 ± 50 0.19 -26.2 ± 10.8 
Spheres RPMI 439 ± 43 0.17 -27.3 ± 11.8 
Rods RPMI+FCS 656 ± 42 0.24 -11.8 ± 12.1 
Spheres RPMI+FCS 472 ± 36 0.24 -13.3 ± 8.6 
a Intensity-weighted size distribution. b Value ± Standard Deviation (n = 3). CD with 2.3 
mol/g is used on the experiment. PDI: polydispersity index. 
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The instability can be assigned to the high ionic strength of HBSS. When dispersed 
in RPMI-1640 medium without serum, the carriers are fairly stable, maintaining a 
zeta-potential of around -26 mV and hydrodynamic diameters of 700 nm (
for rods and 440 nm (PdI 0.17) nm for spheres. In RPMI with 10% fetal calf serum 
(FCS), the zeta-potential dropped to –12 mV and the polydispersity index was over 
0.3. This behavior is to be expected since the presence of serum 
media is known to increase aggregation of negatively charged particles due to 
protein adsorption and corona formation.40–42 To improve stability in protein
containing media, coating with biocompatible polymers, e.g. PEG, will be further 
investigated. 
The safety of this delivery system is assessed on A549 cell line by means of cell 
membrane integrity (LDH) and metabolic activity via mitochondrial enzymes 
(MTT). As depicted in figure 7.5, the effect of particle concentration was evaluated 
for both geometries. According to LDH release, around 5% of A549 cells died 
after 4 h incubation, regardless of the nanohybrids geometry and concentration. 
MTT assay corroborates with the idea of no toxic behavior. For both types of 
particles and concentration, there is no statistical significant deviation from the 
high control. Early reports reveal toxicity associated with an increase in the 
cytosolic Ca2+ concentration. This is associated with an increase in the overall 
 
Figure 7.4: SEM micrographs of CD-CaCO3 precipitated for 48 h by combining PAA 
and PEI at 0, 0.3, and 0.7 g/L. CD with 2.3 mol/g is used on the experiment.
PdI 0.19) 
proteins in the 
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calcium ion concentration when the particles dissolve. A closer inspection is shown 
on supporting information 7.9 and it can be concluded that at 6 and 12 mM of Ca
no toxicity response was found. 
In order to model the delivery of small molecules, the dye Rhodamine B was 
used. This dye was encapsulated via the co-precipitation method, in which the dye 
is dissolved in water prior to particle synthesis. Table 7.2 shows that the loading 
was around 8.6×10-5 % for spheres and 7.4×10-5 % for rods, with an encapsulation 
efficiency (EE) of 32 % and 27 %, respectively. This difference can be attributed to 
the higher surface area of spheres when compared to the rods.  
Figure 7.6a shows the release of encapsulated dye from rod
nanocomposites. At pH 4.8, the carriers rapidly dissolve and completely release the 
dye within 6 hours. At pH 7.4, the release starts with a burst within the first 3 h, in 
which almost 30% is released. This can be attributed to loosely bound dye 
molecules on the surface of carriers. From 6 to 84h, 10 % is released due to dye 
diffusion through the pores within the matrix. As a proof of concept, Figure 7.6b 
shows the pH-triggered release. The sample was kept at pH 7.4 for 54 hours. 
Within this period, 31 % of RhB was released. After that, the pH of the buffer was 
Figure 7.5: Cytotoxicity of both spheres (0.1 g/L PAA) and rod-like (0.7 g/L PAA) 
nanohybrids at different particle concentration assessed by LDH and MTT assay.
2+, 
-like 
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changed to 4.8 by addition of 1M HCl, which triggered the complete release by 
dissolution of the carriers within 5h. 
7.4. Discussion 
Materials with high carboxylic content, such as carbon nanodots,32 graphene 
oxide43 and acidic polyelectrolytes,20,44 have been shown to affect the precipitation 
kinetics of calcium carbonate yielding crystals with intricate morphology and 
metastable polymorphs. Carboxyl groups that are pre-sent on the surface of CDs 
coordinate with Ca2+ leading to an accumulation of ions at the nanodots, while at 
the same time depleting Ca2+-ions in the volume phase. The addition of carbonate 
ions then leads to the nucleation of small primary crystallites, with the carbon dots 
as primary initiators for heterogeneous nucleation. The role of the carboxylic 
polymer PAA in the biomimetic mineralization of CaCO3 is well 
documented19,20,44,45 and is expected to enhance the effect described above for CD 
while at the same time further restricting crystal growth by adsorbing to positively-
charged planes of the crystallites.46,47 This retards both particle growth and 
uncontrolled aggregation and leads to controlled mesoscale self-assembly. 
Moreover, the crystallinity of both primary and final nanoparticles emphasizes the 
role of PAA as an additive and carbon nanodots as the main mediator for 
crystallization. Previous studies20,44,45 revealed amorphous character of CaCO3 if 
precipitation is mediated only by PAA at similar concentrations, while in this 
study, the carbon dot template causes the direct formation of crystalline CaCO3. 
As can be derived from the concentration-dependent behavior, the hierarchical 
structure of the hybrid nanoparticles is most likely to occur if the overall content of 
 
Figure 7.6: a) Release profile of Rhodamine B from 0.7 g/L PAA-CD-CaCO3 at pH 4.8 
and 7.4. b) pH-triggered release: after 56 h, sample A was divided into two and pH was 
changed from 7.4 to 4.8 using 1 M HCl. CD with 2.3 mol/g is used on the experiment.  
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PAA is high enough to avoid direct precipitation of large crystals and sufficiently 
cover the surfaces of the primary particles. The formation of the two distinct 
geometries may be explained by certain alignment of the disc-like primary 
particles during the mesoscale-assembly process (Figure 7.7). At low PAA 
concentration, due to high yield (0.15 g/L), the number of poorly coated crystallites 
in solution is high and the aggregation process tends to occur rapidly and without 
preferential organization.48 This unordered assembly results in the formation of 
spheres with diameters of a few hundred nanometers and with 6 nm pore sizes. 
Increasing the PAA concentration to 0.7 g/L, the yield is lowered to 1.0 g/L due to 
growth inhibition, which leads to sufficient coverage of the anisotropic primary 
particles with PAA at specific growth planes resulting in controlled alignment 
during assembly. The final mesocrystal geometry is most likely a result of the 
anisotropic shape of the primary nanoparticles, which assemble into rod-like 
composite nanoparticles. The structuring of primary particles inside the rods 
(Figure 7.7, parallel white lines) suggests that rods are formed by planes of 
nanoparticles at a distance of around 10.1 ± 1.8 nm, which is very similar to the 
primary nanoparticle size (7.4 ± 2.1 nm). Once assembled, the nanoparticles are 
most likely held together by PAA/CaCO3 coordination. 
The influence of polymer charge on the final structure revealed the absence of 
carboxyl groups, when using PEI as the additive, direct precipitation of large 
calcite crystals can not be prevented. By combining both PEI and PAA, it is no 
longer possible to fully control the morphology as the nanoparticles highly 
aggregate, possibly as a result of electrostatic heteroaggregation which disturbs the 
controlled mesoscale assembly. 
The particles showed reasonable stability in protein free RPMI medium. 
However, when introduced to media supplemented with proteins, the suspension 
tended to aggregate, as could be expected since the particles do not feature a 
protective layer of poly(ethylene glycol) or similar. The safety of this delivery 
system to the pulmonary epithelial cells was also assessed. Cytotoxicity 
experiments revealed that for both morphologies, there was no toxicity in both 
LDH and MTT assays. Special consideration is given to the toxicity associated 
with varying Ca2+ concentration, as was previously reported for calcium phosphate 
particles.49 The dissolution of such carriers increases the overall calcium ion 
concentration. This can lead to an elevation in the cytosolic Ca2+ concentration and 
therefore induce apoptosis. A closer inspection with a control system using CaCl2 
shown on supporting information 7.9 reveals that at 6 and 12 mM of Ca2+, no 
toxicity response was found. One of the main advantages of using CaCO3 is that 
this mineral is already produced by the body and is generally recognized as safe. 
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Rhodamine B can be encapsulated with an encapsulation efficiency (EE) of 32% 
for spheres, slightly higher than for rods (27%). This can be attributed to the higher 
surface area of spheres when compared to rods. The release of encapsulated dye 
from rod-like nanocomposites occurs either by desorption-diffusion or carrier 
dissolution, depending upon the environmental pH. At pH 4.8, the release is 
complete within 6 hours due to rapid carrier dissolution. However at pH 7.4, 
loosely bound dye molecules desorb from the CaCO3 surface within 6h, as can be 
seen by the initial burst release. From 6 to 84h, the slow rate of release is most 
likely the result of a desorption-diffusion mechanism. Considering that both 
polymer and the nanocomposite are negatively charged at neutral pH, electrostatic 
interaction can play a role in the release profile, especially at neutral-basic 
conditions, slowing down the release rate. Triggered pH release was achieved by 
shifting the pH from neutral to acid, as shown in Figure 7.6b. Here, the change of 
pH promotes fast release of dye molecules due to carrier dissolution. 
 
 
 
 
 
 
Table 7.2 Encapsulation efficiency and loading of Rhodamine-B. 
Shape PAA (g/L) Loading (%) 
Loading rate 
(µM/mg) 
Encapsulation 
Efficiency 
(%) 
Spheres 0.15 8.6×10-5 ± 4×10-6 3.8×10-1 ± 1.8×10-2 32.0 ± 8.4 
Rod 0.7 7.4×10-5 ± 6×10-6 3.2×10-1 ± 2.2×10-2 27.4 ± 7.6 
Value ± Standard Deviation (n = 3). Initial [RhB] 12 µM. CD with 2.3 mol/g is used on 
the experiment. Loading: % of mass encapsulated dye per total mass of particles. 
Loading rate: mM of encapsulated dye per total mass of particles. Encapsulation 
Efficiency: % encapsulated dye compared to initial amount. 
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7.5. Conclusion 
In summary, carbon nanodots and poly(acrylic acid) sodium salt were used to 
modify the precipitation of calcium carbonate for the synthesis
composite nanoparticles. The mesoscale assembly during the precipitation of CD
CaCO3 allows the formation of porous organic-inorganic composite particles with 
controlled geometry. At low polymer concentration, spherical morphology is 
achieved while at higher concentration, rod-like structures are formed. Since the 
primary nanoparticles do not fuse together after assembly as a result of polymer 
stabilization, the carriers are porous and have rough surfaces. These pores, allow 
the occlusion of molecules within the CaCO3 matrix, which was studied b
a model low-molar dye, Rhodamine B. The release of the dye is governed by 
desorption-diffusion at pH 7.4 and by carrier dissolution at pH 4.8. Given the 
morphological control, simplicity of synthesis and pH-triggered release, the CD
CaCO3 system can be a potential drug carrier. The ability to adjust the geometry 
while still maintaining appropriate size, medium stability and absence of toxicity 
highlights the potential use for biological applications. Rod-shaped CaCO
can potentially benefit from better targeted-uptake when compared to spherical 
particles50 as well as higher receptor-mediated accumulation.
 
Figure 7.7: Schematic drawing and 
TEM micrographs of oriented and 
unordered mesoscale assembly 
mechanism proposed in this paper.
 
 of porous CaCO3 
-
y loading 
-
3 carriers 
14 With respect to 
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pulmonary delivery, these anisotropic particles can potentially benefit from lower 
phagocytosis clearance, due to the orientation-dependent uptake by macrophages.51 
Moreover, in the field of materials science, the knowledge on mesoscale assembly 
is valuable for a comprehensive control and design of inorganic crystals mediated 
by organic additives. 
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8. An evaluation of colloidal and crystalline properties of 
CaCO3 nanoparticles for biological applications 
8.1. Introduction 
Abstract: Biodegradable calcium carbonate carriers are a promising and safe 
nanoparticle platform, which might enable various applications as an engineered 
nanomaterial in health care, food and cosmetics. However, engineered 
nanoparticles can exhibit new forms of toxicity that must be carefully evaluated 
before being widely adopted in consumer products or novel drug delivery systems. 
To this end, we studied four common calcium carbonate particle systems (calcite 
nanoparticles, amorphous sub-micrometer and vaterite sub-micrometer and 
micrometer particles) and compared their behavior in biological medium and in 
cell culture experiments. The thermodynamically stable calcite phase is shown to 
maintain its morphological features as no phase transformation occurs. Size- and 
time-dependent phase transformation of the less stable vaterite particles are 
observed within 96 hours in cell medium. The protein serum albumin can be an 
effective inhibitor of phase-transition and it is shown to improve colloidal stability. 
The impact of the biological environment goes beyond protein-corona formation, 
as we observed rapid dissolution of amorphous particles in high ionic strength cell 
medium, but not in Millipore water. Cellular responses of human osteoblasts 
against CaCO3 particles indicate that increased extracellular calcium ions 
improve viability and that particle internalization is not size-dependent. Useful 
insights for designing CaCO3-based delivery systems are provided and also 
corroborate to the idea that intrinsic material properties as well as environmental 
conditions are of relevance for the successful implementation of dispersed CaCO3 
particles in drug delivery systems and in other applications. 
The use of engineered nanoparticles (ENPs) in consumer products is becoming 
increasingly prevalent.1 Clothing,2 cosmetic1 and food industries3 are just a few 
examples of today’s use of ENPs. The particles are mainly applied as pigments and 
fillers, for the occlusion and delivery of active ingredients and as antimicrobial 
agents. Another field in which the use of nanoparticles holds great potential is 
nanomedicine,4,5 especially considering tumor targeting, diagnostics, imaging and 
treatment.6 With the increasing use of ENPs, the necessity for nanosafety 
assessments is well recognized,2 as evidenced by the strong increase in the 
publications numbers within the past two decades.7 
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As a consequence of various strategies to trick the immune system, like change 
of particle aspect ratio or functionalization with stealth polymers and self-peptides, 
these colloidal systems are able to avoid clearance.6,8,9 Accordingly, these materials 
can exhibit new forms of toxicity, especially as a result of long-term accumulation 
in the body.10 To avoid such undesirable effects, biodegradable and biocompatible 
materials are a promising option. Food and Drug Administration (FDA)-approved 
polymers like chitosan and poly(lactate) (PLGA) received special attention as they 
are well tolerated by the body.8 Another alternative is the use of endogenous 
materials, like calcium phosphate, calcium carbonate and phosphosilicates.11 
Calcium carbonate (CaCO3) holds great potential, as it is highly pH-sensitive and 
dissociates into calcium and carbonate ions, which already are ubiquitous in the 
body.  
CaCO3 exists in six different crystal morphologies: the naturally occurring 
calcite, aragonite, vaterite and amorphous calcium carbonate (ACC) phase and the 
highly unstable ikaite and monohydrocalcite. Only calcite is thermodynamically 
stable, while aragonite and vaterite are slightly unstable and tend to transform into 
calcite in the presence of water/humidity.12–14 The same is true of amorphous 
calcium carbonate which in nature often occurs as a precursor to the more stable 
polymorphs.15 All CaCO3 polymorphs have a certain solubility in water which is 
determined by the solubility product and scales with the thermodynamic stability 
of each crystal phase.16 This instability is more pronounced at the nanoscale, at 
which solubility and reactivity increases due to an enhanced surface to volume 
ratio.17 Additionally, the dissolution rate is known to be highly dependent on the 
intrinsic nature of the particles (composition and crystal phase)15 as well as on the 
environmental conditions (pH, presence of proteins and calcium-chelating 
moieties, ionic strength).18–20 Moreover, the dissolution of nanoparticles in 
biological medium can impact the biological systems interacting with the material, 
potentially changing the toxicity behavior from nano to ion-related.7 Given that, to 
properly design CaCO3-based drug delivery systems (DDS) or similar 
nanostructures with dispersed CaCO3 particles considering particle solubility in the 
respective media is critical. Furthermore, colloidal stability and consequently 
biological availability of CaCO3 particles could be influenced by their crystal phase 
and morphology as a consequence of different surface properties of the 
nanomaterials including their interactions with media biomolecules.  
As a result of the detailed and inspired studies of CaCO3 biomineralization, a 
vast number of publications report the design of CaCO3 particles for drug delivery. 
However, just for a fraction of these publications in vitro or in vivo studies were 
performed.21–65 The latter studies evaluated different aspects of the CaCO3-cellular 
interactions: intracellular behavior,36,65 pH modulation,37 bubble generation,34,35,53 
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bone remodeling,24 photothermal therapy,22,28,43,49 drug / protein delivery,21,23,25–
27,29–33,38,41,42,46–48,50–52,60–62 gene transfection,44,45,54–59 cellular uptake,63 toxicity 40,65 
and bioavailability studies.39,64,65 Among these publications, crystalline particles 
like calcite, vaterite and aragonite38 phases have been utilized. These particle-
systems varied in size from bulk material, to micrometer (1 – 1.5 µm), sub-
micrometer (150 – 800 nm) and nanometer (30 – 100 nm) particles. In the case of 
amorphous carriers, the range of particle size was narrower, from 100 to 230 nm.44–
49 In some cases, the interplay of both amorphous and crystalline CaCO3 phases 
was also reported.24,41–43 In others, the crystallinity of the particles was not 
described.50–65 Moreover, the aforementioned systems were tested with different 
cell culture media, incubation periods and cell lines. While most studies report 
viable nanoparticle systems in their own context, comparing the results is a 
challenging task. The lack of standardization when assessing biological responses66 
along with the incomplete information on the colloidal characterization makes it 
difficult to generalize the results, especially considering the real-live performance 
of particle-based drug delivery systems.  
With the above discussion in mind, we designed a study that would allow us to 
compare the biological behavior of different CaCO3 systems with varied 
crystallinity, solubility and colloidal properties. To this end, we analyzed the 
material properties of four different types of CaCO3 particles commonly described 
in the literature as potential drug delivery systems and investigated their biological 
behavior against human osteoblasts in the Dulbecco's Modified Eagle's Medium 
(DMEM). Here, we focused on the changes in material properties in the cell 
medium and on the impact of the particles on the cells. For our study, we chose 
calcite, ACC particles, and vaterite particles in the range of 90 nm to 1 µm which 
we consider representative in regard to polymorphism and size of those described 
in the literature as potential drug delivery systems. 
8.2. Experimental section 
8.2.1. Materials 
Calcium chloride (CaCl2 dihydrate, purity > 96 %), sodium carbonate (Na2CO3, 
purity > 99.5 %), poly(acrylic acid) sodium salt (PAA, Mw 8000 g/mol, 45 wt % in 
water), bovine serum albumin (BSA, lyophilized powder), glycerol (Gly, 
purity > 99.5 %), sodium hydrogen carbonate (NaHCO3, purity > 99.5 %), ethylene 
glycol (EG, purity ≥ 99 %) were purchased from Sigma-Aldrich and used without 
further purification. The experiments were performed using double deionized water 
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with a conductivity of 0.04 mS/cm from Synergy (Millipore, Darmstadt, 
Germany). 
Cell culture tests were carried out on human osteoblast cells (HOB, lot no. 
232R020412 obtained from Provitro - Germany). Dulbecco’s Vogt modified 
Eagle’s minimal essential medium (DMEM, high glucose), antibiotic-antimycotic 
(AB/AM), Alexa Fluor 488 phalloidin (AF488) were obtained from Invitrogen 
(Germany). Fetal calf serum (FCS), phosphate buffered saline (PBS), 
trypsin/ethylenediamine tetraacetic acid (0.25% Trypsin, 0.02% EDTA), Triton X-
100, 4′,6-diamidino-2-phenylindole (DAPI, 0.5 μg/mL), paraformaldehyde (PFA, 
95.0-100.5%), osmium tetroxide solution (OsO4, 4% in water), glutaraldehyde 
solution (Grade 1, 25% in water) and an epoxy embedding medium kit (Epon 812 
substitute) were purchased from Sigma-Aldrich (Germany). The water-soluble 
tetrazolium salt (WST-1) cell toxicity assay (Roche Diagnostics GmbH, Germany) 
and the lactate dehydrogenase (LDH) Pierce assay (Thermo Scientific, Germany) 
were directly purchased from the suppliers.  
8.2.2. Synthesis of crystalline and amorphous nanoparticles 
Calcite nanoparticles, purchased from PlasmaChem GmbH (Berlin, Germany) 
are produced by a sol-gel process and used as purchased. Amorphous particles 
were prepared as previously described.67 In short, 10 mL aqueous solution with a 
final concentration of 1.9 g/L of PAA and 12 mM of CaCl2 was prepared. To 
mineralize the particles, an aqueous solution of Na2CO3 was added to the reach the 
final concentration of 12 mM. The suspension was centrifuged at 5000 rpm for 10 
minutes, the supernatant discarded and particles dried in an oven at 70 °C for 1 
hour.  
Vaterite particles were prepared in a similar way as previously reported.37,68–70 
Micrometer particles were synthesized in a water:EG solution (1:6, v/v). First, 207 
µL of 2 M CaCl2 aqueous solution was first added to 4.15 mL of EG solution, 
stirred for 5 min and followed by 415 µL of 1 M NaHCO3 aqueous solution and 
227 µL of water. The final concentration of carbonate was kept equimolar at 83 
mM. The solution turned turbid after 5 minutes, indicating the formation of 
particles. After 1 hour stirring at 500 rpm, 30 mL of 100% ethanol was added to 
the suspension. Particles were collected by centrifugation at 5000 rpm for 10 min. 
This washing step was repeated twice and the collected particles were dried at 
70°C for 2 hours. Sub-micrometer particles were prepared in a similar fashion but 
with a few modifications. The 1:6 water:EG solution was substituted by 
water:EG:Gly 1:1.25:3.7 in volume. Both CaCl2 and NaHCO3 aqueous solutions 
were added to a 4.15 mL solution containing 1.04 mL of EG and 3.11 mL of Gly. 
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The final concentration of calcium and carbonate was kept equimolar at 83 mM. 
The solution remained transparent for about 1 hour. The dispersion turned turbid 
after this period. Particles were collected by centrifugation after 2h 30min, 
followed by washing the particles twice in 100% ethanol and drying at 70°C for 2 
hours. For experiments without BSA-stabilization, the particles were dispersed in 
the respective medium in an ultrasound bath for 10 minutes. 
8.2.3. Particle-stabilization by BSA  
Dried particles were dispersed in 0.2% BSA in Millipore water to prepare 1.2 
g/L particle concentration. The suspension was ultrasonicated for 15 minutes to 
ensure that no aggregates remained in solution and to fully coat the particles. 
Afterwards, it was centrifuged for 10 minutes at 5000 rpm and dried at 70°C for 1 
hour.  
8.2.4. Calcium-ion release from nanoparticles 
The calcium content in the supernatant was quantified using the o-
cresolphthalein complexone colorimetric kit (Fluitest CA-CPC). Briefly, an 
amount of dried particles were added to the respective medium to prepare a particle 
concentration of 1.2 g/L. The suspension was serially diluted in the same medium 
to prepare 0.6, 0.3, 0.15 and 0.075 g/L. The suspensions were centrifuged for 10 
minutes at 5000 rpm. 10 µL of the supernatant was added to a 96-well plate 
containing 50 µL of reaction mixture 1 (reagent obtained in the kit). 50 µL of 
reaction mixture 2 was added and the well plate was shaken for 30 s to allow 
homogeneous mixing. The plate was incubated for 10 minutes at room temperature 
(RT) and the absorbance was measured at 570 nm with plate reader. The calcium 
concentration was calculated using a standard curve by a serial dilution of the 2.5 
mM standard acquired with the kit.  
8.2.5. Toxicity profile assessment 
To assess toxicity of the CaCO3 particles, cell viability at different 
concentrations was tested in a similar way to 71, by means of membrane integrity 
via LDH release (Pierce assay) and metabolic activity via mitochondrial activity 
(WST-1 assay, Roche). Particles stabilized by BSA were centrifuged and sterilized 
overnight under a UV lamp and redispersed in DMEM at different concentrations. 
Human osteoblast cells (4th to 11th passage) were cultured in DMEM 
supplemented with 10% heat-inactivated FCS and 1% antibiotics/antimycotics in 
an incubator (C200, Labotect Labor Technik, Germany) at 37 °C with 10% CO2 
and 95% relative humidity (RH). One day prior to the experiments, the cells were 
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detached and seeded in a 24-well plate at a density of 2 × 104 cells per well. On the 
following day, the dispersions were added and incubated for 24 h. In addition, for 
the WST-1 assay, cells grown in culture medium were set as high control (100% 
cell viability), and others incubated with Triton X- 100 (2%, w/v) were used as low 
control (0% cell viability). For the LDH assay, the cytotoxicity was calculated 
relative to Triton X-100 as high control and cells in culture medium as low control. 
Samples were measured in triplicates and evaluated as mean and standard 
deviations (SD). 
Particle uptake studied via electron microscopy. For Transmission electron 
microscopy (TEM) analysis, a similar procedure to 72 was used. Shortly, 
osteoblasts were washed once with PBS, detached with Trypsin/EDTA and 
transferred to 2 mL Eppendorf cups. The cups were centrifuged at 6000 rpm for 6 
min, fixed with standard 2.5% glutaraldehyde, 2.5% formaldehyde in 0.1 M 
Na‐cacodylate for 1 h at RT. After removal of the fixative, the cells were washed 
several times with phosphate buffer and post-fixed with Osmium tetroxide solution 
for 1 hour at RT. The black pellet was washed twice and dispersed in 2% agar 
(Sigma‐Aldrich) in Millipore water, and allowed to solidify at 4°C. The pellet in 
agar was cut into squares of about 1 mm wide. The blocks were dehydrated in a 
graded series with ethanol (twice for 5 minutes in 30% and 50% ethanol, 3 times 
for 10 minutes in 70%, 90% and twice for 15 minutes in 100% ethanol). Blocks 
were embedded in Epon 812. Ultrathin sections were taken with an ultramicrotome 
(Ultracut R, Leica, Wetzlar, Germany). No surface markers were used (uranyl 
acetate or ruthenium red), in order to enhance the contrast of intracellular 
components, as these are not the focus of the analysis. 
8.2.6. Characterization techniques 
For the measurement of particle size and zeta-potential, dried particles were 
ultrasonicated for 10 minutes in the respective medium. Particle size and zeta 
potential were determined by a Zetasizer after 4 h of incubation (Malvern 
Instruments, Nano ZSP). The data is given as mean ± standard deviation (SD) 
based on three independent measurements. The aggregation behavior was 
evaluated in terms of the particle size distribution and polydispersity index (PDI). 
The morphology of the carriers was evaluated by scanning electron microscopy 
(Zeiss, SUPRA 40), with an acceleration voltage of 15 kV as well as transmission 
electron microscopy with a Zeiss EM 900 (Zeiss, Oberkochen, Germany) at 80 kV. 
Images were acquired using a CCD-camera (TRS, Dünzelbach, Germany) with the 
software ImageSP (TRS). X-ray diffraction (XRD) analysis was carried out using a 
JSO-Debyeflex 2002 device, with Cu Kα radiation (λ = 1.542 Å). The samples 
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were ground to a powder, placed on the holder with silicone grease and scanned 
from 20° to 50°, 1 second per step. UV- Vis spectroscopy was performed on a 
Multiskan Go device (Thermo Scientific). Thermogravimetric measurements 
(TGA) were performed in STA 503 (Bähr Thermoanalyse) with a heating rate of 4 
°C/min under 2 L/min of atmospheric air. The specific surface area (SBET) of the 
samples was determined by nitrogen adsorption (Belsorp-Mini, Bel Japan, Osaka, 
Japan), using the BET-method. The pore size distribution was determined by the 
BJH method from the adsorption/desorption hysteresis of the BET-isotherms. 
8.3. Results 
8.3.1. Material characterization of the CaCO3 particles  
The CaCO3 particles were fully characterized prior to the cell experiments. 
Figure 8.1 shows a TEM overview of the particles immediately after synthesis 
(vaterite and ACC) or as purchased (calcite). The calcite particles are 
monodispersed and exhibit a rhombohedral shape with a particle size of 90 ± 10 
nm. The amorphous particles are synthesized in Millipore water by the complex 
coacervation of [Ca2+] ions and PAA, followed by mineralization with Na2CO3, as 
previously reported by us.67 As the size can be controlled by complexation time 
and PAA concentration, the smallest particle size that can be obtained with this 
method is 250 ± 20 nm in diameter. Due to the nature of the synthesis, smaller 
nanoparticles (8 nm particles in diameter) are also formed.73 Vaterite particles are 
prepared in a water-solvent mixture.37,68–70 Sub-micrometer particles are prepared 
in 1:1.25:3.7 water:EG:Gly in volume ratio and yield particles size of 600 nm ± 20 
nm while micrometer particles are prepared in 1:6 water:EG, which yields 1 µm ± 
0.1 µm particles. Supporting Figure 8.1 shows an XRD analysis of the crystal 
phases of calcite and vaterite particles, as well as the absence of reflexes in the 
amorphous phase. BJH characterization of the samples showed that both vaterite 
particles are porous, with a mean pore diameter of 7 nm for sub-micrometer and 9 
nm for micrometer, respectively (Supporting Figure 8.2). The amorphous sub-
micrometer particles as well as calcite nanoparticles are not porous. 
8.3.2. Time-dependent phase-transformation in DMEM 
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It is well known that thermodynamically metastable phases tend to transform 
into more stable phases, like calcite.15 This transformation is triggered in the 
presence of water/moisture12 and can be a concern when designing CaCO
DDSs. To analyze the phase-transformation in cell culture medium
the influence of protein-coating in this transformation, CaCO
dispersed in DMEM and SEM images were taken at 24 and 96 hours after initial 
dispersing.  
The SEM analysis of the samples dispersed in DMEM for 24 and 
or without BSA-coating is summarized in Figure 8.2. In the absence of BSA
stabilization, it was observed that calcite nanoparticles neither dissolve in DMEM 
nor grow within the time frame of the experiment. Moreover, the X
patterns (Supporting Figure 8.3) confirm that calcite does not phase
within 96 h. For vaterite sub-micrometer particles, morphological changes at 96 
hours from rods to micrometer-sized, rhombohedral-shaped crystals indicate a 
phase transformation. This is also observed in the XRD data, where a peak at 29 ° 
indicates the complete transformation into the calcite phase. On the other hand, 
micrometer-sized vaterite particles do not phase-transform into calcite and 
maintain their morphology and size. Amorphous sub-micrometer particles are not 
Figure 8.1: TEM overview of calcite, amorphous, micrometer and sub
vaterite particles. Crystalline and amorphous particles are dispersed in Millipore water 
while vaterite particles in ethanol. 
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shown in the picture because of their complete dissolution in DMEM.  
The presence of BSA can act as a phase-stabilizer of less stable polymorphs. 
The shape and size of BSA-coated calcite nanoparticles and vaterite microparticles 
is not affected by the presence of the protein and both size and crystallinity remain 
constant throughout the experiment. As opposed to the BSA-free solution, BSA-
stabilized sub-micrometer vaterite particles remain stable in solution for 96 h 
without appreciable change in shape or size. A closer inspection of the XRD data 
(Supporting Figure 8.3) reveals that the rate of the transformation is drastically 
reduced by the protein coating. It is worth mentioning that the phase-
transformation appears to be both size-dependent, as it just occurs in the sub-
micrometer vaterite particles as well as time-dependent, as no phase transformation 
is observed after 24 h. This behavior can be explained by the higher surface-to-
volume ratio of the smaller particles which goes along with higher instability and 
enhanced solubility.68 For instance, the surface area of micrometer vaterite 
particles is 44 m2/g, which is low compared to sub-micrometer sized particles with 
 
Figure 8.2: SEM overview of calcite, amorphous, micrometer vaterite and sub-
micrometer vaterite particles after 24 and 96 hours of incubation in DMEM. Both bare 
and BSA-stabilized particles are reported. Amorphous particles immediately dissolved 
in DMEM and therefore are not shown. Arrows indicate the possible formation of 
calcite microcrystals. 
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104 m2/g. Finally, the addition of BSA does not prevent the dissolution of the 
amorphous particles in DMEM. 
8.3.3. Colloidal stability in different media 
As shown above, the presence of proteins can alter the phase transformation of 
CaCO3 particles in cell culture medium. The presence of BSA in medium and its 
adsorption at the surface of the nanoparticles directly affect the colloidal stability, 
as shown in Figure 8.3. The physisorption of the protein can be quantified via 
thermogravimetric. In the absence of protein (Figure 8.3a), calcite particles do not 
show a mass loss up to 600 °C. As the temperature rises, calcination takes place, 
which accounts for around 50 % of the weight loss. Vaterite particles show a 
similar trend. Up to 200 °C, absorbed and intrinsic water are removed. Between 
200 and 300 °C left-over solvents are removed, followed by a calcination reaction. 
The amorphous particles show the highest weight loss of about 70 % ± 10 %, from 
which around 20 % can be attributed to absorbed water, 25 % from PAA and 17 % 
from calcination. By comparing the TGA data in the presence of proteins (Figure 
8.3d) it is possible to calculate the weight loss associated with protein absorption 
within the temperature range from 210 °C to 405 °C. For calcite nanoparticles, 
BSA accounts for 4.2 ± 3.1 % of the weight loss. This relates to around 0.45 mM 
of BSA per g of particle. In the case of the micrometer vaterite particles, 3.1 ± 2.9 
% of the weight is related to BSA, which represents approximately 0.60 mM of 
BSA / g of particle. Sub-micrometer particles absorbed 5.0 ± 4.5 % of its weight, 
around 0.75 mM of BSA / g of particle. Amorphous particles did not absorb any 
appreciable amount of protein.   
CaCO3 has an isolectric point around pH 6 in ultrapure water,74 and is therefore 
negatively charged at physiological pH. In Millipore water at pH 7 and in the 
absence of BSA, the dispersed calcite particles have a mean hydrodynamic 
diameter of 91 ± 16 nm (Figure 8.3b) and show good colloidal stability (PDI 0.29) 
with a zeta-potential of -29.6 ± 2.3 mV (Figure 8.3c). The amorphous particles also 
show good stability with the lowest zeta-potential in water, around - 46.8 ± 3.6 
mV, while the hydrodynamic size is 220 ± 35 nm. The high zeta-potential value 
can be explained by the inclusion of PAA molecules, which are negatively charged 
at neutral pH. The micron-sized vaterite particles showed strong agglomeration and 
sedimentation in water which prevented accurate DLS measurements. The sub-
micrometer vaterite particles have a hydrodynamic size of around 712 ± 40 nm and 
zeta-potential of - 16.7 ± 1.3 mV. 
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When the bare particles (in absence of BSA) were dispersed in DMEM, rapid 
agglomeration and sedimentation took place and therefore DLS measur
were not possible. The instability can be related to the high ionic
medium, which reduces the Debye-length and the repulsion forces between 
nanoparticles.75 On the other hand, BSA-stabilized suspensions are partially stable 
in DMEM, showing PDI values of around 0.3 and zeta-potential around 
medium, the calcite dispersion exhibited a mean hydrodynamic diameter of 255 ± 
30 nm (Figure 8.3e) and a zeta-potential of -6.1 ± 1.0 mV (Figure 8.
to dispersions in Millipore water, amorphous particles dissolved upon redispersion 
in DMEM. Note that this dissolution is not caused by a low pH, but is instead 
probably a result of chelating of Ca2+ ions by the various amino acids and 
phosphate salts contained in DMEM. Vaterite microparticles showed a size of 712 
± 50 nm and a zeta-potential of about - 9.2 ± 1.0 mV. Sub-micrometer vaterite 
particles have a hydrodynamic size of around 396 ± 30 nm and a zeta
Figure 8.3: Thermogravimetric analysis (a,d), number-weighted particle size 
distribution (b,e) and zeta-potential (c,f) of calcite, amorphous, micrometer and sub
micrometer vaterite particles. (a) Dried bare particles, (b – c) Bare particles dispersed in 
Millipore water, (d) Dried BSA-stabilized particles, and (e – f) BSA-stabilized particles 
dispersed in DMEM. 
ements 
-strength of the 
-10 mV. In 
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-potential of - 
 
-
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8.9 ± 1.0 mV. In DMEM, it is observed that the stabilization of particles with 3 to 
5 % of BSA can hinder aggregation and improve colloidal stability of all types of 
particles (Figure 8.3b, c, e, f). These findings are also supported by a previous 
report.36 
8.3.4. Dissolution behavior in different media 
As shown previously, the incorporation of BSA improves colloidal stability and 
slows down the rate of phase transformation of sub-micrometer vaterite particles. 
Serial dilution of particles along with determining the free calcium ions allowed us 
to examine the dissolution behavior of each particle type in both water and 
DMEM. In Millipore water, bare particles are tested while in DMEM, BSA
stabilized particles are used due to the improved colloidal stability. In water, all 
particles are stable with low calcium ion release (Figure 
amorphous particles show the highest calcium ion release, approximately 1.2 ± 0.3 
mM, followed by vaterite sub-micrometer particles at 0.9 ± 0.2 mM, calcite 
nanoparticles at 0.8 ± 0.2 mM and vaterite microparticles at 0.7 
If the particles are dispersed in DMEM, the minimum calcium concentration 
detected is 1.80 ± 0.2 mM, which corresponds to the calcium concentration in the 
 
Figure 8.4: Dissolution of calcite, 
micro- and sub-micrometer vaterite and 
amorphous particles upon serial dilution 
in aqueous medium. (a) Bare particles 
(no BSA-stabilization) dispersed in 
Millipore water pH 7. (b) BSA
particles dispersed in DMEM pH 7.4.
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medium (Figure 8.4b). Crystalline particles remain stable and barely dissolve. The 
calcium concentration remains constant with values ranging around 1.8 mM for all 
different particle concentrations. Amorphous particles on the other hand, readily 
dissolve in DMEM, increasing the Ca2+ concentration up to 6.0 ± 0.3 mM at 1.2 
g/L. The dissolution of amorphous particles is confirmed by turbidity 
measurements at 450 nm and by SEM. Moreover, additional experiments of BSA-
coated particles in water and bare particles in DMEM (Supporting Figure 8.4) 
revealed similar results. 
8.3.5. Toxicity profile of CaCO3 particles against HOBs  
Toxicity experiments were performed using a HOB cell line and incubated with 
BSA-stabilized particles for 24 h in serum-free DMEM at different particle 
concentrations (Figure 8.5). Two standard experiments were performed: the LDH 
release assay, which indicates membrane damage with increasing LDH release and 
hence toxicity, and the WST-1 assay which indicates viability by quantifying the 
mitochondrial activity of the investigated cells. Amorphous particles did not show 
any significant deviation from the control (pure medium) both for LDH release and 
for viability (Figure 8.5a and b). However, it must be noted that for mitochondrial 
activity, the values approached 80 % indicating a possible toxic effect of the 
amorphous particles or its constituents that are released upon the already described 
dissolution of the particles in DMEM. Calcite particles displayed conflicting 
results. Regarding LDH release, a concentration-dependent increase in LDH 
release was observed. At higher particle concentration, 1.2 g/L, the LDH release 
showed significant values close to toxic levels (20%). On the contrary, viability 
experiments displayed improved viability, up to 125% at the highest particle 
concentration. Both types of vaterite particles show no significant deviations from 
the control for LDH release. Moreover, as with calcite, improvement in viability is 
observed for sub-micrometer particles at 0.6 g/L and at 1.2 g/L for micrometer-
sized particles. 
Control experiments were performed using CaCl2 and PAA and are shown in 
Figure 8.5c and d. Poly(acrylic acid) can be toxic depending on its molecular 
weight. According to the LDH release, no significant values are observed when 
compared to the control. However, the viability decreases considerably at 1.9 g/L 
of PAA, which is similar to the concentration of PAA used in the preparation of the 
amorphous particles. At lower concentrations, 0.15 and 0.7 g/L, no toxic effect can 
be observed. In the calcium chloride control experiments, optimal conditions for 
cell viability can be obtained by adding additional CaCl2 up to 2 mM to DMEM 
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medium, while higher concentrations reduce cell viability and also show an 
increase in membrane damage. 
By comparing the experiments using Ca2+ as control and the ones with 
crystalline particles, better viability for crystalline particles is observed (around 
150%) than for 0.5 mM [Ca2+] as control (127 ± 15%). Since in both experiments 
the extracellular calcium is kept roughly the same, around 2 mM and 2.3 mM 
respectively, the difference in viability cannot just be explained by the elevation in 
the extracellular calcium concentration. Accordingly, due to the particle uptake 
followed by lysosomal dissolution (see below), the increase in intracellular calcium 
levels might cause even stronger cellular excitation, and therefore cellular viability. 
Live-dead staining experiments were performed to validate the aforementioned 
experiments and the results are shown in Supporting Figure 8.5. In these 
experiments with all particle types, all cell cultures are observed to be 100% viable 
for a particle concentration of 0.3 g/L.  By analyzing fluorescent micrographs of 
cells incubated with 0.3 g/L of particles (Supporting Figure 8.6), no morphological 
alterations were observed. 
8.3.6. Particle-dependent uptake by human osteoblasts 
Calcite nanoparticles are internalized by HOB cells, as observed on microtome 
sections analyzed via TEM (Figure 8.6). As a result of trypsinization, the cells 
appeared to be spherical with a diameter of about 15 to 20 µm. Since the cells were 
not stained with surface markers for practical reasons, the identification of 
intracellular membranes was not optimized. Control experiments with cells 
incubated in the absence of particles also show spherical cells in which the 
mitochondria could be observed as a denser region (Supporting Figure 8.7). The 
embedding resin that encloses the cell has a lighter colour, which allows for good 
distinction between cells and resin. When incubated with calcite nanoparticles, the 
size of the nanoparticles (90 nm) closely matches the size of the microtome slices 
(60 – 85 nm). Therefore, entire nanoparticles can remain in the slice and can be 
observed as dark dots in the TEM images. Internalized nanoparticles are located 
within endosomes. In the case of amorphous particles, which readily dissolved in 
DMEM, no particles can be observed within or outside the cells.  
Due to the large size of the sub-micrometer and micrometer vaterite particles, 
these particles are shattered during slicing. What remains appears as an open space 
with a shape similar to the initial particles. As these spaces are transmitting, they 
appear as brighter regions dotted with remaining bits of CaCO3 (dark dots). Both 
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types of vaterite particles seem to be internalized and are located within 
endosomes. 
Upon internalization, the particles can be dissolved in the acidic environment of 
the lysosomes. As discussed above, increased intracellular Ca2+ levels could be the 
reason for elevated mitochondrial activity as observed via the WST-
8.5). Supporting Figure 8.8 shows fluorescent micrographs of intracellular calcium 
stained with Fluo-3 AM. Analysis of the images indicates a higher calcium 
concentration in the cytosol than in the nucleus, but no clear significant distinction 
between the different particle types could be observed. 
Figure 8.5: HOB intracellular LDH release (a, c) and mitochondrial viability (b, d) when 
incubated with calcite, amorphous and vaterite particles at different particle concentration 
as well as with CaCl2 and PAA. (a,b) incubation with BSA-stabilized particles. (c, d) 
control experiments using CaCl2 and PAA. * Significant value p < 0.05, n.s. Non 
significant value. 
1 assay (Figure 
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8.4. Discussion 
The phase transformation of less stable phases to calcite is a phenomenon that 
occurs in air 12,14 and in aqueous solutions.13,68 The observed phase transformation 
of sub-micrometer particles is a function of the increasing surface-to-volume ratio 
and overall free energy, with decreasing particle size. Moreover, the ion-exchange 
mechanism that leads to phase transformation is dependent on the diffusion rate, 
which is also enhanced with a higher surface-to-volume ratio.68 The phase-
transformation is usually accompanied by changes in morphology and size, which 
can alter the colloidal stability and the biological responses of crystalline particles. 
Our findings suggest that the adsorption of BSA on the surface of CaCO3 crystals 
can hinder the phase transformation of sub-micrometer vaterite particles. These 
results are supported by previous studies,37 which stated that nanosized vaterite 
particles can be stabilized by 2% BSA in PBS. The use of proteins to modulate 
crystal precipitation, morphology and crystallinity is also observed in nature.76,77 
Accordingly, proteins and analogous polyionic polymers have been widely studied 
in the field of biomineralization for modifying crystal nucleation and growth.78 
Additionally, a series of proteins like BSA, R-chymotrypsin and lysozyme have 
been physically adsorbed to porous CaCO3 microcrystals and studied as protein-
delivery systems.79 
Colloidal stability in biological medium is also recognized as an important 
parameter for drug delivery systems.80 It is also known that a reduction of the 
particle concentration in the nanometer range due to colloidal instability can result 
in lower cytotoxicity profiles.81 In Millipore water, nanometer and sub-micrometer 
CaCO3 particles are well dispersed. However, micrometer vaterite particles did not 
yield stable suspensions as these large particles rapidly sediment. In DMEM, 
however, agglomeration and sedimentation is observed for all bare particle 
systems, due to the elevated ionic-strength of this medium and possibly due to 
adsorption of small molecules like sugars and amino acids present in DMEM. The 
increased ionic strength reduces both the Debye-Hückel length and the electro-
static potential, hence the repulsive force between nanoparticles, which can lead to 
destabilization.75 It must be pointed out that the presence of divalent ions in 
DMEM (1.8 mM of calcium ions) can also significantly contribute to the 
destabilization in the cell medium.75 On the other hand, BSA-stabilized 
suspensions are more stable in DMEM according to PDI values. This can partially 
be explained by the steric stabilization provided by the bulky BSA molecules. 
Similar stabilization provided by proteins was previously reported.36,82 Finally, 
regarding the relationship between crystalline phases and the colloidal stability, no 
apparent role can be observed. Since the zeta potential of all types of BSA-
Chapter 8 
   
120 
 
stabilized CaCO3 particles was very similar, colloidal stability seems to be mostly 
dependent on particle size and ionic strength.  
The dissolution behavior of each particle-system was determined in both 
Millipore water pH 7 and DMEM pH 7.4. As dissolution is dictated by the 
solubility product of each CaCO3 phase, it can be expected that less 
thermodynamically stable phases are more soluble than other phases.16,19 
Accordingly, amorphous particles in water partially dissolved and a low increase in 
the calcium ion concentration was detected. Crystalline phases barely dissolved, 
and the difference in the dissolution behaviors of calcite and vaterite was not 
strongly pronounced at our experimental conditions. It is well-known that 
additional molecules in the medium, such as calcium chelators (particularly 
leucine, lysine and phosphate salts in DMEM, but also reported for citrates and 
EDTA in other buffers 19) can significantly alter the phase equilibrium, which we 
experimentally observed for amorphous particles in DMEM. Amorphous particles 
readily dissolved in DMEM increasing the [Ca2+] in the medium. However, 
beneath the crystalline phases, the differences seem to be insignificant. 
Toxicity experiments revealed that increased [Ca2+] concentration of around 2 to 
6 mM can improve cell viability, which is a similar concentration range as was 
 
Figure 8.6:  TEM of HOB cells incubated with calcite, amorphous, sub-micrometer and 
micrometer vaterite particles for 24 hours. Particle concentration: 0.3 g/L. Right panel is 
a high magnification image from selected area on left panel. Labels: C – cytosol, M - 
mitochondrion, NPs - calcite nanoparticles, VS – vaterite sub-micrometer particles, V – 
vaterite microparticles. 
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reported elsewhere.83 This behavior occurred for all three types of crystalline 
particles, but not for the amorphous particles, indicating that the observed increase 
in cell viability might be a result of cell internalization followed by lysosomal 
dissolution of the more stable CaCO3 particles. For the amorphous particles, the 
release of the additive PAA, which was used to stabilize the amorphous phase, 
possibly caused membrane damage. Our findings are supported by 84, which 
described that PAA molecules (25 k mol/g) can actively disrupt cellular membrane 
of mammalian cells and cause cytotoxicity.  
The TEM micrographs of HOB cells suggest that calcite and vaterite particles 
are internalized by the cells. In the micrometer range, the shape of CaCO3 particles 
on the uptake by cervical carcinoma cells was studied.63 It was suggested that the 
number of internalized particles is dependent on the aspect ratio of the particles. In 
regard to CaCO3 in the nanometer scale, the uptake of nanoparticles by A549 cells 
was also observed.36 However the role of crystallinity in the uptake has not yet 
been differentiated. Considering that all three particle-systems investigated here, 
apart from amorphous particles, were internalized, no clear dependency could be 
observed, regardless of size or crystallinity.  
8.5. Conclusion 
In summary, we examined four common types of dispersed calcium carbonate 
particles that are regularly studied as novel drug delivery systems and which might 
eventually find their way into health-related consumer products. Both crystallinity 
and environmental conditions (ionic strength, presence of proteins and chelators) 
play key roles in the colloidal behavior and phase-stability of CaCO3 particles. 
However, since CaCO3 is basically nontoxic and biocompatible, these aspects do 
not strongly affect their cellular response and toxicology profile. The behavior of 
the particles regarding their crystallinity, solubility and colloidal stability was 
evaluated by various standard methods for the characterization of nanomaterials 
and showed that the crystalline particles remained dispersed in solution, with no 
appreciable dissolution; however, the amorphous particles readily dissolved in the 
cell nutrition medium DMEM. It is worth mentioning that the sub-micrometer 
vaterite particles phase-transition into the more stable calcite phase accompanied 
by changes in particle size and shape. This change was only observed after 24 h 
and only for the smaller sub-micrometer vaterite particles. The addition of BSA 
generally improved colloidal stability in cell culture medium and diminished the 
rate of phase-transformation of the smaller vaterite particles. While the crystalline 
particles remained in solution with low release of calcium ions, the amorphous 
nanoparticles readily dissolved upon dispersion in DMEM, increasing the 
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extracellular Ca2+ concentration. Two cellular responses were observed: increased 
mitochondrial activity induced by an internal increase of calcium ion concentration 
for crystalline particles, and cell death by membrane damage due to the presence of 
PAA in amorphous particles. Cellular uptake was observed for all crystalline 
particles, even the large micrometer-sized vaterite particles. Consequently, 
crystallinity, solubility and colloidal stability are key parameters for engineering 
CaCO3 nanomaterials for biological applications and should also be factored into 
all assessments of the feasibility of new drug delivery systems.  
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9. Conclusion and perspectives 
In this dissertation, significant effort has been devoted to the synthesis of CaCO3 
particles with controlled shape and size. To this end, the theories that govern the 
complex coacervation and biomineralization processes are modified to allow the 
production of particles with tailored physical properties. As these particles are 
intended for drug delivery applications, encapsulation assessments of proteins and 
fluorescent dyes are performed along with colloidal- and phase- stability studies in 
cell nutrition media. In addition, to estimate the toxic behavior and cellular 
internalization, the particles are assessed in vitro with two different cell lines. 
The first study focused on the control of particle size and the ability to 
encapsulate proteins. As reported, the modified complex coacervation method is 
suitable for encapsulation of positively charged biomolecules, however the control 
of particle size is limited. As the complex coacervation phenomenon is based on 
the electrostatic interaction, charged proteins are shown to comprise one of the 
assembling components along with calcium ions and poly(acrylic acid) (PAA). 
Positively-charged lysozyme is shown to strongly coordinate with PAA, being 
highly incorporated into the coacervate phase. Considering the high protein 
loading, the coacervate size increases to 900 nm and can no longer be fully tailored 
by the complexation time. When tested with negatively-charged bovine serum 
albumin (BSA), due to repulsion with the negatively charged PAA, BSA is 
encapsulated at low concentrations and allows for good control of particle size 
similarly to unloaded coacervate droplets. Considering these features, the 
coacervate-directed method presents a cost-effective, easy to scale-up way to 
synthesize pH-responsive carriers that can be potentially used in gene and drug 
delivery. 
Another synthesis method reported in the thesis is the template-assisted method, 
which uses poly(acrylic acid) as an additive and highly-carboxylated carbon dots 
(CDs) as templates for the mineralization of calcium carbonate. This technique 
allows the synthesis of particles with tailorable anisotropy in the sub-micrometer 
range. As a result of the high concentration of carboxylic groups provided by the 
additives, the bulk solution is depleted of free calcium ions by Ca2+-carboxyl 
coordination. This coordination avoids both the direct precipitation of crystals in 
solution and allows the heterogeneous nucleation of CaCO3 at the template surface. 
The particles self-assemble in either spheres or rods depending on the PAA 
concentration. Accordingly, the ability to adjust the particle geometry while still 
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maintaining appropriate size and encapsulation ability highlights the potential use 
as delivery vehicles to biological systems.  
With biological applications in mind, the third study relates the role of size, 
morphology and crystallinity on the cellular response. In this context, commonly 
reported particle systems are characterized in terms of stability in medium. It is 
shown that the thermodynamically stable calcite particles maintain their 
morphological features as no phase transformation occurs. However, the sub-
micrometer vaterite particles displayed a time- and size-dependent phase 
transformation to calcite. This transformation is effectively inhibited by the 
stabilization with albumin. In regard to the cellular response of human osteoblasts, 
it is reported that the particle uptake is not particle dependent, as all particles were 
internalized. Moreover, the viability assessment is shown to be dependent on the 
release of calcium ions by the particles. The partial dissolution of the carriers 
increased the extracellular and, probably, the intracellular calcium concentration in 
medium, which improved the viability. At the same time, the dissolution of 
amorphous particles released PAA and showed high levels of toxicity.  
Accordingly, these studies present plenty of opportunities for further 
optimization. Given the aforementioned ability to modify the physical properties of 
calcium carbonate carriers, their use should not just be limited to drug delivery. 
This material is especially interesting in biological systems that respond to Ca2+ 
ions. In bone regeneration for example, scaffolds could incorporate calcium 
carbonate particles. Upon dissolution, these particles provide a boost in the 
environment’s calcium concentration. As calcium ions are known to regulate the 
cell cycle, this may offer an opportunity for osteoblast and osteoclast cell lines 
stimulation and improved bone regeneration. In addition, therapeutic ingredients 
can be encapsulated within the CaCO3 particles and sustained release. 
The complex coacervation method also offers opportunities for improvement. In 
our complex coacervation system, the choice of the acidic polyelectrolyte is based 
on a previous report that utilizes poly(acrylic acid). However, the cellular 
experiments showed that this polymer promoted cellular toxicity at 1.9 g/L when 
tested with osteoblast cell line. Possibly, the utilization of a more biocompatible 
polymer, like polyphosphate, may still allow phase-separation with the added 
benefit of improved morphogenetic activity on bone cells.  
In the case of template-assisted assembly, there is the possibility of utilizing 
different templates. In this system, fluorescent carbon dots could be substituted by 
superparamagnetic iron oxide, anti-microbial nanodiamonds, or even a 
combination of more than one template type to create a multifunctional carrier. 
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Regarding the cellular studies, some critical aspects still have to be addressed. 
In vitro studies are very limited in their own context, as just a fraction of all 
possible nanoparticle-cellular interactions can occur in such model studies. 
Therefore, there is still doubt as to whether the reported in vitro behavior will hold 
true when performed in a living organism. In a more general sense, this is the 
central debate on nanoscience, in which, there still marginal improvement to the 
therapeutic outcome of clinical diseases despite 3 decades of research. To address 
this issue, studies should be devoted to the transition to in vivo experiments, up-
scaling studies, to the improvement of active targeting moieties and in the design 
of more accurate computer simulations.   
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10.  Appendix 
10.1. Supporting information Chapter 2 
The solubility of weak acids is very dependent on the pH. If the hydrolyses of 
carbonate is considered, the following equilibrium equations allow the calculation 
of the solubility of calcium carbonate as a function of pH: 
????? ????? [Ca??] + [?????] Eq. 7 
[?????] ????? [H?] + [?????] Eq. 8 
[?????] ????? [H?] + [?????] Eq. 9 
[??O] ???? [H?] + [OH?] Eq. 10 
[Ca??] = [?????] + [?????]  + [?????] Eq. 11 
[Ca??] = [?????] + [?????] [H?]???  + [?????]
[H?]???? ??? 
Eq. 12 
[Ca??] = [?????] ?1 + [??]???  + [??]???? ????   Eq. 13 
[Ca??]? = [Ca??][?????] ?1 + [??]???  + [??]???? ????   Eq. 14 
[Ca??]? = ??? ?1 + [??]???  + [??]???? ????   Eq. 15 
?? = ??? ?1 + [??]???  + [??]???? ????                                                              Eq. 2
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10.2. Supporting information Chapter 6 
 
 
Supporting Figure 6.1: Size-distribution of the native coacervate droplets at different 
complexation time points. The tail is located at the large diameter side of the curve, which 
suggests the coalescence grow mechanism. 
 
 
 
Supporting Figure 6.2: Zeta-potential of coacervates droplets at pH 9. The zeta-potential 
decreases with the increase of negatively charged PAA. 
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Supporting Figure 6.3: SEM, TEM and HAADF-STEM of fully mineralized microcarriers 
(a) and hollow capsules (b). 
 
 
 
 
Supporting Figure 6.4: Comparison of X-ray diffraction patterns of native, BSA and LSZ-
loaded microcarriers.    
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10.3. Supporting information Chapter 7 
Supporting Information 7.1: Composition of Hank’s balanced salt solution (HBSS). 
 
Ingredient  Concentration 
  NaCl   136.90 mM 
KCl    5.40 mM 
NaHCO3   4.26 mM 
Na2HPO4 7 H2O  0.34 mM 
KH2PO4   0.35 mM 
Glucose   5.50 mM 
 HEPES   10.00 mM 
CaCl2   1.26 mM 
MgCl2 6H2O     0.50 mM 
MgSO4 7H2O   0.40 mM 
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Supporting Information 7.2: Potentiometric titration of control (Millipore water), 
[CD]COOH 2.3 and [CD]COOH 0.5. For sample [CD]COOH 2.3, which carboxyl content is 11.6 
mM, the yield is around 0.005 g/L. The carboxyl concentration can be calculated by diving 
these two values and results in 2.3 mol/g. Sample  [CD]COOH 0.5, has the same 11.6 mM 
carboxyl content but much higher yield, 0.022 g/L, resulting in 0.5 mol/g [CD]COOH. The 
solid content was measured by evaporating 1 mL of CD dispersion at 70°C for 3 days and 
weighting the resultant particles. 
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Supporting information 7.3: Fluorescence intensity of RhB as a function of time. For 96h 
the fluorescence intensity remained constant without appreciable variation. 
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Supporting information 7.4: Quantum yield of both [CD]COOH 2.3 and 0.5 mol/g CDs in 
water when using DAPI as standard (~4%1). 
 
 
 
Supporting information 7.5: SEM of CD-CaCO3 synthesized at 1.4 g/L PAA. Very small 
nanoparticles (under 90 nm) are stabilized by the high polymer concentration, which hinders 
aggregation. 
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Supporting information 7.6: TEM micrographs as an overview of CD
with 15k and 100k g/mol PAA at 0.15 and 0.7 g/L of PAA. Samples were mineralized 
the [CD]COOH 2.3 g/mol. 
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Supporting information 7.7: Nitrogen adsorption-desorption of 0.3 and 0.7 g/L PAA 
samples. Pore size distribution calculated by BJH shows a monomodal (about 6 nm) 
distribution of pores. 
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Supporting information 7.8: XRD patterns of PAA-CD-CaCO3 immediately after 
synthesis and after 48 h. PAA concentration is 0.7 g/L. 
 
 
Supporting information 7.9: Evaluation of Ca2+-induced cytotoxicity assessed by means of 
LDH and MTT assay. 
 
Additional reference: (1) Li, M.; Wu, R. S.; Tsai, J. S. C. DAPI Derivative: A Fluorescent 
DNA Dye That Can Be Covalently Attached to Biomolecules. Bioorganic Med. Chem. Lett. 
2003, 13, 4351–4354.  
 
Chapter 10 
   
139 
 
10.4. Supporting information Chapter 8 
 
Supporting Figure 8.1: X-ray diffraction of calcite, amorphous, micrometer and sub-
micrometer vaterite particles immediately after synthesis. 
 
 
Supporting Figure 8.2: Nitrogen adsorption-desorption of calcite, amorphous, micrometer 
and sub-micrometer vaterite particles. Particles were dried for in absence of BSA overnight 
prior to the experiment. Inset: pore size distribution calculated by BJH. 
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Supporting Figure 8.3: X-ray diffraction of calcite, vaterite micrometer and vaterite sub-
micrometer particles after 96 hours incubation in DMEM. (a) bare particles in absence of 
BSA, (b) BSA-stabilized particles. 
 
 
 
 
Supporting Figure 8.4: Dissolution of calcite, micro- and sub-micrometer vaterite and 
amorphous particles upon serial dilution in aqueous medium. (a) BSA-stabilized particles 
dispersed in Millipore water pH 7. (b) Bare particles dispersed in DMEM pH 7.4.  
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Protocol live/dead: HOB cells were seeded onto 6-well cell culture plates at a 
density of 2x104 cells / mL in DMEM 10% FCS. After 24 h of incubation, the 
culture medium was replaced with 1 mL of BSA-stabilized particles with a particle 
concentration of 0.3 g/L in DMEM. After 24 h of incubation, the cells were 
washed with the PBS. A live/dead solution (5 mM Propidium Iodide (PI), 10 mM 
Hoechst 33342 in DMEM) was added and incubated for 15 min at 37 °C. The 
solution was removed and cells were washed twice with PBS. PI stains dead cells 
(red) while Hoechst live cells (blue). 
 
 
Supporting Figure 8.5: HOB cells stained with the live/dead assay kit after 24 hours 
incubation with calcite, amorphous, micrometer and sub-micrometer vaterite particles at 
particle concentration of 0.3 g/L. Left panel indicates the results obtained for positive 
control DMEM (incubation in DMEM without particles) and negative control PFA (fixation 
with paraformaldehyde, PFA). Live cells stained red by Hoechst and dead cells stained blue 
by propidium iodide (PI). 
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Protocol 2D staining:1 After exposure to CaCO3 particles, the HOB c
rinsed twice with PBS, fixed for 15 min at RT with 4% PFA in PBS. After the 
washing steps, the cells were permeabilized with 0.5 % Triton X-100 in PBS for 3 
min at RT. Fluorescent stain solution (DAPI 0.5 µg/mL, Phalloidin AF 488 10 
µg/mL in PBS) was added to the cells, incubated for 45 min and rinsed a few times 
prior the microscopy. Positive control DMEM – cells incubation in 
the absence of particles. Negative control Triton – cells were incubated with 
Supporting Figure 8.6: (a) 2D staining of HOB cells after 24 hours incubation with calcite, 
amorphous, micrometer and sub-micrometer vaterite particles at 0.3 g/L. (b) Controls: 
DMEM (positive control, incubation in DMEM without particles), Triton 
cells treated with Triton X-100, 0.5%), high calcium levels (8 mM CaCl
levels (1.9 g/L PAA).  
 
Supporting Figure 8.7: TEM of biological samples incubated in absence of particles for 
24 h. Right panel is a high magnification image from selected area on left panel. Labels: C 
cytosol, M - mitochondrion.  
ells were 
DMEM and in 
triton. 
 
(negative control, 
2) and high PAA 
– 
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Protocol for intracellular calcium imaging with Fluo-3AM:2 After exposure to 
CaCO3, intracellular Ca2+ was observed by fluorescence microscopy using Fluo 3-
AM (1 mM in DMSO, ≥ 99.0 %, Sigma-Aldrich). A staining solution (10 µM Fluo 
3-AM, 0.17 g/L Pluronic F127 (BioReagent, Sigma-Aldrich)) was added to the 
cells and incubated at 37 °C for 20 min. After incubation, DMEM 10% FCS was 
added to cells at the same volume as the staining solution, and incubated for 1 h at 
37 °C. The cells were then washed once with PBS and observed at the microscope 
at Excitation 495 nm - Emission 519 nm. Control DMEM: absence of particles. 
Control Calcium 2 mM: DMEM supplemented with 2 mM Ca2+.  
 
Supporting figure 8.8: Fluo-3AM imaging of intracellular calcium of HOB cells after 24 
hours incubation with calcite, amorphous, micrometer and sub-micrometer vaterite particles 
at 0.3 g/L. Control DMEM: tested with DMEM in absence of particles. Control Calcium 
2 mM: DMEM supplemented with 2 mM of calcium chloride. 
Additional references: 
1) S. Shahabi, S. Döscher, T. Bollhorst, L. Treccani, M. Maas, R. Dringen, K. Rezwan, 
Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles 
via Surface Functionalization: Effects of Serum, ACS Appl. Mater. Interfaces. 7 (2015) 
26880–26891.  
2) M. Horie, K. Nishio, H. Kato, S. Endoh, K. Fujita, A. Nakamura, S. Kinugasa, Y. 
Hagihara, Y. Yoshida, H. Iwahashi, Evaluation of cellular influences caused by calcium 
carbonate nanoparticles, Chem. Biol. Interact. 210 (2014) 64–76. 
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